[
    {
        "pmid": "40822640",
        "title": "Mapping antimicrobial susceptibility of community-acquired uropathogenic Escherichia coli across low, middle and high-income countries highlights significant differences: insights for empiric treatment.",
        "abstract": "Rising antimicrobial resistance AMR iEscherichia colii urinary tract infection UTI pose global challenge Evidencebased treatment cystitis requires local resistance data DASH Protect Antibiotics httpsdashuticom multiregional group support center generating sharing focused antibiograms guide stewardship community UTIs multicountry study aimed describe antimicrobial susceptibility pattern communityacquired iE colii isolates low middle highincome country LMICs HICs study conducted 37 representative center across 13 country Asia Middle East Indian Subcontinent Africa Europe North America rigorous comparative analysis antimicrobial susceptibility iE colii isolated case simple cystitis presenting outpatient emergency department carried out impact gross domestic product climate population density per kmsup2sup iE colii susceptibility profile analyzed using KruskalWallis test twoway analysis variance Antimicrobial susceptibility varied significantly LMICs HICs nitrofurantoin 89 fosfomycin 96 emerging empiric choice globally Across centers susceptibility oral antimicrobial low cotrimoxazole 60 amoxicillinclavulanic acid 70 firstgeneration cephalosporin 50 fluoroquinolones 60 Injectable antibiotic fared better piperacillintazobactam 70 amikacin meropenem 80 Higher susceptibility noted country high gross domestic product iPi  0001 humidity iPi  0002 Marked geographical difference iE colii susceptibility pattern support need localized antibiograms tailored empirical therapy study reinforces utility nitrofurantoin fosfomycin firstline agent discourages use fluoroquinolones thirdgeneration cephalosporins",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40822640/"
    },
    {
        "pmid": "40819493",
        "title": "Precision oncology informatics for anticancer drug combination responses: A systematic review.",
        "abstract": "Drug combination therapy cancer promising approach precision oncology recent literature anticancer drug combination ADC estimated derived independent drug response efficacy Synergistic drug combination response effective drug therapy various cancer treatments However ADC identification problem challenging practically infeasible exhaustively screen experimentally extensive ADCs Therefore computational approach efficiently used measure identify drug combination response precision oncology recent decades numerous computational approach applied proposed predict response clinical ADC using different pharmacological multiomics cancer data Effective computational tool approach needed predict measure ADC address challenges reduce complexity reviewed stateoftheart computational method ADC prediction recent decade review paper provided overview synergistic ADC response computational machinelearning approach ADC critical discussion advantage limitation also provided Moreover reviewed recent existing drug combination resource ADC response prediction found influential computational method anticancer drug combination response Finally compared different computational approach using benchmark data ADC response discussed experimental results limitations future direction ADC response precision oncology",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40819493/"
    },
    {
        "pmid": "40812962",
        "title": "Implementing lifestyle interventions in mental health care: third report of the Lancet Psychiatry Physical Health Commission.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812962/"
    },
    {
        "pmid": "40805183",
        "title": "Cancer-Associated Fibroblasts: Immunosuppressive Crosstalk with Tumor-Infiltrating Immune Cells and Implications for Therapeutic Resistance.",
        "abstract": "Cancer longer considered isolated event Rather occurs complex biological drive orchestrating different cell types growth factors cytokines signaling pathway within tumor microenvironment TME Cancerassociated fibroblast CAFs populous stromal cell within complex ecosystem TME significant heterogeneity plasticity origin functional phenotypes enigmatic cells CAFs determine progress outcome tumor extensive reciprocal signaling different tumor infiltrating immune cell TME biological drive CAFs release numerous chemical mediator utilize various signaling pathway recruit modulate tumorinfiltrating immune cells CAFinduced secretome exosomes render immune cell ineffective antitumor activities Moreover upregulating immune inhibitory checkpoints CAFs create immunosuppressive TME impedes susceptibility tumor cell tumorinfiltrating lymphocyte TILs Further depositing remodeling extracellular matrix ECM CAFs reshape TME enhances tumor growth invasion metastasis chemoresistance Understanding CAF biology crosstalk tumorinfiltrating immune cell crucial gain insight tumorigenesis optimize potential novel targeted immunotherapy cancers complex relationship CAFs tumorinfiltrating immune cell remain unclear need study Herein narrative review focused update CAF biology interaction tumorinfiltrating immune cell generating immunosuppressive TME resistance cell death",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40805183/"
    },
    {
        "pmid": "40798885",
        "title": "Validation of the Korean Version of the Anxiety and Preoccupation About Sleep Questionnaire and Comparisons With Other Sleep-Related Cognition Scales Among the General Population.",
        "abstract": "developed Koreanlanguage version Anxiety Preoccupation Sleep Questionnaire APSQ assessed reliability validity among general population comparing result preexisting questionnaire regarding sleeprelated cognition study participant n300 completed newly translated APSQ well Korean version Dysfunctional Beliefs Attitudes Sleep16 item DBAS16 Scale Metacognitions QuestionnaireInsomnia14 item MCQI14 Glasgow Sleep Effort Scale GSES Insomnia Severity Index ISI online platform accessible 1727 July 2023 confirmatory factor analysis APSQ revealed good fit fullscale twofactor models consistent original version Korean version APSQ also demonstrated good internal consistency showing Cronbachs alpha value 0965 full scale 0954 factor I 0928 factor II addition fullscale APSQ subscales demonstrated good convergent validity ISI DBAS16 MCQI14 GSES evidenced strong correlation corresponding scores scale information curve revealed APSQ provided information latent trait worry regarding sleep sleep measures APSQ scale two subscales valid tool measuring sleeprelated worry among general South Korean population Additional study specific clinical group required confirm scope applicability utility treatment insomnia",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40798885/"
    },
    {
        "pmid": "40789079",
        "title": "Radiometric study and associated radiological hazards in soil near the Bheramara 410 MW Combined Cycle Power Plant, Kushtia, Bangladesh.",
        "abstract": "pioneering study assesses radiological risk naturally occurring radionuclides soil around Bheramara 410 MW Combined Cycle Power Plant natural gas highspeed diesel Kushtia Bangladesh Thirty soil sample collected radial distance 50 m 500 m 1000 m 3000 plant distance strategically selected represent immediate proximity 50 m nearfield 500 m midrange 1000 m farfield 3000 m zones enabling gradient analysis potential radiological impact Using highpurity germanium HPGe gammaray spectrometry activity concentration sup226supRa sup232supTh sup40supK found range 20 ± 2 28 ± 3 Bqkg 25 ± 2 41 ± 4 Bqkg 310 ± 21 440 ± 34 Bqkg respectively sup226supRa concentration global average 30 Bqkg measured value sup232supTh exceeded global average 35 Bqkg sup40supK concentration certain sample higher global average 400 Bqkg detectable sup137supCs observed confirming artificial contamination Radiological hazard index radium equivalent activity mean 10060 Bqkg outdoor absorbed dose rate mean 4856 nGyh outdoor annual effective dose mean 006 mSvyear external hazard index mean 027 gamma representative level index mean 074 excess lifetime cancer risk mean 022 × 10sup3sup within recommended safety limits Various statistical analyses including descriptive statistics Pearson correlation principal component analysis PCA hierarchical cluster analysis HCA performed revealed sup226supRa sup232supTh main contributor radiological risk sup40supK showed weaker associations finding suggest soil safe agricultural construction use routine monitoring recommended ensure environmental protection study provides essential baseline data analytical insight radiological risk management power generation industrial region Bangladesh",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40789079/"
    },
    {
        "pmid": "40787574",
        "title": "Demographic and racial disparities in small-cell lung carcinoma: trends in diagnosis to treatment time, chemoradiotherapy seeking, and incidence rates-A SEER database analysis (2000-2021) with Bayesian multilevel regression modeling.",
        "abstract": "Small celllung carcinoma SCLC aggressive cancer poor prognosis influenced demographic factor race sex age Racial demographic disparity SCLC incidence treatment outcome evident minority experiencing higher incidence rates Understanding disparity essential addressing healthcare inequities study analyzed 243 825 SCLC case Surveillance Epidemiology End Results database 20002021 examining demographic variable age sex race effect treatmentseeking behavior treatment delay using Bayesian multilevel regression modeling cohort consisted 482 male 518 females racial composition 351 White 255 Black 225 AsianPacific Islander 169 American IndianAlaska Native American IndianAlaska Native individual higher incidence SCLC β  647 95 CI 526769 iPi  00001 followed White β  485 95 CI 386584 iPi  00001 Black β  415 95 CI 312517 iPi  00001 patient compared AsianPacific Islander patients significant racial disparity observed chemotherapy χsup2sup  084 df  6 iPi  09909 radiotherapy χsup2sup  1475 df  27 iPi  09728 time treatment initiation χsup2sup  1236 df  9 iPi  01938 Bayesian regression model confirmed higher SCLC incidence older age group 7074 years β  962 95 CrI 177 1771 7579 years β  1287 95 CrI 506 2099 8084 years β  1280 95 CrI 503 2089 85  years β  816 95 CrI 038 1624 male β  377 95 CrI 337 417 Rsubhatsub  100 compared females study highlight significant racial demographic disparity SCLC incidence particularly among minority populations treatmentseeking behavior delay exhibit significant racial differences age sex critical factor influencing SCLC incidence",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40787574/"
    },
    {
        "pmid": "40786828",
        "title": "Contraceptive Use Patterns and Associated Determinants in a Rural Population of Narayanganj District, Bangladesh.",
        "abstract": "Contraceptive use pattern rural community shaped complex interplay social economic factors Bangladesh significant disparity birth control use rural urban areas study aim explore patterns practices barrier contraceptive use rural community goal bridging gap promoting sustainable development study combined quantitative qualitative method explore contraceptive use rural Bangladesh community involved crosssectional survey assess pattern perception contraceptive use followed focus group discussion FGDs explore practice barrier within community study involved 100 married couple rural Bangladeshi community 69 reporting contraceptive use contraceptive user 812 women oral pill common method Decisions regarding family size typically made husband 63 FGDs revealed husband seen primary decisionmakers whereas wife responsible contraception Barriers included lack sex education fear side effects noncooperation husbands woman feeling dependent husband obtain contraceptives finding highlight significant cultural gendered factor affecting contraceptive use rural communities study highlight social economic demographic factor shape contraceptive use rural Bangladesh challenge stress need genderinclusive culturally tailored intervention improve contraceptive use empower rural communities",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40786828/"
    },
    {
        "pmid": "40780251",
        "title": "Enhancing B-mode-based breast cancer diagnosis via cross-attention fusion of H-scan and Nakagami imaging with multi-CAM-QUS-driven XAI.",
        "abstract": "Bmode ultrasound widely employed breast lesion diagnosis due affordability widespread availability effectiveness particularly case dense breast tissue mammography may less sensitive However disregard critical tissue information embedded raw radiofrequency RF data modality demonstrated promise ComputerAided Diagnosis CAD combined potential remains largely unexploredxDApproachThis paper present automated breast lesion classification network utilizes Hscan Nakagami parametric image derived RF ultrasound signals combined machinegenerated Bmode images seamlessly integrated Multi Modal Cross Attention Fusion MMCAF mechanism extract complementary information proposed architecture also incorporates attentionguided modified InceptionV3 feature extraction KnowledgeGuided CrossModality Learning KGCML module inter‑modal knowledge sharing AttentionDriven Context Enhancement ADCE module improve contextual understanding fusion classification network network employ categorical crossentropy loss MultiCAMbased loss guide learning toward accurate lesionspecific features MultiQUSbased loss embed clinically meaningful domain knowledge effectively distinguishing benign malignant lesions supporting explainable AI XAI principlesxDMain results Experiments conducted multicenter breast ultrasound datasetsBUETBUSD ATL OASBUDcharacterized demographic diversity demonstrate effectiveness proposed approach achieving classification accuracy 9254 8993 900 respectively along high interpretability trustworthiness result surpass existing method based Bmode andor RF data highlighting superior performance robustness proposed technique integrating complementary RF‑derived information B‑mode imaging pseudo‑segmentation domain‑informed loss functions method significantly boost lesion classification accuracyenabling fully automated explainable CAD paving way widespread clinical adoption AI‑driven breast screening",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40780251/"
    },
    {
        "pmid": "40760471",
        "title": "The research progress on diagnostic indicators related to prostate-specific antigen gray-zone prostate cancer.",
        "abstract": "review offer distinctive perspective integrating critically evaluating latest advancement noninvasive biomarkers ProstateSpecific Antigen PSA grayzone prostate cancer synthesizing data Prostate Health Index PHI Prostate Cancer Antigen 3 PCA3 Transmembrane Protease Serine 2ETSrelated Gene fusion TMPRSS2ERG fusion gene proteomics microRNA miRNAs work highlight potential enhance diagnostic precision minimizing unnecessary biopsies Furthermore review explores clinical applicability biomarkers bridging gap research innovation realworld diagnostic strategiesThe primary objective review analyze emerging biomarkers clinical indicator address inherent diagnostic uncertainty within PSA gray zone 410 ngmLGiven overlap benign malignant condition range traditional PSAbased screening lack specificity often leading overdiagnosis overtreatmentThis review critically examines diagnostic performance free PSAtotal PSA fPSAtPSA ratio Prostate Health Index PHI molecular marker PCA3 TMPRSS2ERG fusion genesAdditionally discus integration proteomic miRNAbased approaches emphasizing potential role refining risk stratification advancing noninvasive prostate cancer diagnostics systematic review conducted focusing peerreviewed research database PubMed MEDLINE othersThe study included reported diagnostic accuracy sensitivity specificity clinical outcome biomarkers associated PSA grayzone prostate cancerThe inclusion criterion emphasized study evaluated human subject presented measurable diagnostic outcome related fPSAtPSA ratio PHI PCA3 TMPRSS2ERG additional proteinbased biomarkers finding reveal fPSAtPSA ratio enhances diagnostic sensitivity specificity making valuable tool within PSA gray zonePHI demonstrates superior diagnostic accuracy compared traditional marker like tPSAMolecular markers PCA3 TMPRSS2ERG fusion genes show considerable potential distinguishing benign malignant conditions effectively reducing need unnecessary biopsiesAdditionally proteomics glycoprotein biomarkers offer noninvasive diagnostic possibilities although validation necessary confirm efficacy Incorporating multiple biomarkers including fPSAtPSA ratio PHI PCA3 TMPRSS2ERG present accurate patientfriendly approach diagnosing PSA grayzone prostate cancerThis multimarker strategy enhances diagnostic precision reduces biopsy rates support early detection aggressive disease forms representing significant step forward prostate cancer management prognosis",
        "mesh_terms": [
            "Humans",
            "Male",
            "Prostatic Neoplasms",
            "Prostate-Specific Antigen",
            "Biomarkers, Tumor",
            "Oncogene Proteins, Fusion",
            "MicroRNAs",
            "Proteomics",
            "Early Detection of Cancer",
            "Antigens, Neoplasm"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760471/"
    },
    {
        "pmid": "40760406",
        "title": "Cancer-specific Regulation of Metabolic and Epigenetic Pathways by Dietary Phytochemicals.",
        "abstract": "Cancer complex disease triggered combination genetic mutations metabolic reprogramming epigenetic modifications environmental factors one leading health burden worldwide Dietary phytochemical effective reducing incidence cancer regulating epigenetic metabolic pathway possess great potential cancer prevention treatment review aim summarize relevant metabolic epigenetic change cancer recent research progress mechanism study dietary phytochemical regulating key pathway provides new insight research searched relevant literature searching common databases PubMed Medline ScienceDirect Google Scholar Web Science summarized anticancer effect potential dietary phytochemical regulating epigenetic metabolic pathway common cancers colorectal cancer prostate cancer lung cancer skin cancer breast cancer Natural phytochemical regulate key pathways DNA methylation histone modifications oxidative stress inflammation metabolic reprogramming also demonstrate multitargeted intervention tumor therapy inducing apoptosis inhibiting cell proliferation angiogenesis metastasis Additionally potential dietary phytochemical reverse metabolic epigenetic change make promising adjunctive alternative therapies Phytochemicals exhibit significant effect cancer prevention treatment targeting metabolic epigenetic regulatory networks Future research explore mechanisms clinical translational value synergistic effect traditional therapy provide theoretical foundation practical guidance developing new cancer intervention strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760406/"
    },
    {
        "pmid": "40757093",
        "title": "Spotlighting healthcare frontline workers´ perceptions on artificial intelligence across the globe.",
        "abstract": "sought define healthcare workers HCW view integration generative artificial intelligence AI healthcare delivery explore associated challenges opportunities ethical consideration low middleincome country LMICs analysed unified data selected 2023 Gates Foundation AI Grand Challenges project using mixedmethods crosssectional survey evaluated international panel across eight countries Perceptions rated simplified threepoint Likert scale sceptical practical enthusiastic Among 191 frontline HCWs interacted AI tools 617 response assessed nine evaluators Enthusiastic response accounted majority 754 216 practical 30 sceptical overall interclass correlation coefficient 093 95CI 091094 average rating iki  9 indicated excellent interrater reliability quantitative data underscored generally positive attitude towards AI qualitative finding revealed recurring cultural linguistic barrier ethical concerns unique study analysing data first application generative AI health LMICs finding offer early insight generative AI implementation LMIC healthcare setting highlight transformative potential need careful policy contextual adaptation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757093/"
    },
    {
        "pmid": "40756695",
        "title": "Off-label use of Avastin in Pakistan: Lessons from the 2023 Punjab outbreak.",
        "abstract": "Offlabel drug use involves prescribing medication beyond approved indication dosages common country like Pakistan regulatory oversight limited Avastin Bevacizumab originally approved cancer treatment widely used offlabel ophthalmology treat condition diabetic retinopathy due antiVEGF effect lower cost compared approved alternative like Ranibizumab However intravitreal use requires strict sterility compounding standards 2023 outbreak vision loss occurred Punjab Pakistan affecting 66 patient following intravitreal Avastin injections Investigations linked incident contamination caused improper repackaging handling outside sterile conditions revealing significant gap regulatory enforcement clinical safety protocols outbreak highlight urgent need clear national guidelines strict compounding practices informed consent ensure patient safety Although Avastin remains valuable ophthalmic use safe administration depends rigorous quality control Lessons incident guide effort improve drug safety prevent future adverse events",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40756695/"
    },
    {
        "pmid": "40750539",
        "title": "Exosome: The hidden messengers in cancer detection and immunotherapy.",
        "abstract": "Cancer continues pose significant global health challenge driving need innovative approach early detection treatment management Exosomes small extracellular vesicle secreted various cell types play pivotal role intercellular communication transferring molecular cargo donor recipient cells emerged key player cancer progression therapy Exosomes contribute tumor growth mediating immune suppression drug resistance metastasis Yet distinctive property also present valuable tool cancer diagnosis Tumorderived exosomes abundant body fluids promising candidate liquid biopsies offering noninvasive biomarkers aid cancer detection prognosis realtime monitoring disease progression Beyond diagnostics exosomes forefront cancer immunotherapy particularly developing exosomebased vaccine targeted therapies capacity deliver molecular cargo directly cancer immune cell allows personalized highly effective cancer treatments review explores current understanding exosomes cancer biology underscore emerging diagnostic potential examines transformative role advancing future cancer immunotherapy strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750539/"
    },
    {
        "pmid": "40747150",
        "title": "Comparative efficacy and safety of two radiotherapy protocols for ovarian ablation in patients with metastatic breast cancer.",
        "abstract": "present study aimed evaluate efficacy safety radiotherapy RT ovarian ablation OA patient metastatic breast cancer comparing two RT protocols 15 Gy 5 fraction arm A vs 20 Gy 10 fraction arm B purpose present study enrolled 68 patients divided equally two study arms patient followedup 24 week postintervention primary endpoint efficacy RT inducing OA assessed amenorrhea hormone level folliclestimulating hormone FSH estradiol Toxicities evaluated using Common Toxicity Criteria Adverse Events version 50 postmenopausal symptom assessed using Menopause Rating Scale result revealed significant difference two study arm A vs B rate amenorrhea development persistence 857 vs 895 achievement postmenopausal estradiol 912 vs 941 FSH level 794 vs 882 regimen led significant reduction estradiol level increase FSH level compared baseline levels grade ≥3 toxicity observed Common postmenopausal symptom included hot flush irritability significant difference groups whole present study demonstrates RT regimen effective safe OA patient metastatic breast cancer significant difference efficacy toxicity finding particularly relevant resourcelimited settings underscoring potential flexible shorter treatment regimen environment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40747150/"
    },
    {
        "pmid": "40745032",
        "title": "Assessment of groundwater quality and potential health risks related to heavy metals in a peri-urban area of a developing country.",
        "abstract": "Little information available general groundwater quality Bangladeshs Ishwardi Upazila periurban area current study 35 groundwater sample collected randomly chosen deep tube well determine general quality groundwater water quality index whether fit human consumption Estimating pH EC TDS concentration HCOsub3subsupsup Clsupsup Fe Mn As NOsub3subsupsup POsub4subsup3sup Zn Cu used assess groundwater quality Using atomic absorption spectroscopy AAS Fe Mn Cu Zn concentration determined HCOsub3sub Fe Mn concentration exceeded Bangladesh drinking water standard BDWS drinking requirement 100 23 54 samples respectively According water quality indicator 83 groundwater sample study area unfit human consumption hazard index HI hazard quotient HQ also used measure noncarcinogenic health concern associated groundwater drinking oral intake people may exposed intolerable noncarcinogenic health risk periurban region approximately 91 sample exceeded allowable level HI Additionally resident may unfavorable risk cancer due arsenic approximately 97 water sample level permissible limits Multivariate statistical analysis cluster principal component analysis indicated inappropriate waste disposal industrial discharge Ishwardi export processing zone EPZ agricultural runoff potential source contaminant groundwater study finding provide information policymakers addressing groundwater pollution periurban area Bangladesh ensure sound health socioeconomic development study area Bangladesh",
        "mesh_terms": [
            "Groundwater",
            "Metals, Heavy",
            "Developing Countries",
            "Bangladesh",
            "Drinking Water",
            "Humans",
            "Risk Assessment",
            "Cities"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40745032/"
    },
    {
        "pmid": "40742520",
        "title": "Genetically Modified Lactic Acid Bacteria: a Promising Mucosal Delivery Vector for Vaccines.",
        "abstract": "advent mucosal vaccine target primary entry point many pathogen revolutionized field immunology Genetically modified lactic acid bacteria gmLAB include genus Lactobacillus Bifidobacterium emerged promising vector delivering antigen mucosal surfaces grampositive nonpathogenic microorganism exhibit inherent probiotic properties survive gastrointestinal tract efficiently interact host immune system Advances genetic engineering enabled expression wide range antigen gmLAB promote systemic mucosal immunity Studies demonstrated gmLABbased mucosal vaccine elicit mucosal systemic immune responses providing protective immunity specific pathogenic infections addition gmLAB vector offer good safety profiles stability costeffective production compared traditional vaccine platforms Recent study demonstrated potential LAB vaccine preventing infection caused viral bacterial parasitic pathogen immunotherapy treating allergy cancers review highlight mechanism underlying gmLABbased mucosal vaccine delivery current advancements challenges prospect recombinant mucosal vaccines",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40742520/"
    },
    {
        "pmid": "40738921",
        "title": "In silico exploration of anticancer plant phytochemicals for EGFR-targeted lung cancer therapy.",
        "abstract": "Mutations epidermal growth factor receptor EGFR particularly tyrosine kinase domain exon 19 deletion L858R point mutation play critical role development nonsmall cell lung cancer NSCLC EGFR wellestablished therapeutic target management NSCLC study targeted mutated EGFR kinase domain L858R using crystal structure PDB ID 2EB3 design EGFR tyrosine kinase inhibitors curated library 687 phytoconstituents four anticancer plant Camellia sinensis Curcuma longa Ginkgo biloba Vitis vinifera using IMPPAT database Kaempferol morin isorhamnetin Ginkgo biloba emerged promising candidates Druglikeness ADMET analysis performed evaluate pharmacokinetic safety profile compounds Pharmacophore modeling bioactivity score analysis also conducted Finally molecular dynamic MD simulation performed assess stability EGFRligand complexes docking study revealed high binding energy kaempferol  85 kcalmol morin  85 kcalmol isorhamnetin  87 kcalmol ATPbinding site EGFR compared reference drug erlotinib  7 kcalmol compound exhibited superior pharmacokinetic properties including high gastrointestinal absorption noninhibition Pglycoprotein activity unlike erlotinib Toxicity prediction showed mild immunotoxicity morin isorhamnetin compound demonstrating hepatotoxicity inhibition CYP3A4 CYP2D6 enzymes Structural analysis highlighted hydroxyl group selected compound key hydrogen bond Hbond formation EGFR residues enhancing inhibitory potential MD simulation confirmed stability EGFR complex selected compounds showing lower average RMSD value better convergence compared EGFRerlotinib complex research underscore potential kaempferol morin isorhamnetin novel EGFR inhibitor derived Ginkgo biloba NSCLC treatment compound demonstrated strong binding affinities favorable pharmacokinetic properties stability silico vitro vivo validation necessary confirm efficacy mutated EGFR NSCLC",
        "mesh_terms": [
            "ErbB Receptors",
            "Humans",
            "Lung Neoplasms",
            "Molecular Docking Simulation",
            "Phytochemicals",
            "Molecular Dynamics Simulation",
            "Protein Kinase Inhibitors",
            "Carcinoma, Non-Small-Cell Lung",
            "Antineoplastic Agents, Phytogenic",
            "Kaempferols",
            "Computer Simulation",
            "Mutation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40738921/"
    },
    {
        "pmid": "40736027",
        "title": "Evaluating the Role of PD1 and MTNR1B Gene Variants in Breast Cancer Susceptibility: A Case-Control Study in Bangladesh.",
        "abstract": "Breast cancer one common malignancy women PD1 MTNR1B gene polymorphism extensively studied potential role cancer susceptibility study aimed investigate association breast cancer risk PD1 rs36084323 MTNR1B rs10830963 polymorphisms casecontrol study conducted 112 breast cancer patient Dhaka Cancer General Hospital Bangladesh 124 age sexmatched healthy controls Genotyping PD1 rs36084323 MTNR1B rs10830963 polymorphism performed using Polymerase Chain ReactionRestriction Fragment Length Polymorphism PCRRFLP method genotype distribution SNPs adhered HardyWeinberg equilibrium HWE PD1 GG genotype prevalent controls indicating protective effect whereas GG genotype MTNR1B showed statistically significant association breast cancer risk recessive model PD1 GG vs AG  AA demonstrated lower odds ratio 02873 recessive model MTNR1B 2307 suggested potential risk Dominant model gene AG  GG vs AA PD1 CG  GG vs CC MTNR1B showed statistically significant association breast cancer susceptibility PD1 GG genotype exhibited significant protective effect breast cancer MTNR1B CG genotype associated reduced risk GG showed correlation Larger study across diverse population recommended validate findings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40736027/"
    },
    {
        "pmid": "40735254",
        "title": "A Case-Control Study on the Association Between <i>MMP2</i> and <i>MMP9</i> Genetic Polymorphisms and Breast Cancer.",
        "abstract": "Matrix metalloproteinase 2 MMP2 MMP9 associated degradation type IV collagen leading invasion metastasis Polymorphisms gene could influence biological activity contribute cancer development progression study evaluated relationship iMMP2i rs2285053 iMMP9i rs3787268 gene polymorphism susceptibility breast cancer Bangladeshi breast cancer patients casecontrol study included 105 female diagnosed breast cancer 108 healthy controls Following DNA extraction blood samples genotyping carried tetraprimer amplification refractory mutation systempolymerase chain ARMSPCR reaction gel electrophoresis case rs2285053 polymorphism CT genotype OR  212 95 CI  103436 dominant model OR  221 95 CI  108452 overdominant model OR  210 95 CI  102431 allele OR  213 CI  108418 significantly associated increased breast cancer risk rs3787268 polymorphism additive model 1 OR  020 95 CI  005078 additive model 2 OR  023 95 CI  006086 dominant model OR  022 CI  006081 significantly decreased breast cancer risk population result conclude iMMP2i rs2285053 associated increased risk breast cancer iMMP9i rs3787268 polymorphism may correlated reduced risk breast cancer Bangladeshi females Future study warranted validate finding populations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40735254/"
    },
    {
        "pmid": "40731088",
        "title": "A systematic nomenclature for mpox viruses causing outbreaks with sustained human-to-human transmission.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40731088/"
    },
    {
        "pmid": "40731006",
        "title": "High-risk human papillomavirus testing for underscreened populations: cost-effectiveness and affordability in three country settings.",
        "abstract": "highrisk human papillomavirus hrHPVbased screening recommended World Health Organization expected lead worldwide reduction cervical cancer burden country burdened cervical cancer also struggle cost transitioning approach Countryspecific evaluation needed inform policymakers implementation hrHPVbased screening setting Following initial implementation Uganda Bangladesh Slovakia focused underscreened woman PRESCRIPTEC project investigated potential costeffectiveness affordability hrHPVbased screening strategies Countryspecific modelbased costeffectiveness budget impact analysis conducted three countries comparing PRESCRIPTEC strategy existing screening strategy setting Data initial project implementation informed relevant model parameters PRESCRIPTEC strategy resulted disabilityadjusted life year DALY gain three countries cervical cancer incidence rate reduced third Uganda 15 Bangladesh 11 Slovakia incremental costeffectiveness ratio UGX 056 million per DALY Uganda I 475 BDT 76 thousand per DALY Bangladesh I 1698 EUR 1782 I 3637 per DALY Slovakia Substantial additional funding required enable implementation particularly relation initial startup costs provided estimate serve inform policymakers researcher context implementing hrHPVbased screening diverse settings",
        "mesh_terms": [
            "Humans",
            "Cost-Benefit Analysis",
            "Female",
            "Uganda",
            "Uterine Cervical Neoplasms",
            "Bangladesh",
            "Papillomavirus Infections",
            "Slovakia",
            "Mass Screening",
            "Adult",
            "Disability-Adjusted Life Years",
            "Early Detection of Cancer",
            "Middle Aged",
            "Human Papillomavirus Viruses"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40731006/"
    },
    {
        "pmid": "40727248",
        "title": "Exploring the Epigenetic and Metabolic Pathways for Antioxidant and Anti-Inflammatory Potentials of Tart Cherry Juice Concentrate.",
        "abstract": "Tart cherry TC iPrunus cerasusi high antioxidant antiinflammatory potential due rich bioactive component like anthocyanins polyphenols vitamins betacarotene ellagic acid chlorogenic acid Oxidative damage inflammation underlying reason chronic disease pathogenesis Oxidative stress usually caused imbalance antioxidant prooxidants Additionally chronic inflammatory state typically modulated oxidative stress Inflammation play critical role chronic health conditions cardiovascular diseases hypertension insulin resistance arthritis cancer Numerous study indicate strong relationship TC inhibition inflammation oxidative damage regulating different epigenetic metabolic pathways review recent development TC component metabolite inflammatory oxidative damage discussed challenge limitation better support future research including clinical trial confirm findings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40727248/"
    },
    {
        "pmid": "40725000",
        "title": "In Silico Evaluation of Quinolone-Triazole and Conazole-Triazole Hybrids as Promising Antimicrobial and Anticancer Agents.",
        "abstract": "Cancer remains one leading cause death globally highlighting urgent need novel anticancer therapy higher efficacy reduced toxicity Similarly rise multidrugresistant pathogen emerging infectious disease underscore critical demand new antimicrobial agent target resistant infection unique mechanisms study used computational approach investigate twenty quinolonetriazole conazoletriazole hybrid derivative antimicrobial anticancer agent b1bb20b nine reference drugs studying interaction 6 bacterial DNA gyrase 10 cancerinducing target protein iE faecalisi iM tuberculosisi iS aureusi iE colii iM smegmatisi iP aeruginosai EGFR MPO VEGFR CDK6 MMP1 Bcl2 LSD1 HDAC6 Aromatase ALOX15 comparing established drug ampicillin cefatrizine fluconazole gemcitabine itraconazole ribavirin rufinamide streptomycin tazobactam compound b15b b16b emerged noteworthy antimicrobial anticancer agents respectively molecular dynamic simulations compound b15b b16b strongest binding 106 kcal molsup1sup 120 kcal molsup1sup crucial 5CDQ 2Z3Y proteins respectively exceeded druglikeness criteria displayed extraordinary stability within enzymes pocket varied temperature 300320 K addition used density functional theory DFT calculate dipole moment molecular orbital characteristic analyze thermodynamic stability putative antimicrobial anticancer derivatives finding reveals welldefined possibly therapeutic relationship supported theoretical future vitro vivo studies Compounds b15b b16b thus emerged intriguing contender fight infectious disease cancer",
        "mesh_terms": [
            "Triazoles",
            "Antineoplastic Agents",
            "Molecular Dynamics Simulation",
            "Quinolones",
            "Molecular Docking Simulation",
            "Humans",
            "Anti-Infective Agents",
            "Microbial Sensitivity Tests",
            "Computer Simulation",
            "DNA Gyrase"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40725000/"
    },
    {
        "pmid": "40724637",
        "title": "Automatic Fracture Detection Convolutional Neural Network with Multiple Attention Blocks Using Multi-Region X-Ray Data.",
        "abstract": "Accurate detection fracture Xray image important initiate appropriate medical treatment timein study advanced combined attention CNN model multiple attention mechanism developed improve fracture detection deeply representing features Specifically model incorporates squeeze block convolutional block attention module CBAM block improve models ability focus relevant feature Xray images Using computed tomography Xray images study assesses diagnostic efficacy artificial intelligence AI model optimization compare performance detecting fracture not training evaluation dataset consists fractured nonfractured Xrays various anatomical locations including hips knees lumbar region lower limb upper limb give extremely high training accuracy 9998 validation accuracy 9672 attentionbased CNN thus showcase role medical image analysis aspect complement point highlighted research establish role attention CNN architecturebased model achieve desired score fracture medical image allowing model generalize study represents first step improve fracture detection automatically also brings solid support doctor addressing continued time examination also increase accuracy diagnosing fractures improving patients outcome significantly",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40724637/"
    },
    {
        "pmid": "40721470",
        "title": "Genetic and computational analysis of AKR1C4 gene rs17134592 polymorphism in breast cancer among the Bangladeshi population.",
        "abstract": "Breast cancer characterized unchecked proliferation breast cells Variations metabolism steroid hormone influence risk disease modifying concentration potency hormones enzyme AKR1C4 primarily found liver crucial regulating hormone level bloodstream research examined relationship polymorphic variant rs17134592 AKR1C4 gene susceptibility breast cancer among Bangladeshi population casecontrol study conducted 310 breast cancer patient 310 healthy individual Bangladesh DNA extracted using organic process followed genotyping PCRRFLP technique validate accuracy genotyping results subset PCR product randomly selected confirmed using Sanger sequencing Statistical assessment conducted analyze association polymorphism molecular dynamic simulation diverse computational method employed predict structural functional impact SNP result indicate rs17134592 AKR1C4 gene linked heightened risk breast cancer p  00001  339 95 CI  180 650 GG genotype additive model 2 recessive model GG vs CC  CG also showed enhanced risk susceptibility breast malignancy p  00001  325 95 CI  178 608 subgroup postmenopausal women risk developing breast cancer significantly higher carrier GG genotype relative risk 402 392 additive model 2 recessive model respectively However significant correlation observed genotype tumor grade size breast cancer patients Computational analysis suggested L311V mutation rs17134592 could potentially reduce stability protein Additionally molecular dynamic simulation indicated L311V mutation introduces notable conformational instability AKR1C4 enzyme potentially impacting biological functionality catalytic efficiency conclusion genetic variant rs17134592 identified significantly correlated prevalence breast cancer Bangladeshi population Computational study suggest L311V mutation AKR1C4 gene corresponding rs17134592 result marked conformational instability change enzyme functionality",
        "mesh_terms": [
            "Humans",
            "Female",
            "Breast Neoplasms",
            "Polymorphism, Single Nucleotide",
            "Bangladesh",
            "Genetic Predisposition to Disease",
            "Case-Control Studies",
            "Middle Aged",
            "Adult",
            "Genotype",
            "Molecular Dynamics Simulation",
            "Computational Biology"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40721470/"
    },
    {
        "pmid": "40717210",
        "title": "Current Insights of the Potential Plant Bioactive Compounds on Modulating the mTOR Signaling Pathway in Regulating Oncological Disorders.",
        "abstract": "Deregulation mechanistic target rapamycin mTOR pathway play important role cancer genesis progression making attractive target cancer treatment Disrupting mTOR pathway contributes uncontrolled cell growth increased proliferation enhanced cell survival hallmark cancer finding imply deregulation mTOR pathway cancer provides compelling basis therapeutic treatments Phytochemicals flavonoid polyphenols shown play key role suppressing different kinase implicated PI3KAKTmTOR signaling cascades thorough study molecular connection bioactive substances mTOR signaling autophagy activation lead creation personalized treatment work better fewer side effects Finding important target mTOR pathway use bioactive chemical plant treat cancer important discovery could lead precise medicine development effective cancer drugs Finally targeting mTOR pathway using plantderived chemical may promising therapy strategy cancer review try summarize putative plant bioactive chemical act malignancy via mTOR signaling pathways Furthermore paper discusses role mTOR pathway cancer specifically influence cell growth proliferation survival",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40717210/"
    },
    {
        "pmid": "40720480",
        "title": "Mathematical bridge between epidemiological and molecular data on cancer and beyond.",
        "abstract": "least six different mathematical model cancer countless variation combination published date scientific literature reasonably explain epidemiological prediction multistep carcinogenesis Background least six different mathematical model cancer countless variation combination published date scientific literature reasonably explain epidemiological prediction multistep carcinogenesis one deal particular set problem given organizational level ranging population genes model adopted article far account epidemiological molecular level carcinogenesis developed mathematically rigorous system derive equation satisfying basic assumption epidemiology molecular biology without incorporating arbitrary numerical coefficient constant devoid causal explanation fit empirical data dataset used encompasses 21 major category cancer 124 selected populations 108 cancer registries 5 continents 14067894 individual cases generalized epidemiological molecular data using derived equation linear nonlinear regression found necessary coefficient explain data also tested equation nonneoplastic condition satisfying equivalent mathematical assumptions finding show new mathematical framework effectively bridge epidemiological molecular data carcinogenesis Validated across various cancer type extended nonneoplastic conditions unified approach lay strong foundation future integrative cancer research",
        "mesh_terms": [
            "Neoplasms",
            "Humans",
            "Models, Theoretical",
            "Carcinogenesis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40720480/"
    },
    {
        "pmid": "40718465",
        "title": "Cervical cancer trends, HPV vaccine utilization, and screening in low- and lower-middle-income countries: an updated review.",
        "abstract": "Cervical cancer fourth common cancer among woman worldwide 660000 new case 350000 death reported 2022 disease mainly affect woman low lowermiddleincome country LMICs 90 case occur study explored LMICs responding World Health Organizations WHO call eliminate cervical cancer looked cervical cancer rates use human papillomavirus HPV vaccines suggested strategy fight disease study analyzed rate cervical cancer death LMICs effectiveness HPV vaccination programs well screening effort working compare data across countries used agestandardized incidence rate ASIRs agestandardized mortality rate ASMRs per 100000 woman per year 2022 ASIR 254 lower income country 169 lowermiddleincome countries ASMR also higher lower income country 185 compared lowermiddleincome country 103 HPV vaccine coverage remains low many LMICs significant difference rate first final dos completed 2050 number new cervical cancer case expected rise Although aim eliminate cervical cancer achieving 90 HPV vaccination age 15 70 screening coverage 90 access treatment many challenge remain LMICs include weak healthcare systems poor infrastructure lack health education Overcoming challenge better vaccine distribution improved screening programs stronger healthcare system essential eliminate cervical cancer",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40718465/"
    },
    {
        "pmid": "40715725",
        "title": "Planetary Health Consequences of Telecoupled Shrimp Farming.",
        "abstract": "international demand shrimp Bangladesh exhibit Telecoupled system Semiintensive intensive shrimp farming changed vast coastal area saline zone altering land use land cover shrimp cultivation significantly contributes foreign exchange earnings also lead various social environmental impact affect planetary health study see shrimp farming result Telecoupled dynamics us mixedmethods approach combining primary secondary data examine effect planetary health Bangladeshs southwestern coastal areas finding reveal several important health social issue associated shrimp farming include i scarcity drinking household water ii infectious diseases iii noninfectious diseases iv food nutritional insecurity v antimicrobial resistance chemical contamination vi mental pressure vii disasterrelated health vulnerability viii social conflict ix healthcare inequality x ruralurban migration analysis enhances understanding complex interaction human nature shrimp farming system evolving impact planetary health southwestern coastal Bangladesh study stress urgent need integrated ecosystembased agricultural practice find balance economic benefit sustainable health environmental outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40715725/"
    },
    {
        "pmid": "40712618",
        "title": "National cancer control plans in ANCCA member countries: advancing a pan-Asian cancer initiative.",
        "abstract": "Asia home nearly 60 worlds population bear substantial portion global cancer burden making effective control strategy crucial 2017 resolution cancer prevention control highlighted importance developing implementing National Cancer Control Plans NCCPs reviewed current landscape NCCPs 21 country Asian National Cancer Centers Alliance found marked variation plan status across Asia framework ranging comprehensive NCCPs noncommunicable disease plan include cancer plans 90 plan included component primary secondary tertiary prevention cancer treatment Air pollution critical growing cancer risk factor region addressed 43 plans concentrated middleincome countries Treatment protocol included 91 plans endoflife care appeared 48 Stakeholder involvement appeared 86 plans legal evaluation mechanism less common 57 each Locally adapted comprehensive strategy addressing continuum care prevention survivorship supported strong legal financial governance structure enhanced regional collaboration essential equitable cancer control",
        "mesh_terms": [
            "Humans",
            "Neoplasms",
            "Asia",
            "Global Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40712618/"
    },
    {
        "pmid": "40698174",
        "title": "Protein profile of the Escherichia coli strain, BW25113, exposed to two novel iron-halide compounds: Fe(Hampy)2Cl4 and Fe(Hampy)2Br4.",
        "abstract": "mortality rate economic burden infection caused antimicrobialresistant pathogen increasingly higher frustrating scenario emphasizes urgent need developing new antimicrobial drugs previously addressed problem studying antimicrobial activity two novel ironhalide complexes FeHampysub2subClsub4sub iron tetrachloride FeHampysub2subBrsub4sub iron tetrabromide compound showed bactericidal antibiofilm activity bacteria antimicrobial resistance phenotype Herein used proteomic approach investigate proteomic profile bacterial cell previously exposed ironhalide complexes study iEscherichia colii strain BW25113 used model facilitate rapid identification deregulated proteins Heat map analysis common deregulated protein highlighted complex caused downregulation protein associated key metabolic pathways biofilm formation cell envelope biogenesis iron ion binding addition network study suggested influential protein tetrachloride activity involved TCA cycle oxidative phosphorylation iron ion homeostasis carbonsecondary metabolism proteinprotein interaction analysis also hinted main driver tetrabromide activity protein involved translation ribosomal biogenesis cell motility result strongly suggested presence different halide ligand could used generate compound potentially different molecular mechanisms Importantly finding study also used reference compare protein profile bacteria exposed future variant ironhalide complexes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40698174/"
    },
    {
        "pmid": "40694861",
        "title": "The impact of using AI-powered voice-to-text technology for clinical documentation on quality of care in primary care and outpatient settings: a systematic review.",
        "abstract": "AIpowered Voicetotext Technology AIVT offer promising solution reduce clinicians documentation burden consultations allowing focus patient interaction systematic review assesses AIVTs impact care quality primary care outpatient settings focusing seven components effectiveness efficiency safety patientcentredness timeliness equity integration systematic search five database Medline Embase Global Health CINHAL Scopus conducted study published September 20 2024 Studies included assessed use AIVT medical documentation primary care outpatient settings compared manual nonAI documentation methods reported outcome relevant seven quality components narrative synthesis conducted metaanalysis unfeasible due study heterogeneity 1924 papers nine study included n  524 healthcare professionals n  616 patients 1069 consultations n  7 USA others Bangladesh Philippines study assessing effectiveness patientcentredness efficiency n  9 6 5 respectively reported improvements including faster documentation reduced administrative burden enhanced patientprovider interaction Safety finding inconclusive three six study raised concerns Four study highlighted seamless AIVT integration Electronic Health Records improving service timeliness Three study identified equity issues referring limited diversity controlled simulation settings AIVT tool enhance documentation efficiency patientcentred care concern transcription error generalisability warrant testing largescale diverse realworld settings study supported National Institute Health Care Research NIHR NorthWest London Patient Safety Research Collaboration NIHR NWL PSRC Ref NIHR204292 infrastructure support NIHR Imperial Biomedical Research Centre",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40694861/"
    },
    {
        "pmid": "40694161",
        "title": "Natural bioactive compounds as notch signaling modulators: cutting-edge strategies for cancer therapy.",
        "abstract": "Natural bioactive compound demonstrated potential altering Notch signaling system crucial regulator cancer development review discusses molecular interaction various substance flavonoids polyphenols terpenoids alkaloid ligands receptors downstream effectors Terpenoids like curcumin combat Notchmediated medication resistance flavonoid like quercetin prevent Notch receptor activation Alkaloids directly indirectly modulate Notch signaling anticancer effects Preclinical clinical investigation demonstrated effectiveness several drugs several progressed clinical trials review emphasizes clinical trial optimize pharmacokinetics safety therapeutic potential natural medicine cancer treatment Natural bioactive substance targeting Notch signaling system potential develop cancer treatment treatment provide potential alternative supplement current treatment due targeted less toxic approach cancer cells Natural bioactive compound require research enhance pharmacokinetics investigate processes conduct clinical trials",
        "mesh_terms": [
            "Humans",
            "Neoplasms",
            "Receptors, Notch",
            "Signal Transduction",
            "Animals",
            "Biological Products",
            "Flavonoids",
            "Antineoplastic Agents",
            "Terpenes"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40694161/"
    },
    {
        "pmid": "40694144",
        "title": "Computational biology meets oncology: designing custom protein and peptide binders to outsmart cancer.",
        "abstract": "Cancer remains one formidable global health challenges conventional therapy often limited offtarget toxicity drug resistance inability target key oncogenic drivers recent years de novo protein peptide binder engineering emerged approach overcome barriers offering precise customizable solution cancer diagnosis treatment leveraging computational design directed evolution artificial intelligence researcher engineer binding molecule high specificity stability therapeutic potential unconstrained limitation natural protein scaffolds review explores methodology de novo binder design computational algorithm like Rosetta AlphaFold although limitation accuracy disordered region conformational dynamics innovative scaffold optimization strategies highlight groundbreaking applications including direct tumor inhibition targeted drug delivery immune modulation diagnostic biosensing showcasing case study Designed Ankyrin Repeat Proteins DARPins PD1PDL1 miniprotein inhibitors Looking ahead field promise improve personalized medicine tumorspecific binders synthetic biology circuits nextgeneration delivery systems convergence biotechnology computational modeling translational medicine de novo binder engineering represents powerful frontier cancer therapy potential redefine precision oncology address unmet clinical needs insight presented herein underscore growing relevance shaping future therapeutic strategy cancers complexity",
        "mesh_terms": [
            "Humans",
            "Neoplasms",
            "Computational Biology",
            "Peptides",
            "Proteins",
            "Protein Engineering",
            "Precision Medicine",
            "Drug Design",
            "Medical Oncology"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40694144/"
    },
    {
        "pmid": "40692603",
        "title": "CCL18 and EGF May Serve as Potential Prognostic Biomarkers and Therapeutic Targets for Human Breast Cancer.",
        "abstract": "bBackgroundb Breast cancer BRCA remains leading cause cancerrelated mortality among women CCL18 EGF implicated tumor biology however role BRCA remain partly defined study investigates expression profiles immune associations prognostic relevance epigenetic regulation molecular networks bMethodsb Expression data TCGA UALCAN GSCA analyzed compare CCL18 EGF level BRCA normal tissues Immune infiltration assessed using TIMER survival analysis performed via KaplanMeier plotter TCGA subcohorts including menopausal status Promoter DNA methylation examined using UALCAN Gene correlation network proteinprotein interaction assessed using UALCAN STRING bResultb CCL18 significantly upregulated BRCA tissues EGF showed consistent increase compared normal tissue gene strongly correlated immune cell infiltration High CCL18 EGF expression associated reduced relapsefree survival BRCA Promoter region gene exhibited reduced DNA methylation supporting elevated expression tumors Interaction analysis revealed distinct immune signalingrelated gene protein networks bConclusionb CCL18 show strong prognostic immunological relevance BRCA EGF appears play broader oncogenic role Hypomethylation gene may drive aberrant expression involvement tumor progression",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40692603/"
    },
    {
        "pmid": "40689422",
        "title": "Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles.",
        "abstract": "Serous tubal intraepithelial carcinoma lesions human fallopian tube epithelium hFTE theorized give rise highgrade serous ovarian cancers Small extracellular vesicle sEV known mediate key signaling normal cancerous tissues ex vivo system exist studying impact sEV hFTE tissue study present microfluidic tissue culture platform combined spatial transcriptomic proteomic readout allows u profile dual response tissue exposed sEV messagescapturing shortterm transcriptomic shift tissue longterm change protein cargo secreted EVs the reply Using spatial transcriptomics show shortterm 1day exposure ovarian cancerderived sEVs alters expression 68 transcript secretory cells progenitor highgrade serous ovarian cancer notably upregulating immunerelated mRNA including CXCL family chemokines VCAM1 proinflammatory mediator NFKB1 IL1B IFNA717 Additionally observed longterm 14day exposure sEVs alters expression seven transcript 25 EV cargo protein fallopian tubederived EVs secondary release EVs following stimulus cancer EVs Together tissue transcriptomics tissuederived EV proteomics indicate ovarian cancerderived sEVs rewire target cell signaling modify tubal immune landscape study provides insight early molecular change associated pathogenesis ovarian cancer tissue origin providing platform study EVtissue interaction identify sEVs drive cell signaling reprogramming hFTE model fallopian tube preneoplastic landscape using microfluidic platform study EVinduced stress show cancer EVs promote immune signaling change representing earliest stage ovarian cancer pathogenesis",
        "mesh_terms": [
            "Female",
            "Humans",
            "Extracellular Vesicles",
            "Ovarian Neoplasms",
            "Fallopian Tubes",
            "Precancerous Conditions",
            "Epithelium",
            "Fallopian Tube Neoplasms",
            "Proteomics",
            "Transcriptome",
            "Gene Expression Regulation, Neoplastic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40689422/"
    },
    {
        "pmid": "40688368",
        "title": "Cancer-specific cut-offs of treatment initiation delay and assessment of their associated variables: a research concern.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40688368/"
    },
    {
        "pmid": "40688034",
        "title": "CaF<sub>2</sub> nanoparticles deliver siRNA targeting STAT6 and PPAR- <math xmlns=\"http://www.w3.org/1998/Math/MathML\"><mi>γ</mi></math> to depolarise tumour-associated macrophages.",
        "abstract": "Breast cancer leading cause death women partly due challenge posed constituent tumourmicroenvironment tumourassociated macrophage TAMs Polarisation macrophage protumour phenotype usually involves STAT6 PPAR math xmlnshttpwwww3org1998MathMathMLmiγmimath pathways study CaFsub2sub nanoparticles developed bound siRNA inhibit expression STAT6 PPAR math xmlnshttpwwww3org1998MathMathMLmiγmimath vitro model TAMs CaFsub2sub nanoparticles synthesised precipitation reaction characterised spectrophotometry dynamic light scattering FTIR electron microscopy MTT assay binding affinity siRNA confirmed cellular uptake TAMs CaFsub2subbound siRNAs targeting STAT6 PPAR math xmlnshttpwwww3org1998MathMathMLmiγmimath found reduce expression M2 phenotype assessed PCR microscopy finding open possibility using nanoparticlebound siRNA target gene associated protumour polarisation macrophages potential repolarise inflammatory phenotype",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40688034/"
    },
    {
        "pmid": "40685378",
        "title": "Undiagnosed depressive and anxiety disorders in a nationally representative sample of Bangladeshi and Nepali women: prevalence and associated factors.",
        "abstract": "Undiagnosed depressive anxiety disorder may widespread study aimed assess prevalence associated factor undiagnosed depressive andor anxiety disorder DAD among woman two lowresource countries Bangladesh Nepal Data analyzed 19987 woman aged 1549 years 2022 Bangladesh Demographic Health Survey 7442 woman aged 1549 years 2022 Nepal Demographic Health Survey completed interviewadministered nationally representative subsurvey component mental health DAD categorized either undiagnosed DAD meeting symptom criterion PHQ9 andor GAD7 without prior diagnosis treatment diagnosed DAD having prior diagnosis andor current treatment Relative diagnosed DAD association undiagnosed DAD estimated using logistic regression analytic sample included 2388 woman Bangladesh 960 woman Nepal undiagnosed DAD diagnosed DAD prevalence undiagnosed DAD 448 Bangladesh 600 Nepal Bangladesh adjusted logistic regression analysis big problem permission go health facility Adjusted Odds RatioAOR 153 95 Confidence Interval CI 121193 p  0001 widowed AOR 204 95 CI 140299 p  0001 divorced separated AOR 230 95 CI140377 p  0001 significantly positively associated undiagnosed DAD secondary higher education AOR 075 95 CI 058097 p  0028 significantly negatively associated undiagnosed DAD Nepal compared rich richest wealth status poor poorest wealth status AOR 155 95 CI 109 221 compared BraminChhetri ethnicity Dalit AOR 177 95 CI 108289 Janajati AOR 172 95 CI 117254 positively associated undiagnosed DAD Increasing age AOR 097 95 CI 096099 negatively associated history cervical cancer screening AOR 057 95 CI 032102 marginally negatively associated undiagnosed DAD Nearly half woman Bangladesh three five woman Nepal undiagnosed DAD Targeted intervention addressing factor needed improve mental health screening access care woman Bangladesh Nepal",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40685378/"
    },
    {
        "pmid": "40682681",
        "title": "Monitoring and Health Risks Assessment of Primordial Radionuclides in Vegetables and Agricultural Soils in Some Hilly Regions of Southeastern Bangladesh.",
        "abstract": "study demonstrates naturally occurring radioactive material NORMs sup226supRa sup232supTh sup40supK vegetable corresponding agricultural soil sample collected southeastern Bangladesh Chittagong Elemental abundance measured neutron activation analysis converted associated radioactivities Meansubn30sub specific radioactivity sup226supRa sup232supTh sup40supK soil 435 615 6452 Bq kgsup1sup respectively relatively higher compared corresponding recommended values Activities NORMs vegetable edible parts ranged Bq kgsup1sup 175 16sup226supRa 082309sup232supTh 1741743sup40supK higher corresponding recommended values respectively Higher radioactivity studied vegetable mostly attributable fertilizer usage specifically phosphate potash organic fertilizers irrigation processes Averagesubn9sub transfer factor sup226supRa sup232supTh sup40supK undersurface vegetable eg potato 0078 00933 0799 whereas averagesubn21sub TFs oversurface vegetable eg tomato 0078 0102 15 respectively Human health concern demonstrated estimating standard radiologicalrisk indices cancer risk tomato sample surpass allowable limit 35 × 10sup3sup Svsup1sup Estimated ingestion dose higher tomato okra yardlong bean eggplant compared corresponding world average 290 µSv ysup1sup Ingestion NORMs uptake vegetable cause severe damage different tissue digestive system receiving alpharadiations decay product sup238supU sup232supTh Optimized usage chemical fertilizers crop rotation elevated use organic compost fertilizer recommended controlling NORMs abundance edible part vegetables",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40682681/"
    },
    {
        "pmid": "40678696",
        "title": "World health Organization's guidance for tracking non-communicable diseases towards sustainable development goals 3.4: an initiative for facility-based monitoring.",
        "abstract": "Noncommunicable disease NCDs account 60 annual global deaths disproportionately affecting low middleincome countries trend undermines progress toward Sustainable Development Goal SDG 34 seek reduce premature mortality NCDs onethird 2030 Despite availability effective relatively affordable interventions addressing NCDs requires sustained coordinated effort robust monitoring systems Facilitybased monitoring offer dynamic alternative static surveys enabling continuous assessment healthcare quality utilization study followed systematic approach develop standardized global national NCD monitoring indicators using Donabedian model conceptual framework focused four major NCD categories hypertension cardiovascular disease CVDs diabetes chronic respiratory diseases cancers methodology included systematic scoping review inception November 2021 multiround Delphi process involving global expert assess validity feasibility proposed indicators study funded internally WHO payment participants final output consisted 81 validated indicators22 core 59 optional indicator demonstrated high feasibility relevance facilitybased monitoring NCD service delivery provide actionable metric assessing improving quality care across diverse health system settings study highlight urgent need comprehensive contextsensitive NCD monitoring frameworks proposed set indicator offer validated foundation improving NCD care delivery aligns effort achieve SDG target 34 Ongoing update local adaptation essential ensure continued relevance effectiveness study funded internally WHO",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40678696/"
    },
    {
        "pmid": "40676081",
        "title": "Unlocking the therapeutic potential of Catharanthus roseus leaves via in-vitro, in-vivo, and in-silico study.",
        "abstract": "Catharanthus roseus L CR perennial flowering herb traditionally used local population South Asia Africa China Malaysia treat diabetes cancer microbial infection principal objective study investigate antidiabetic antilipidemic antiarthritic effect methanol MCR ethanol ECR extract dichloromethane fraction DCR Catharanthus roseus leaf invitro invivo insilico model invivo antihyperglycemic activity C roseus explored streptozotocin STZinduced Type 1 diabetic mouse model MCR ECR DCR exhibited significant ability lower fasting blood glucose level normalized altered body weight treatment carried 20 day dosedependent manner Among experimental samples ECR 200 mgkg 495 ± 031 mmolL showed greater fasting blood glucose lowering activity standard drug metformin 68 ± 034 mmolL glibenclamide 520 ± 029 mmolL MCR 200 mgkg likewise significantly p  0001 reduced blood glucose 570 ± 012 mmolL compared control day 20 lipid profile LDL HDL TG TC diabetic mouse significantly reduced ECR biochemical study compared control group invitro antidiabetic study revealed dosedependent hypoglycemic potential extract fraction ECR showed highest αamylase αglucosidase inhibitory effect ICsub50sub value 062 ± 002 mgml 064 ± 001 mgml respectively antiarthritic activity assessed using bovine serum albumin denaturation inhibition assay denaturation found inhibited extract fraction MCR DCR fraction inhibited denaturation 7020 6209 respectively 1600 µgmL compared standard aspirin 8157 Moreover Gas chromatographyMass spectrometric GCMS investigation extract revealed several bioactive constituent insilico docking study suggested Ergost 5en 3ol 3beta Stigmasterol 919Cyclolanostan 3ol acetate 3betagammaSitosterol 24Norursa 312diene would probable lead compound hypoglycemic antiarthritic effect many potential targets however mechanistic experimental elucidation needed solidify findings",
        "mesh_terms": [
            "Catharanthus",
            "Animals",
            "Plant Leaves",
            "Plant Extracts",
            "Diabetes Mellitus, Experimental",
            "Mice",
            "Hypoglycemic Agents",
            "Blood Glucose",
            "Male",
            "Computer Simulation",
            "Hypolipidemic Agents"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40676081/"
    },
    {
        "pmid": "40675748",
        "title": "Aflatoxin exposure and mortality in acutely ill children: results from the CHAIN network cohort.",
        "abstract": "Chronic exposure aflatoxin associated liver cancer impaired child growth compromised immune function Childhood Acute Illness Nutrition CHAIN Network cohort established identify risk factor mortality acutely ill child admitted nine hospital four African two South Asian countries examined role aflatoxin exposure inpatient postdischarge mortality nested casecohort CHAIN cohort compared aflatoxin exposure admission discharge death survival hospital n755 180days postdischarge n585 community participant CP n222 Children stratified nonwasting mediumwasting severewasting group based midupper arm circumference Serum sample analysed aflatoxin exposure biomarker aflatoxinalbumin adduct AFalb using ELISA Overall 56 hospitalised participant tested positive AFalb admission AFalb level higher deceased geometric mean 95 CI GM 95 CI 59 49 71 survivor 42 38 47 CP 37 31 43 pgmg alb AFalb concentration higher admission 47 42 51 discharge 37 33 41 CP group 37 31 43 pgmg alb p001 African v Asian child 74 65 85 v 19 18 21 p0001 Adjusted logistical regression showed significant association AFalb level mortality separating nutrition strata AFalb significantly associated mortality highest v lowest quartile group OR484 p0014 nonwasted children Moderate severe malnutrition important risk factor mortality aflatoxin acutely ill children aflatoxin exposure may contribute mortality nonwasted children Controlling aflatoxin exposure integrated clinical public health intervention reduce mortality area high level exposure Bill Melinda Gates Foundation OPP1131320  INV003225",
        "mesh_terms": [
            "Humans",
            "Aflatoxins",
            "Male",
            "Female",
            "Child, Preschool",
            "Infant",
            "Acute Disease",
            "Child",
            "Risk Factors",
            "Cohort Studies",
            "Biomarkers",
            "Albumins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40675748/"
    },
    {
        "pmid": "40670873",
        "title": "FSS-ULivR: a clinically-inspired few-shot segmentation framework for liver imaging using unified representations and attention mechanisms.",
        "abstract": "Precise liver segmentation critical accurate diagnosis effective treatment planning serving foundation medical image analysis However existing method struggle limited labeled data poor generalizability insufficient integration anatomical clinical features address limitations propose novel FewShot Segmentation model Unified Liver Representation FSSULivR employ ResNetbased encoder enhanced SqueezeandExcitation module improve feature learning enhanced prototype module utilizes transformer block channel attention dynamic feature refinement decoder improved attention gate residual refinement strategy recover spatial detail encoder skip connections extensive experiments FSSULivR model achieved outstanding Dice coefficient 9894 Intersection Union IoU 9744 specificity 9378 Liver Tumor Segmentation Challenge dataset Crossdataset evaluation demonstrated generalizability Dice score 9543 9298 9072 9405 3DIRCADB01 Colorectal Liver Metastases Computed Tomography Organs CTORG Medical Segmentation Decathlon Task 3 Liver datasets respectively multiorgan segmentation CTORG delivered Dice score ranging 8593 9426 across bladder bones kidneys lungs brain tumor segmentation BraTS 2019 2020 datasets average Dice score 9064 8936 across whole tumor tumor core enhancing tumor regions result emphasize clinical importance model demonstrating ability deliver precise reliable segmentation artificial intelligence technique engineering solutions even scenario scarce annotated data",
        "mesh_terms": [
            "Humans",
            "Liver Neoplasms",
            "Liver",
            "Tomography, X-Ray Computed",
            "Algorithms",
            "Image Processing, Computer-Assisted"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40670873/"
    },
    {
        "pmid": "40669660",
        "title": "Unveiling the hidden pollutants in the indoor environment: Focus on microplastic pollution and its related risks in the educational institutions of megacity, Bangladesh.",
        "abstract": "Microplastics MPs defined plastic particle smaller 5 mm emerging environmental contaminant increasing concern due potential adverse effect human health indoor environment represent significant location human exposure data MP occurrence characteristic setting remain limited particularly densely populated urban areas study first investigated abundance distribution characteristics potential risk MPs settled dust collected classroom within educational institution megacity Bangladesh Microplastics extracted dust sample using wet peroxide oxidation Quantification morphological characterization shape size color performed using stereomicroscopy Polymer identification conducted using Attenuated Total Reflectance Fourier Transform Infrared spectroscopy ATRFTIR Scanning electron microscopy coupled energydispersive Xray spectrometry SEMEDS employed analyze surface morphology elemental composition mean abundance MPs 1643667 ± 853406 nkg considerable variability observed across sampling locations Fibers comprised predominant shape 89  100500 μm size range prevalent 44  Black frequently observed color 355  Polystyrene PS abundant polymer type 406  followed polypropylene PP polyethylene PE polyethylene terephthalate PET polyamide PA polyvinyl chloride PVC polyurethane PUR pollution load index PLI value exceeded 1 indicating significant MP contamination risk assessment indices including contamination factor range 100614 Nemerow pollution index range 440614 suggested moderate high level MP pollution polymeric hazard index 26933115073 indicated considerable high polymerassociated risks SEMEDS analysis revealed presence secondary MPs associated potentially toxic element eg Hg Pb As Principal component analysis PCA suggested indoor activity outdoor environment contribute MP pollution classrooms Estimated daily intake EDIs via dust ingestion 039 ± 020 particlesday child 029 ± 015 particlesday adults Lifetime cancer risk LTCR assessment indicated potential moderate carcinogenic risk exposure groups child exhibiting higher estimated risk finding highlight need research fully characterize indoor MP exposures sources pathways health risk develop effective mitigation strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40669660/"
    },
    {
        "pmid": "40668877",
        "title": "Metabolic Signature of Arsenic Exposure and Metabolism: The Folic Acid and Creatine Trial.",
        "abstract": "Arsenic exposure remains leading public health concern Folic acid FA supplementation enhances onecarbon metabolism OCM thus promoting arsenic methylation facilitating urinary arsenic elimination Here investigate metabolic profile linked arsenic exposure metabolism based FA clinical trial Arsenic exposure assessed concentration blood arsenic bAs species arsenite InAssupIIIsup arsenate InAssupVsup monomethyl MMA dimethyl DMA arsenicals Arsenic metabolism assessed relative distribution  arsenical urine Nontargeted metabolomic profiling analyzed LCHRMS OCMrelated metabolite analyzed HPLCMSMS Metabolomic profiling identified 8 unique metabolite 812 metabolomic feature FDR  005 associated bAs predominantly AssupVsup 66 metabolite 285 metabolomic feature uAs predominantly uInAs Metabolic pathway enriched bAs uAs similar highlighting phenylalanine tyrosine tryptophan biosynthesis FAinduced uInAs change associated four metabolites three share link acetylCoA metabolism 11 measured OCM metabolites cystathionine positively associated bAs species Methionine Sadenosylmethionine Sadenosylhomocysteine cysteine choline betaine dimethylglycine associated increased methylation profile urine FDR  005 Collectively finding may aid discovery mechanism underlying arsenicinduced health outcome potential targeted interventions trial registered clinicaltrialsgov NCT01050556",
        "mesh_terms": [
            "Adult",
            "Female",
            "Humans",
            "Male",
            "Arsenic",
            "Creatine",
            "Folic Acid"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40668877/"
    },
    {
        "pmid": "40668852",
        "title": "An explainable and federated deep learning framework for skin cancer diagnosis.",
        "abstract": "Skin cancer SC prominent form cancer humans 1 million new case reported worldwide year Early identification SC play crucial role effective treatment However protecting patient data privacy major concern medical research Therefore study present smart framework classifying SC leveraging deep learning DL federated learning FL explainable AI XAI tested presented framework two wellknown datasets ISBI2016 ISBI2017 data first preprocessed several techniques resizing normalization balancing augmentation Six advanced DL algorithmsVGG16 Xception DenseNet169 InceptionV3 MobileViT InceptionResNetV2were applied classification tasks Among these DenseNet169 algorithm obtained highest accuracy 833 ISBI2016 9267 ISBI2017 model tested FL platform maintain data privacy FL platform VGG16 algorithm showed best results 9208 accuracy ISBI2016 94 ISBI2017 ensure model interpretability XAIbased algorithm named Local Interpretable ModelAgnostic Explanations LIME used explain prediction proposed framework believe proposed framework offer dependable tool SC diagnosis protecting sensitive medical data",
        "mesh_terms": [
            "Deep Learning",
            "Humans",
            "Skin Neoplasms",
            "Algorithms"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40668852/"
    },
    {
        "pmid": "40665219",
        "title": "The global burden of typhoid and paratyphoid fever from 1990 to 2021 and the impact on prevention and control.",
        "abstract": "Typhoid paratyphoid fever common infectious disease remain heavy burden especially lowincome countries Although global burden decreased past three decades analysis burden typhoid paratyphoid fever help inform public health strategies study aimed comprehensively evaluate global regional national burden typhoid paratyphoid temporal trend exploring potential association sociodemographic development three decade 19902021 Data typhoid paratyphoid fever analyzed using Global Burden Disease GBD study 2021 analysis calculated demonstrate temporal trend incidence mortality disability adjusted life year DALYs typhoid paratyphoid fever 1990 2021 1990 2021 typhoid paratyphoid fever showed declining trend globally different sociodemographic index SDI regions including incidence mortality DALYs typhoid fever worldwide new case decreased 6212 EAPC 392 414 371 death decreased 5065 EAPC  283 299 266 DALYs decreased 5230 EAPC  282 300 264 paratyphoid fever new case decreased 7315 EAPC 477 529 426 death decreased 6544 EAPC  374 424 324 DALYs decreased 6842 EAPC  387 442 331 typhoid paratyphoid fever child highest morbidity mortality rates male higher rate incidence mortality DALYs females However among older patients absolute number new case DALYs higher women burden concentrated South Asia Southeast Asia Oceania South Asia suffering severely paratyphoid fever Regarding typhoid fever top three country highest ASRs incidence Burkina Faso 32848 SDI 0285 Bangladesh 30314 SDI 0492 Papua New Guinea 29945 SDI 418 Western SubSaharan South Asia Oceania top three country term mortality DALYs Bhutan 561 43423 SDI 0473 Bangladesh 506 38238 Burkina Faso 464 35257 Regarding paratyphoid fever top three country highest ASRs mortality DALYs same including Pakistan 105 7266 India 075 5342 Nepal 072 5065 SDI 0433 located South Asia",
        "mesh_terms": [
            "Humans",
            "Typhoid Fever",
            "Paratyphoid Fever",
            "Incidence",
            "Global Burden of Disease",
            "Male",
            "Female",
            "Disability-Adjusted Life Years",
            "Adult",
            "Child",
            "Global Health",
            "Child, Preschool",
            "Adolescent",
            "Middle Aged",
            "Young Adult",
            "Infant",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40665219/"
    },
    {
        "pmid": "40662545",
        "title": "Neural Networks of Knowledge: Ontologies Pioneering Precision Medicine In Neurodegenerative Diseases.",
        "abstract": "review focus way ontology revolutionising precision medicine effort understand neurodegenerative illnesses Ontologies structured framework outline relationship concept certain field offer crucial foundation combining different biological data Novel insight construction precision medicine approach treat neurodegenerative disease NDDs given growing advancement area pharmacogenomics Affected part central nervous system may develop neurological disorders including Alzheimers Parkinsons autism spectrum attentiondeficithyperactivity disorder model allow standard helpful data marking needed crossdisciplinary study teamwork case studies see ontology used find biomarkers understand sickness work make model predicting drug work disease get worse example problem data quality meaning variety need constant change reflect growing body scientific knowledge discussed review also look semantic data mixed cuttingedge computer method artificial intelligence machine learning make brain disease diagnostic prediction model exact accurate collaborative network aim identify patient risk identify patient preclinical early stage illness develop tailored preventative intervention enhance patient quality life prognosis also seek identify new robust effective method patient identification tasks end current study considered examine essential component may part precise tailored therapy plan used neurodegenerative illnesses",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40662545/"
    },
    {
        "pmid": "40657492",
        "title": "Machine Learning based Model Reveals the Metabolites Involved in Coronary Artery Disease.",
        "abstract": "Coronary artery disease CAD major global cause morbidity mortality Therefore advance early identification individualized treatment plan crucial article present machine learning ML based model recognize metabolomic compound associated CAD Qatari population early detection CAD also identified statistically significant metabolic profile potential biomarkers using ML methods Among ML models artificial neural network ANN outstands accuracy 9167 recall 800 specificity 100 result show 173 metabolite iPi  05 significantly associated CAD metabolites majority 95173 5491 high CAD patients 4509 78173 high control group Two metabolite 2hydroxyhippurate salicylurate salicylate notably higher CAD patient compared control group Conversely 4 metabolites cholate 3hydroxybutyrate BHBA 4allyl catechol sulfate indolepropionate showed relatively higher level control group believe study support advancing personalized diagnosis plan CAD patient considering metabolite involved CAD",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40657492/"
    },
    {
        "pmid": "40655790",
        "title": "Exploration of Quantum Dot Imaging for Enhanced Detection of Oral Diseases.",
        "abstract": "Quantum dot QDs nanoscale semiconductor particle unique optical properties including high photostability broad excitation spectra narrow emission spectra attribute make QDs promising candidate advanced imaging technique detection oral diseases Early accurate detection oral pathologies oral cancer periodontal diseases critical effective management treatment outcomes study QDs conjugated diseasespecific antibody used enhance imaging oral tissues total 50 oral biopsy sample analyzed 25 sample serving control 25 sample displaying confirmed pathological conditions Samples incubated QD conjugate imaged using fluorescence microscopy Signal intensity target specificity evaluated using image analysis software Arbitrary fluorescence intensity value measured quantify imaging efficiency fluorescence intensity value pathological tissue labeled QDs showed mean 120 ± 10 arbitrary unit AUs significantly higher compared 50 ± 5 AU control tissues use QDs demonstrated enhanced sensitivity detecting pathological changes specificity 95 sensitivity 90 distinguishing diseased healthy tissues Additionally photostability QDs ensured consistent imaging result prolonged observation times Quantum dot imaging offer novel highly sensitive approach detection oral diseases enhanced fluorescence intensity disease specificity highlight potential diagnostic tool research clinical trial needed establish clinical applicability safety QDs routine oral diagnostics",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40655790/"
    },
    {
        "pmid": "40655657",
        "title": "<i>In Vitro</i> Study on the Effect of Smoking and Alcohol on the Proliferation of Oral Cancer Cells.",
        "abstract": "Alcohol use smoking shown substantial risk factor oral cancer serious worldwide health problem growth oral cancer cell thought influenced certain lifestyle choices Oral squamous cell carcinoma SCC25 cell line used carefully monitored iin vitroi investigation Three set cell created one smoking exposure treated cigarette smoke extract CSE concentration 10 μgmL 20 μgmL 50 μgmL one alcohol exposure treated ethanol concentration 1 5 10 one control no exposure also combined exposure group comprised drinking smoking MTT test used measure cell viability proliferation rate 24 48 72 hours ANOVA used statistical analysis compare groups Exposure ethanol CSE dramatically decreased cell viability way dependent time dosage 10 μgmL 20 μgmL 50 μgmL smoking groups proliferation reduced 25 35 50 72 hours respectively 1 5 10 ethanol concentrations alcohol group also showed reduction 20 30 45 respectively 60 decrease proliferation combined exposure group showed strongest inhibition suggesting synergistic impact Statistical significance noted every experimental group iPi  005 alcohol exposure smoking significantly reduce growth oral cancer cells combined effect synergistic result highlight important lifestyle change managing preventing oral cancer",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40655657/"
    },
    {
        "pmid": "40655578",
        "title": "Evaluation of Salivary Biomarkers in the Early Detection of Oral Squamous Cell Carcinoma.",
        "abstract": "prevalent cancer oral cavity oral squamous cell carcinoma OSCC often present advanced stage poor prognosis high death rates noninvasive diagnostic methods salivary biomarkers shown promise early diagnosis OSCC purpose research assess certain salivary biomarkers ascertain well detect OSCC early phases Ninety participant split three group crosssectional study 30 OSCC patients 30 people oral premalignant lesion OPLs 30 healthy controls enzymelinked immunosorbent assay used measure level interleukin6 IL6 matrix metalloproteinase9 MMP9 lactate dehydrogenase LDH unstimulated saliva samples ANOVA posthoc Tukey test used statistical analysis compare amount biomarkers group OSCC patient mean IL6 concentration 250 ± 25 pgmL substantially greater OPL groups concentration 100 ± 15 pgmL healthy controls concentration 30 ± 5 pgmL iPi  0001 Similarly OSCC patient higher MMP9 level 500 ± 50 ngmL OPL 300 ± 40 ngmL control 100 ± 20 ngmL iPi  0001 OPL group 600 ± 60 UL control 300 ± 50 UL lower LDH activity OSCC patient 850 ± 70 UL iPi  0001 High sensitivity specificity shown receiver operating characteristic curve analysis three biomarkers differentiating OSCC OPL healthy controls Salivary biomarkers including MMP9 LDH IL6 show great promise early noninvasive identification OSCC integrating biomarkers standard diagnostic procedures OSCCrelated morbidity mortality may decreased early diagnosis treatment result may enhanced",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40655578/"
    },
    {
        "pmid": "40651674",
        "title": "Repurposing neurological drugs for brain cancer therapeutics: A systematic approach to identify charged molecules for affinity-based local drug delivery systems.",
        "abstract": "Treatment glioblastoma GBM present significant challenge due high degree heterogeneity poor prognosis Recurrence malignancy frequent even standard treatment including surgery radiotherapy chemotherapy temozolomide Drug repurposing offer costeffective strategy identify new treatments affinitybased local delivery system could provide controlled release therapeutic within tumor resection cavity aim study twofold Firstly categorize currently available neurological therapeutic according charge suitability use affinitybased drug delivery systems Secondly systematically search evaluate evidence anticancer andor antiglioblastoma activity potentially repurposedrepositioned neurologypsychiatry category Broad Institute Drug Repurposing Hub 468 compounds screened chemical suitability anticancer efficacy Charge lipophilicity solubility pH 74 calculated using Chemicalize systematic search anticancer efficacy charged compound carried via following databases PubMed Scopus SciFinder Ovid via Medline Cochrane ClinicalTrialgov Among 468 compounds 283 identified charged physiological pH Notably 146 charged candidate found anticancer activity 91 showed promising activity least one type brain neoplasm compounds chlorpromazine valproic acid sertraline investigated clinical settings assessed vitro viability studies data complied herein serve repository starting point future research repurposing neurological drug anticancer property via electrostatic affinitybased drug delivery systems",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Antineoplastic Agents",
            "Brain Neoplasms",
            "Drug Delivery Systems",
            "Drug Repositioning",
            "Glioblastoma"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40651674/"
    },
    {
        "pmid": "40647683",
        "title": "Predicting the Recurrence of Differentiated Thyroid Cancer Using Whale Optimization-Based XGBoost Algorithm.",
        "abstract": "bBackgroundObjectivesb Differentiated Thyroid Cancer DTC comprising papillary follicular carcinomas common type thyroid cancer highly infectious increasing higher rate patient experience recurrence even undergoing successful treatment Early sign recurrence hard identify existing health care system cannot always identify time Therefore predicting recurrence accurately early stage significant clinical challenge Numerous advanced technologies machine learning used overcome clinical challenge Thus study present novel approach predicting recurrence DTC key objective improve prediction accuracy hyperparameter optimization bMethodsb order achieve this used metaheuristic algorithm whale optimization algorithm WOA modified version modification introduced original WOA algorithm piecewise linear chaotic map population initialization inertia weight algorithm optimize hyperparameters Extreme Gradient Boosting XGBoost model increase overall performance proposed algorithm applied dataset collected University California Irvine UCI Machine Learning Repository predict chance recurrence DTC dataset consists 383 sample total 16 features feature capture critical medical demographic information bResultsb model shown accuracy 99 optimized WOA 97 accuracy optimized modified WOA bConclusionsb Furthermore compared work innovative work validated performance model prediction DTC recurrence",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40647683/"
    },
    {
        "pmid": "40644440",
        "title": "Herd immunity and prevention in HPV transmission with exogenous reinfection.",
        "abstract": "Cervical cancer major global health concern primarily caused human papillomavirus HPV spread unsafe sexual contact Natural immunity often fails provide full protection permitting exogenous reinfection play key role persistence transmission HPV paper present analyzes deterministic mathematical model HPV transmission incorporating exogenous reinfection utilized VIA test result data 2019 2023 Bangladesh estimate key parameter values finding validated numerical simulation using MATLAB analytical result demonstrated strong consistency numerical outputs critical insight presence reinfectioninduced backward bifurcation indicating targeting primary infection alone insufficient eradication highlighting need address exogenous reinfection effective control propose optimal control strategy tailored resourcelimited setting like Bangladesh limited vaccine access present significant challenges communitydriven education safe sexual practice crucial continuously evolving result emphasize effective approach combine targeted prevention widespread community education precision intervention implementation essential prevent reinfection surge could prolong disease persistence undermine control efforts insight provide strong foundation refining intervention strategy offer valuable guidance controlling HPV transmission nonpharmaceutical interventions particularly resourceconstrained settings",
        "mesh_terms": [
            "Humans",
            "Papillomavirus Infections",
            "Female",
            "Immunity, Herd",
            "Uterine Cervical Neoplasms",
            "Bangladesh",
            "Reinfection",
            "Papillomavirus Vaccines",
            "Models, Theoretical",
            "Papillomaviridae"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40644440/"
    },
    {
        "pmid": "40643139",
        "title": "Setting stakeholder-led research priorities for advancing Sexual and Reproductive Health and Rights in Bangladesh using CHNRI method: an icddr,b initiative.",
        "abstract": "Sexual reproductive health right SRHR essential individuals health wellbeing survival economic development stakeholderled approach research prioritisation essential guide SRHRrelated research Bangladesh Accordingly conducted research prioritisation exercise identify health research priority related SRHR Bangladesh adopted Child Health Nutrition Research Initiative CHNRI method study Five theme  adolescent Health AH fertility gynaecological issue GI maternal neonatal health MNH SRH key population SRHKP  selected broader field SRHR Seventysix expert submitted 454 research question RQs condensed 197 unique RQs distributed expert scoring based five preselected criteria Weighted unweighted research priority score RPS average expert agreement AEA calculated compile list topranked RQs weighted RPSs 197 RQs ranged 0944 0623 median 0848 Among top 20 list six RQs belonged AH one Fertility two GI six MNH five SRHKP AH top ranked RQs included adolescent pregnancy sexual health education mental health Promoting proper birth spacing among newlywed underaged married woman top RQs fertility GI priority emphasised early detection gynaecological cancers including HPV testing cervical cancer screening MNH research focused Newborn Stabilizing Units subdistrict hospitals PPH bundle approaches counselling danger sign prevent adverse birth outcomes topranked RQs SRHKP addressed stigma discrimination towards key population KPs impact SRH behaviours significant overlap top 20 RQs ranked RPS AEA study emphasis need intervention research address barriers assess effectiveness enhance uptake evidencebased innovative intervention SRHR Bangladesh",
        "mesh_terms": [
            "Bangladesh",
            "Humans",
            "Reproductive Health",
            "Sexual Health",
            "Female",
            "Adolescent",
            "Health Priorities",
            "Research",
            "Reproductive Rights",
            "Stakeholder Participation",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40643139/"
    },
    {
        "pmid": "40642559",
        "title": "Breast Cancer Knowledge and Self-Examination Practices Among University Female Students in Dinajpur, Bangladesh: A Cross-Sectional Study.",
        "abstract": "Breast cancer BC common cancer among woman worldwide increasing incidence rate developing countries including Bangladesh Understanding BC awareness selfexamination practice among young woman essential enhancing early detection prevention efforts study aim assess BC awareness knowledge risk factors practice breast selfexamination BSE among female university student Dinajpur District Bangladesh crosssectional survey conducted among 400 undergraduate postgraduate female student Hajee Mohammad Danesh Science Technology University HSTU May 12 June 20 2024 Data collected using selfstructured questionnaire facetoface interviews collected information sociodemographic characteristics BC awareness risk factors selfexamination practices Descriptive statistics percentages binary logistic regression used analyze data SPSS version 260 R software version 402 employed statistical analysis study found 924 participant heard BC social medium primary source information Although 884 recognized importance early detection 191 practiced BC screening 28 undergone mammography 518 reported awareness BSE 48 performed regularly Significant barrier BSE included lack knowledge 707 concern effectiveness privacy Socioeconomic factor found significantly influence BC awareness rural student lowerincome family exhibiting lower awareness Additionally student relying family income scholarship lower awareness compared business study highlight high level BC awareness among female university students significant gap remain selfexamination practice practical engagement Socioeconomic status income source key factor influencing BC awareness Targeted educational intervention needed address gap improve early detection preventive practice among female university students",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40642559/"
    },
    {
        "pmid": "40638667",
        "title": "In silico identification of promising PD-L1 inhibitors from selected indian medicinal plants for treatment of triple negative breast cancer.",
        "abstract": "Triplenegative breast cancer TNBC aggressive among breast cancer subtypes pose unique therapeutic challenge due distinct characteristic like lack specific therapeutic targets TNBC demonstrates poor survival rate enhanced immunogenic characteristic favorable tumor microenvironment breast cancer variants Also TNBC patient show elevated level programmed death ligand1 PDL1 expression contrast nonTNBC patients Binding PDL1 PD1 produce inhibitory signal resulting suppression Tcell Therapeutic approach utilizing immunotherapy PDL1 exhibit promising outcome treatment TNBC Limitations like suboptimal efficacy inadequate oral bioavailability associated immunerelated adverse effect antibodymediated anti PD1PDL1 therapy necessitated exploration alternative therapeutic approaches Thus small molecule become alternate option PD1PDL1 inhibition present study used virtual screening identify potential phytochemical selected Indian medicinal plant PDL1 inhibitors total 953 phytochemical derived eleven selected medicinal plant initially screened molecular docking using PyRx tool Among 953 identified phytochemicals top 20 compound exhibiting highest binding affinity docking study selected analysis Following comprehensive ADMET analyses 2 compound ultimately identified suitable candidate molecular dynamic MD simulation study study identified 4hydroxychalcone flavylium Glycyrrhiza glabra Catharanthus roseus respectively potential PDL1 inhibitor enhanced stability relative reference molecule compound also showed enhanced gastrointestinal absorption predicted cytotoxic immunotoxic effects Consequently compound present promising candidate novel PDL1 inhibitor development TNBC therapy experimental investigation necessary facilitate clinical translation",
        "mesh_terms": [
            "Triple Negative Breast Neoplasms",
            "Humans",
            "B7-H1 Antigen",
            "Plants, Medicinal",
            "Female",
            "Molecular Docking Simulation",
            "Immune Checkpoint Inhibitors",
            "India",
            "Computer Simulation",
            "Phytochemicals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40638667/"
    },
    {
        "pmid": "40638627",
        "title": "Nuclei segmentation and classification from histopathology images using federated learning for end-edge platform.",
        "abstract": "Accurate nucleus segmentation classification histology image critical cancer detection remain challenging due color inconsistency blurry boundaries overlapping nuclei Manual segmentation timeconsuming laborintensive highlighting need efficient scalable automated solutions study proposes deep learning framework combine segmentation classification enhance nucleus evaluation histopathology images framework follows twostage approach first SegNet model segment nucleus regions DenseNet121 model classifies segmented instances Hyperparameter optimization using Hyperband method enhances performance models protect data privacy framework employ FedAvgbased federated learning scheme enabling decentralized training without exposing sensitive data efficient deployment edge devices full integer quantization applied reduce computational overhead maintaining accuracy Experimental result show SegNet model achieves 914 Mean Pixel Accuracy MPA 63 Mean Intersection Union MIoU 906 FrequencyWeighted IoU FWIoU DenseNet121 classifier achieves 83 accuracy 67 Matthews Correlation Coefficient MCC surpassing stateoftheart models Postquantization model exhibit performance gain 13 10 respectively proposed framework demonstrates high accuracy efficiency highlighting potential realworld clinical deployment cancer diagnosis",
        "mesh_terms": [
            "Humans",
            "Deep Learning",
            "Cell Nucleus",
            "Image Processing, Computer-Assisted",
            "Algorithms",
            "Neoplasms",
            "Federated Learning"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40638627/"
    },
    {
        "pmid": "40636313",
        "title": "Nogapendekin alfa Inbakicept-pmln (Anktiva) with BCG: A Promising Arsenal in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer Intervention.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40636313/"
    },
    {
        "pmid": "40634976",
        "title": "Integrated Immuno and bioinformatics assisted novel epitope vaccine against HIV infection: a study based on complete genome.",
        "abstract": "HIVbased complication still going high infection mortality rate requires novel strategy combat infection due unavailability proper therapeutic Therefore utilize integrated immuno bioinformatics approach study design peptide vaccine HIV infection targeting complete genome complete genome sequence analyzed potential B cell predicted Among predicted epitopes promising one selected used adjuvant linker formulate vaccine candidate vaccine modeled activity stability towards TLRs analyzed via docking dynamic 500ns vaccinegenerated immune activity expression via iiniisilicoi cloning also evaluated total 6 B cells 7 CTL 6 HTL identified immunodominant epitope used vaccine formulation epitope fused together via linkers efficiency constancy enhanced Adjuvant PADRE epitope Histag Further formulated vaccine show high population coverage stable feature based 2D 3D assessments docking investigation demonstrated strong activity vaccine towards TLR2 TLR3 binding affinity − 108 kcalmol1 − 158 kcalmol1 also disclosed remarkable constancy based 500ns simulation period vaccineassisted immune simulation expression level vector revealed robust immune response towards host based vaccination significant expression level Based integrated approach validation steps overall finding suggests formulated vaccine may strongly immunodominant property could combat infection online version contains supplementary material available 101186s12985025027640",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40634976/"
    },
    {
        "pmid": "40631888",
        "title": "Areca Nut Production, Imports, and Their Impact on Oral Cancer Incidence.",
        "abstract": "Approximately onethird global lip oral cavity cancer LOC case linked smokeless tobacco areca nut AN consumption past 32 y production significantly increased accompanied rising international trade study explores relationship change productionimport quantity LOC incidence region consumption prevalent LOC incidence rate obtained Global Burden Disease GLOBOCAN databases production import data sourced Food Agriculture Organization Corporate Statistical Database Hainan provinces statistical yearbook Spearmans correlation analysis used evaluated relationship production import LOC incidence rate ANproducingimporting regions Descriptive statistic used describe trend production imports LOC incidence ANproducingimporting regions 2021 total production 12 region Bangladesh Bhutan China mainland Taiwan India Indonesia Malaysia Maldives Myanmar Nepal Sri Lanka Thailand 54 time 1990 average annual production 1177926 tons strong positive correlation iRi ≥ 08 iPi  0001 observed increased production LOC incidence Bangladesh Bhutan China mainland India Myanmar Nepal Sri Lanka Thailand combined data 12 regions Additionally among top 10 country average annual import 2012 2021 positive correlation observed average annual import incidence LOC 2022 finding highlight positive correlation largescale production rising LOC incidence rate import may associated higher incidence LOC result support need regulatory measure similar used tobacco address growing public health concern",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40631888/"
    },
    {
        "pmid": "40631479",
        "title": "A Critical Review of the Impact of Different Types of Complications on Long-Term Survival After Total Gastrectomy for Gastric Cancer: Addressing Methodological Gaps and Clinical Implications.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40631479/"
    },
    {
        "pmid": "40629062",
        "title": "Explainable deep learning approaches for high precision early melanoma detection using dermoscopic images.",
        "abstract": "Detecting skin melanoma early stage using dermoscopic image present complex challenge due inherent variability images Utilizing dermatology datasets study aimed develop Automated Diagnostic Systems early skin cancer detection Existing method often struggle diverse skin types cancer stages imaging conditions highlighting critical gap reliability explainability novel approach proposed research address gap utilizing proposed model advanced layers including Global Average Pooling Batch Normalization Dropout dense layer ReLU Swish activation improve model performance proposed model achieved accuracy 9523 9648 two different datasets demonstrating robustness reliability strong performance across performance metrics Explainable AI technique Gradientweighted Class Activation Mapping Saliency Maps offered insight models decision making process advancement enhance skin cancer diagnostics provide medical expert resource early detection improve clinical outcomes increase acceptance Deep Learningbased diagnostics healthcare",
        "mesh_terms": [
            "Humans",
            "Melanoma",
            "Deep Learning",
            "Dermoscopy",
            "Skin Neoplasms",
            "Early Detection of Cancer",
            "Reproducibility of Results",
            "Image Processing, Computer-Assisted",
            "Image Interpretation, Computer-Assisted"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40629062/"
    },
    {
        "pmid": "40627944",
        "title": "Exploring the anti-cancer potential of daidzin in breast cancer: Integrated bioinformatics and computational insights on oncogene inhibition.",
        "abstract": "Breast cancer BC remains prevalent cancer among women high recurrence rate highlighting urgent need novel therapeutic strategies study evaluates chemopreventive potential daidzin dietary isoflavone targeted inhibitor key oncogenic protein involved BC progression Differentially expressed gene DEGs BC cell normal sample identified using GSE85871 dataset Subsequent pathway enrichment analysis proteinprotein interaction PPI network construction validation using TCGA cohort conducted elucidate daidzins regulatory impact Molecular docking molecular dynamic MD simulations principle component analysis PCA free energy landscape FEL analysis Secondary structure analysis SSA MMGBSA calculations including perresidue decomposition employed characterize binding interactions Furthermore ADMET property also conducted diazin see druggability analysis revealed 449 upregulated 644 downregulated gene following daidzin treatment KEGG pathway enrichment indicated significant downregulation cancerassociated pathways including PI3KAkt signaling focal adhesion cytokinecytokine receptor interactions Expression validation analysis confirmed daidzin effectively target inhibits key oncogene KRAS CCND1 CDH11 MDM2 play crucial role BC progression serve diagnostic biomarkers Molecular docking demonstrated favorable binding affinity daidzin oncogenic proteins MD simulations PCA FEL SSA MMGBSA result confirmed stable favorable interactions particularly KRAS CCND1 MDM2 Additionally frontier molecular orbital FMO molecular electrostatic potential MEP analysis revealed high chemical reactivity daidzin Additionally ADMET profiling confirmed favorable druglike property acceptable pharmacokinetic characteristic daidzin Overall integrated analysis suggests daidzin could serve promising natural agent breast cancer chemoprevention targeting downregulating essential oncogene disrupting critical cancerassociated signaling pathways",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40627944/"
    },
    {
        "pmid": "40623792",
        "title": "Patient experience with cancer care in low- and middle-income Asian countries: a cross-sectional study of patients with advanced cancer.",
        "abstract": "Despite disproportionate burden cancer morbidity mortality low middleincome country LMICs little known patients care experience settings study assesses aspect physician communication care coordination influence patients overall experience care factor associated patient experience ratings inform quality improvement improve cancer care experience LMICs crosssectional study 1933 patient advanced cancer recruited 10 major public hospital seven LMICs Asia patient rated experience physician communication care coordination overall Physician communication mattered patients assessment overall experience care Patient use traditional medicine associated poorer physician communication rating β 138 95 CI 211 065 outpatient care 091 95 CI 024 157 associated higher ratings Patients unsure 077 95 CI 143 010 cancer stage relative aware latestage indicated financial difficulty sufficient money cover daily need fairly well 077 95 CI 150 004 poorly 120 95 CI 230 009 relative well rated care coordination lower Patient experience rating differed minority group status cancer severity understanding Respondents identifying ethnic minority unsure cancer stage rated physician communication significantly higher 164 95 CI 071 258 nonminorities aware advanced cancer Nonminorities unsure cancer stage rated care coordination significantly lower 100 95 CI 164 036 nonminority patient aware cancer stage study provides new understanding care priority among patient advanced cancer LMICs finding highlight importance patient attribute physician communication consideration improving patientcentred communication support equitable culturally appropriate care study also underscore need future work navigating prognostic discussion LMICs",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Neoplasms",
            "Female",
            "Male",
            "Middle Aged",
            "Physician-Patient Relations",
            "Developing Countries",
            "Adult",
            "Asia",
            "Communication",
            "Aged",
            "Patient Satisfaction"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40623792/"
    },
    {
        "pmid": "40621710",
        "title": "L-quebrachitol Modulates the Anti-convulsant Effects of Carbamazepine Possibly Through Voltage-gated Sodium Channel Blocking Mechanism in Chicks: In Vivo and In Silico Studies.",
        "abstract": "LQuebrachitol LQB naturally occurring bioactive compound exhibit antiinflammatory antioxidant anticancer antidiabetic properties However therapeutic potential convulsant management remains largely unexplored objective study investigate anticonvulsant effect LQB Vivo model examine molecular interaction via Silico docking simulations Vivo study pentylenetetrazol PTZ administered intraperitoneally ip 80 mgkg induce convulsions test animal treated orally three dos LQB 1 5 10 mgkg carbamazepine CBZ 80 mgkg standard drug result indicated LQB tested dos significantly p  005 prolonged seizure latency decreased convulsion frequency 10 mgkg dose showing significant effects Furthermore combination LQB 10 mgkg CBZ 80 mgkg resulted synergistic increase anticonvulsant activity Silico study molecular docking analysis revealed LQB CBZ interacted voltagegated sodium channel VGSC key receptor involved convulsions LQB demonstrating binding affinity BA 54 kcalmol moderate compared CBZs BA LQB showed potential anticonvulsant activity PTZinduced convulsion animals possibly blocking sodium channel receptors study needed clarify mechanism clinical potential convulsion treatment",
        "mesh_terms": [
            "Animals",
            "Anticonvulsants",
            "Carbamazepine",
            "Seizures",
            "Pentylenetetrazole",
            "Molecular Docking Simulation",
            "Voltage-Gated Sodium Channel Blockers",
            "Chickens",
            "Voltage-Gated Sodium Channels",
            "Male",
            "Computer Simulation",
            "Convulsants"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40621710/"
    },
    {
        "pmid": "40621696",
        "title": "Terahertz Photonic Crystal Fiber Sensor for Cancer Cell Detection: Performance Analysis and Discrimination.",
        "abstract": "Cancer cell exhibit significant heterogeneity making detection challenging task study unique Photonic Crystal Fiber PCF sensor circular core design curved trapezoidal cladding presented especially designed detect cancer cell efficiently proposed sensor demonstrates exceptional performance achieving maximum relative sensitivity RS 9971 breast cancer type II cells along similarly high sensitivity cervical adrenal gland skin blood breast cancer type cells Key performance parameter highlight accuracy detecting cancer cell via minute change refractive index RI including ultralow confinement loss CL 669 × 10sup13sup dBcm effective material loss EML low 000161 cmsup1sup sensors high accuracy rapid response time ability selectively target tumor cell make breakthrough early cancer detection Moreover compact size potential easy fabrication enhance applicability emergency settings cuttingedge approach represents major advancement medical technology paving way efficient targeted cancer diagnostics",
        "mesh_terms": [
            "Humans",
            "Biosensing Techniques",
            "Neoplasms",
            "Cell Line, Tumor",
            "Optical Fibers",
            "Photons",
            "Female",
            "Equipment Design"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40621696/"
    },
    {
        "pmid": "40619274",
        "title": "From Bench to Bedside in Emerging Therapies for Gynecological Malignancies: A Narrative Review.",
        "abstract": "Gynecological malignancies including cervical endometrial ovarian cancers pose significant global health challenge due increasing incidence limitation conventional treatments Current therapeutic approaches surgery chemotherapy radiation often face obstacle like multidrug resistance tumor recurrence adverse side effects response emerging therapiesincluding targeted therapy immunotherapy gene therapyare reshaping treatment paradigms Precision medicine leveraging Poly ADPribose Polymerase PARP Vascular Endothelial Growth Factor VEGF inhibitors enhances therapeutic efficacy immune checkpoint inhibitor vaccinebased therapy offer promising immunotherapeutic strategies Additionally advancement nanotechnology gene therapy including Clustered Regularly Interspaced Short Palindromic Repeats CRISPR based approach nanoparticlemediated drug delivery provide novel treatment modalities Despite innovations translational challenge persist necessitating research clinical application personalized treatment strategies review highlight latest advancement emerging therapy gynecological malignancies emphasizing potential improve patient outcome address existing treatment limitations",
        "mesh_terms": [
            "Humans",
            "Female",
            "Genital Neoplasms, Female",
            "Genetic Therapy",
            "Immunotherapy",
            "Precision Medicine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40619274/"
    },
    {
        "pmid": "40619062",
        "title": "Estimating the burden of cancer attributable to tobacco in Bangladesh in 2020.",
        "abstract": "Information attributable fraction AF cancer Bangladesh scarce aimed estimating AF tobaccorelated cancer Bangladesh 2020 Data prevalence tobacco use smokeless smoking products secondhand smoke SHS derived Global Adult Tobacco Survey report 2009 data relative risk derived metaanalyses largescale Indian studies GLOBOCAN 2020 database used obtain number cancer case deaths Concomitant use tobacco product accounted for Sexspecific combined estimate calculated based counterfactual scenario exposure tobacco Smokeless tobacco primarily responsible oral 553  esophageal 371  laryngeal 334  pharyngeal 315  cancer Cigarette smoking responsible mainly esophageal 401  pancreatic 342  lung 260  cancer bidi caused mainly pharyngeal 492  laryngeal 364  esophageal 333  cancer Overall smokeless tobacco caused 146  case 151  deaths cigarette smoking caused 118  case 153  death bidi smoking 141  case 158  deaths SHS caused 010  013  case death respectively combined use tobacco product particularly contributed esophageal pancreatic cancers Tobacco major cause cancer Bangladesh 2020 smokeless bidi smoking overcoming cigarettes contribution control would greatly reduce cancer burden",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40619062/"
    },
    {
        "pmid": "40618695",
        "title": "An integrated approach for key gene selection and cancer phenotype classification: Improving diagnosis and prediction.",
        "abstract": "identification key feature reliable phenotype classification remains pivotal cancer research direct implication early diagnosis prognosis treatment optimization cost reduction healthcare study introduces hybrid model integrates statistical machine learning ML algorithm enhance feature selection improve classification accuracy cancer phenotypes Five wellknown statistical test LIMMA SAM ANOVA KWtest ttest employed identify significant feature based statistical decision markers dominant feature identified across binary multiclass datasets used cancer phenotype classification using various ML methods including LDA LR NB GPC KNN ANN SVM with radial polynomial linear kernels RF models robustness validated using eight distinct microarray gene expression datasets combined various resampling protocols result show consistent improvement previous benchmark literature RF classifier performing better binary classification task SVMr demonstrating superior performance multiclass settings Additionally analysis bladder cancer dataset led identification 13 key gene MYH11 CCN1 FHL1 MYL9 EFEMP1 FILIP1L RGS2 MATN2 CALD1 TNC PALLD ADAMTS9AS2 CELF2 demonstrated strong discriminatory power gene validated enrichment relevant GO term KEGG pathways emphasizing diagnostic prognostic significance Moreover GeneTF GenemiRNA network analysis highlighted critical regulators including TFs like CYR61 SMAD4 SOX2 TP63 AR along miRNAs hsalet7b5p hsamiR34a5p hsalet7a5p hsalet7c5p hsamiR165p underscoring functional impact selected features conclusion proposed approach effectively generates streamlined set optimal features providing valuable biological insight laying groundwork accurate effective tool cancer diagnosis prediction",
        "mesh_terms": [
            "Humans",
            "Neoplasms",
            "Biomarkers, Tumor",
            "Databases, Genetic",
            "Machine Learning",
            "Gene Expression Profiling",
            "Algorithms",
            "Phenotype"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40618695/"
    },
    {
        "pmid": "40617988",
        "title": "Developing a formulation of Tinospora cordifolia, identifying its active components, and assessing its anticancer effects on breast cancer cell lines.",
        "abstract": "Tinospora cordifolia Willd Miers medicinal plant recognised pharmacological potential work present development innovative nanoliposomal formulation assesses anticancer efficacy breast cancer cell lines sustainable green extraction method employed isolate bioactive compound T cordifolia followed development nanoliposomal formulation Particle size morphology assessed using field emission scanning electron microscopy FESEM revealing soft globular vesicle average diameter  153 nm GCMS profiling identified 35 phytoconstituents subjected molecular docking topoisomerase IIα predict anticancer potential biological activity formulation validated MTT assay cell viability scratch assay cell migration apoptosis assay MCF7 MDA MB 231 breast cancer cell lines Immunocytochemistry used evaluate expression Bcl2 cytochromeC caspase3 ROS generation also quantified confirm mechanism action silico analysis identified glucobrassicin potent topoisomerase IIα inhibitor docking score  102655 formulation exhibited dosedependent cytotoxicity inhibited cell migration induced apoptosis cell lines ROSmediated cell death associated increased cytochromeC caspase3 expression decreased Bcl2 levels study underscore value integrating green nanotechnology computational docking functional cellbased assay identify characterise bioactive phytochemicals T cordifoliabased liposomal formulation demonstrated promising anticancer activity warrant preclinical evaluation candidate breast cancer therapy",
        "mesh_terms": [
            "Humans",
            "Tinospora",
            "Breast Neoplasms",
            "Female",
            "Apoptosis",
            "Plant Extracts",
            "Cell Line, Tumor",
            "Molecular Docking Simulation",
            "Liposomes",
            "Antineoplastic Agents, Phytogenic",
            "MCF-7 Cells",
            "Cell Movement",
            "Cell Survival"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40617988/"
    },
    {
        "pmid": "40612872",
        "title": "Clinically proven natural products against breast cancer, with mechanistic insights.",
        "abstract": "Breast cancer still stand foremost contributor cancerrelated incidence mortality woman globally accounting 14 female cancerrelated death worldwide research seek illustrate mechanism clinical finding natural product breast cancer treatment Required data review article retrieved employing several readily obtainable search databases including Web Sciencesup®sup Thomson Reuters USA PubMedsup®sup US National Library Medicine USA SciVerse Scopussup®sup Elsevier Properties SA USA taking consideration certain search term like breast cancer natural product breast cancer Clinically proven natural product treatment breast cancer on Several natural products namely Omega3 fatty acids dietary isothiocyanates curcumin green tea flaxseed limonene others found modulate crucial pathway breast cancer cells substance suppressed angiogenesis downregulating vascular endothelial growth factor VEGF promoted apoptosis activating caspase enzymes prevented cell proliferation controlling cyclindependent kinases Clinical study demonstrated improved outcome patient receiving natural product standard treatment procedures finding underscore multifaceted function natural product breast cancer therapy highlighting potential increase efficacy conventional treatment reducing adverse effects exploration synergistic action optimal dosage needed Clinically proven natural product represent potential avenue breast cancer treatment mechanistic insight facilitate incorporation treatment regimens maximize clinical applications future inquiry center elucidating full spectrum anticancer functions",
        "mesh_terms": [
            "Humans",
            "Breast Neoplasms",
            "Female",
            "Biological Products",
            "Apoptosis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40612872/"
    },
    {
        "pmid": "40607631",
        "title": "The Role of Iron Chelation Therapy in Colorectal Cancer: A Systematic Review on Its Mechanisms and Therapeutic Potential.",
        "abstract": "Despite significant therapeutic advancement recent decades colorectal cancer CRC continues exhibit high rate mortality morbidity Chemoresistance cancer recurrence remain substantial challenges underscoring need novel treatment approaches Iron chelation therapy gained profound interest year potential cancer treatment leveraging increased iron demand tumors review evaluates effect iron chelation therapy CRC progression underlying mechanisms comprehensive review vivo vitro study conducted assess effectiveness iron chelation therapy CRC literature search covered PubMed Scopus Medline via Web Science EMBASE January 1995 March 2024 Several vitro vivo study investigated impact iron chelators deferoxamine deferasirox thiosemicarbazonebased chelators quilaminebased chelators novel compound CRC Natural plant extract ironchelating property also explored potential treatments study indicate iron chelation inhibit proliferation colon cancer cells though study suggest cancerpromoting effects Mechanistically iron chelation affect several hallmark CRC modulating histone methylation upregulating NDRG1 influencing Wntβcatenin p53 signaling pathways However certain iron chelators may inhibit TRAILmediated apoptosis activate hypoxiainducible factor HIF potentially accelerating CRC progression Future exploration iron chelation therapy CRC focus extensive vitro vivo clinical study elucidate precise mechanism involved deeper understanding genetic cellular alteration induced iron chelation enhance development effective therapeutic strategy CRC",
        "mesh_terms": [
            "Humans",
            "Iron Chelating Agents",
            "Colorectal Neoplasms",
            "Animals",
            "Iron",
            "Chelation Therapy"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40607631/"
    },
    {
        "pmid": "40606051",
        "title": "Factors affecting disease control after pituitary tumor resection in acromegaly: What is the current evidence?",
        "abstract": "Acromegaly characterized persistent hypersecretion growth hormone GH often caused pituitary neuroendocrine tumor PitNET though less often ectopic GH GHreleasing hormone secretion various neoplasm outside pituitary gland could cause it Nearly 70 somatotroph PitNETs macroadenomas diagnosis Transsphenoidal surgery effective treatment modality acromegaly could achieve remission 73 However remission rate could reach 87 surgery followed medical therapy Due variable therapeutic response surgical medical therapy pretreatment awareness regarding best therapeutic modality based clinical biochemical radiological histopathological genetic parameter would help accurate pretreatment decisionmaking Earlier study identified poor prognosis marker like tumor size tumor invasion T2weighted hyperintensity granulation pretreatment GH andor insulinlike growth factor 1 levels recent study published Alvarez iet ali identified preoperative PitNET volume good predictor control acromegaly following surgical treatment likelihood requiring aggressive additional therapy surgery found PitNET volume exceeding 3697 mm³ associated poorer disease control patient somatotroph PitNETs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40606051/"
    },
    {
        "pmid": "40598504",
        "title": "Out-of-pocket cost and financial catastrophe of patients with cancer: the alarming cost-of-illness in Bangladesh.",
        "abstract": "Outofpocket OOP cost cancer treatment increased substantially globally low middleincome countries many patient face financial distress due cancer patient cancer Bangladesh study aimed 1 estimate annual OOP cost cancer households perspective 2 assess coping strategy financial distress 3 examine factor associated OOP cost used data crosssectional hospitalbased survey conducted three randomly selected hospital Bangladesh bottomup microcosting approach used estimate OOP cost components used logistic regression model generalized linear model examine determinant distress financing OOP cost respectively average annual OOP cost per cancer patient US 6504 range US 959  29681 greater 2 time average annual household income 90 household faced distress financing due cancer least one comorbid condition cancer stage 2 higher household elderly people treatment abroad significantly associated higher OOP cost compared without condition OOP cost cancer treatment proportion patient distress financing financial catastrophe alarmingly high Bangladesh Earlier cancer diagnosis implementation Government financial health protection scheme crucial urgent alleviate enormous economic burden ensure equitable access care patients",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Neoplasms",
            "Female",
            "Male",
            "Cross-Sectional Studies",
            "Health Expenditures",
            "Cost of Illness",
            "Middle Aged",
            "Adult",
            "Financing, Personal",
            "Surveys and Questionnaires",
            "Aged",
            "Financial Stress",
            "Adolescent",
            "Adaptation, Psychological"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40598504/"
    },
    {
        "pmid": "40594738",
        "title": "An enhanced deep learning model for accurate classification of ovarian cancer from histopathological images.",
        "abstract": "Ovarian Cancer malignancy develops ovarian cell frequently characterized aberrant cell proliferation lead creation tumor within ovaries high death rate often delayed discovery Ovarian Cancer make serious healthcare concern Due annual 207000 fatality 314000 new case worldwide Ovarian Cancer pose serious threat public health making quick precise detection classification technique essential work discusses importance Ovarian Cancer diagnosis present new model Ovarian Cancer classification also showcase comparative analysis stateoftheart model Ovarian Cancer Using Ovarian Cancer image dataset data sample named Clear Cell Endometri Mucinous Serous NonCancerous compare proposed OvCanFIND model wide range CNNbased architectures Inception V3 different EfficientNet variants ResNet152V2 MobileNet MobileNetV2 VGG16 VGG19 Xception study examines recent Ovarian Cancer classification algorithm context increase prognosis diagnostic accuracy proposed OvCanFIND model outperforms base model exceptional accuracy 9974 model present significant prospect enhancing ovarian cancer early identification diagnosis ultimately enhance patient outcomes",
        "mesh_terms": [
            "Humans",
            "Female",
            "Ovarian Neoplasms",
            "Deep Learning",
            "Algorithms"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40594738/"
    },
    {
        "pmid": "40593602",
        "title": "Prevalent chromosome fusion in Vibrio cholerae O1.",
        "abstract": "Two circular chromosome defining feature bacterial family Vibrionaceae including pathogen Vibrio cholerae rare report isolates single fused chromosome Here use longread sequencing analyse 467 V cholerae O1 isolates 47 cholera patient household contact Bangladesh identify several independent chromosome fusion event likely transmissible within household Fusions occur 12 kilobasepair homologous sequence shared two chromosome stable least 200 generation laboratory conditions find detectable effect fusion V cholerae growth virulence factor expression biofilm formation factor promoting fusion affecting chromosome stability subtle phenotypic clinical consequence merit investigation",
        "mesh_terms": [
            "Chromosomes, Bacterial",
            "Vibrio cholerae O1",
            "Cholera",
            "Humans",
            "Bangladesh",
            "Biofilms",
            "Virulence Factors",
            "Genome, Bacterial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40593602/"
    },
    {
        "pmid": "40587024",
        "title": "Coumarin derivatives as anticancer agents targeting PI3K-AKT-mTOR pathway: a comprehensive literature review.",
        "abstract": "Coumarin natural benzopyrone compound known diverse pharmacological activities including anticancer antiinflammatory antioxidant properties derivatives exploration cancer specially PI3KAKTmTOR pathwaysbased cancer activity explored yet review aim evaluate anticancer potential coumarin derivatives exploring modulatory effect PI3KAKTmTOR signaling pathway across diverse cancer types review adopted systematic literature approach emphasizing study across various cancer type focusing coumarins mechanism therapeutic potential Results reveal coumarin derivative suppress PI3KAKTmTOR pathway activity across cancers liver breast colorectal ICsub50sub value ranging 4 µM  200 µM vitro confirmed effect vivo modulation pathways including NFκB MAPK underscore multitargeted anticancer action Despite promising preclinical efficacy challenge like low bioavailability potential hepatotoxicity systemic toxicity persist Structureactivity relationship SAR study suggest introducing specific functional group enhance selectivity reduce toxicity improve therapeutic outcomes conclusion reinforces potential coumarin derivative novel anticancer agents advocating structural optimization clinical investigation overcome pharmacokinetic barrier maximize therapeutic benefits exploration offer strategic perspective utilizing coumarinbased molecule advancing cancer therapeutics",
        "mesh_terms": [
            "Humans",
            "Coumarins",
            "TOR Serine-Threonine Kinases",
            "Antineoplastic Agents",
            "Signal Transduction",
            "Proto-Oncogene Proteins c-akt",
            "Neoplasms",
            "Phosphatidylinositol 3-Kinases",
            "Animals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40587024/"
    },
    {
        "pmid": "40583688",
        "title": "Primary Leiomyoma of Ovary: A Case Report.",
        "abstract": "Leiomyoma common benign mesenchymal tumor uterus develop location containing smooth muscle cells broad ligament frequent extrauterine site ovary among rarest representing 0510 benign ovarian tumors Primary ovarian leiomyoma benign ovarian tumor typically occurs woman aged 20 65 often discovered incidentally pelvic examinations ultrasound imaging pathological analysis following surgery reporting case 38yearsold woman presented history lower abdominal pain left side Ultrasonography whole abdomen revealed left adnexal mass Unilateral salpingooophorectomy performed Ovarian leiomyoma diagnosed surgery followed histopathologic examination confirmed immunohistochemistry",
        "mesh_terms": [
            "Humans",
            "Female",
            "Leiomyoma",
            "Adult",
            "Ovarian Neoplasms",
            "Salpingo-oophorectomy"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583688/"
    },
    {
        "pmid": "40583684",
        "title": "Patterns of Presentation of Hepatocellular Carcinoma in a Tertiary Care Hospital in Bangladesh.",
        "abstract": "Hepatocellular carcinoma common primary liver cancer Chronic viral hepatitis alcohol abuse NAFLD common cause hepatocellular carcinoma Usually patient present advanced stage curative treatment longer possible study aimed find clinical presentation etiology stage presentation among patient hepatocellular carcinoma tertiary care center retrospective observational study conducted single tertiary care center July 2023 June 2024 study done among inpatient Department Hepatology 30 Cases recorded confirmed hepatocellular carcinoma period Among 30 patients 5333 patient 60 year age 7666 HBsAg positive 900 patient symptomatic among abdominal pain common Features cirrhosis hepatomegaly main physical findings Normal alphafetoprotein level 1333 patients 9666 patient advanced age curative treatment feasible Hepatocellular carcinoma significant concern crucial identify highrisk patients lead screening using serum alphafetoprotein level ultrasonography liver urgent need discover effective treatment method managing condition particularly advanced stages",
        "mesh_terms": [
            "Humans",
            "Carcinoma, Hepatocellular",
            "Liver Neoplasms",
            "Male",
            "Middle Aged",
            "Female",
            "Tertiary Care Centers",
            "Retrospective Studies",
            "Bangladesh",
            "Adult",
            "Aged",
            "alpha-Fetoproteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583684/"
    },
    {
        "pmid": "40583676",
        "title": "Clinical Significance of Preoperative Serum CEA and CA 19-9 Level in Different Stages of Gastric Cancer.",
        "abstract": "aim prospective study identify relationship CEA CA 199 different stage carcinoma stomach current study conducted Department General Surgery Bangabandhu Sheikh Mujib Medical University Bangladesh January 2021 February 2022 crosssectional observational study 52 patient histologically established stomach cancer enrolled Patient categorized two group elevated not elevated CEA CA199 group preoperative measurement CEA CA199 level 654 cancer stage III 231 stage IV stage tumor account 19 malignancies stage I II III IV stomach cancer CEA increased 43 13 609 217 CA199 increased 00 211 632 158 Gastric cancer raised serum CEA CA 199 level may present advanced stage extensive surgery stage may produce poorer outcome GC CA 199 CEA may used monitoring prognostic tool",
        "mesh_terms": [
            "Humans",
            "Stomach Neoplasms",
            "CA-19-9 Antigen",
            "Carcinoembryonic Antigen",
            "Male",
            "Female",
            "Middle Aged",
            "Cross-Sectional Studies",
            "Prospective Studies",
            "Neoplasm Staging",
            "Aged",
            "Adult",
            "Biomarkers, Tumor",
            "Bangladesh",
            "Preoperative Period",
            "Clinical Relevance"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583676/"
    },
    {
        "pmid": "40583674",
        "title": "High-Risk Human Papilloma Virus Genotyping in Patients with Clinically Suspected Precancerous and Cancerous Lesions of Cervix.",
        "abstract": "Nowadays human papilloma virus HPV testing added cytology aid detection highgrade cervical lesions especially woman aged ≥30 years study aimed evaluate relationship highrisk HPV hrHPV genotype clinicopathological parameter among diagnosed patient precancerous cancerous cervical lesions crosssectional study carried Department Pathology Dhaka Medical College collaboration DNA Solution LTD Dhaka Bangladesh study conducted period 24 month July 2018 June 2020 Following informed written consent total 51 woman 18 patient clinically suspected malignant lesion 33 positive VIA test included study subjected colposcopic examination performed gynecologist Ethical issue ensured accordance 1975 Declaration Helsinki SPSS version 240 used data analysis average age ±SD patient cervical lesion 4186±984 year range 25 60 years Approximately half participant n25 490 married less 16 year almost onetenth multiparous Among cytological histological findings hrHPV16 n21 4118 commonest followed hrHPV18 n3 588 hrHPV68 n1 196 Two patient coinfection hrHPV 16 18 hrHPV 16 51 particular However rest 24 case remained undetected Among hrHPVpositive case n27 hrHPV16 detected 5 case negative intraepithelial lesions cervical swabs 6 case hrHPV16 2 case hrHPV18 one case coinfection hrHPV 16 18 histologically diagnosed invasive SCC GII Among 51 cases common histological diagnosis CIN n18 353 hrHPV genotyping found associated cytological finding histological diagnosis",
        "mesh_terms": [
            "Humans",
            "Female",
            "Adult",
            "Uterine Cervical Neoplasms",
            "Middle Aged",
            "Cross-Sectional Studies",
            "Precancerous Conditions",
            "Papillomavirus Infections",
            "Bangladesh",
            "Genotype",
            "Papillomaviridae",
            "Uterine Cervical Dysplasia",
            "Human Papillomavirus Viruses"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583674/"
    },
    {
        "pmid": "40583670",
        "title": "Fluconazole Prophylaxis in Children with Acute Leukemia during Induction Chemotherapy in a Tertiary Care Hospital in Bangladesh.",
        "abstract": "Patients hematological malignancy often develop febrile neutropenia FN complication cancer chemotherapy Opportunistic infection especially invasive fungal infection IFI frequently encountered neutropenic phase perspective different antifungal agent tried prophylaxis leukemia Evaluation role fluconazole antifungal prophylaxis child acute leukemia induction chemotherapy randomized doubleblind placebo controlled prospective study carried Department Pediatric Hematology Oncology Bangladesh Medical University BMU Bangladesh September 2016 August 2017 Total 60 30 fluconazole 30 placebo group patient age range 1 18 year included study Mean age patient 708±333 year fluconazole group 629±279 year placebo group Male Female ratio 1141 total 60 patient 44 16 AML Mean duration neutropenia fluconazole placebo group 1340±575 day placebo 1683±577 day respectively Success rate fluconazole prophylaxis 25833 Failure rate placebo 400 Duration empirical antifungal therapy fluconazole placebo group differed significantly p0008 Difference neutrophil recovery achievement two group also significant p0015 mean duration AFP EAF therapy 1760±151 day 1433±572 day patient fluconazole placebo group respectively Prophylactic fluconazole used decrease fungal infection well duration febrile neutropenia induction chemotherapy Acute Leukemia children",
        "mesh_terms": [
            "Humans",
            "Fluconazole",
            "Child",
            "Female",
            "Male",
            "Bangladesh",
            "Child, Preschool",
            "Antifungal Agents",
            "Induction Chemotherapy",
            "Adolescent",
            "Double-Blind Method",
            "Infant",
            "Prospective Studies",
            "Tertiary Care Centers",
            "Leukemia, Myeloid, Acute",
            "Precursor Cell Lymphoblastic Leukemia-Lymphoma"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583670/"
    },
    {
        "pmid": "40583667",
        "title": "Comparison of ELTS Score with Sokal, Euro and EUTOS Scores in Risk Stratification of Patients with Chronic Myeloid Leukaemia at a Tertiary Care Hospital in Bangladesh.",
        "abstract": "Chronic myeloid leukaemia CML common myeloproliferative neoplasm characterized constitutional tyrosine kinase activation resulting translocation chromosome 9 22 treatment second line tyrosine kinase inhibitor often preferred ahead first line tyrosine kinase inhibitor patient highrisk disease Historically prognostic score  Sokal Euro European Treatment Outcome Study EUTOS score utilized risk stratification 2016 newer risk scoring system  European Treatment Outcome Study EUTOS Long Term Survival ELTS score formulated European Leukaemia Net recommended ELTS score preferred scoring system CML 2020 study stratified CML Chronic Phase patient utilizing four available risk scoring system observational study conducted among chronic myeloid leukaemia patient Bangabandhu Sheikh Mujib Medical University BSMMU Bangladesh June 2020 April 2021 Fifty CML patient chronic phase enrolled study using purposive sampling technique Risk stratification done using Sokal Euro EUTOS ELTS scores Among study participants 140 identified highrisk case using ELTS score Previously used score  Sokal score Euro score EUTOS score identified 320 80 100 case highrisk disease respectively Sokal Euro score moderate kappa 0403 0469 respectively agreement ELTS score EUTOS ELTS score slight kappa 0073 agreement ELTS score adopted preferred prognostic tool CML patients",
        "mesh_terms": [
            "Humans",
            "Leukemia, Myelogenous, Chronic, BCR-ABL Positive",
            "Male",
            "Female",
            "Bangladesh",
            "Middle Aged",
            "Adult",
            "Tertiary Care Centers",
            "Risk Assessment",
            "Aged",
            "Prognosis",
            "Young Adult",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583667/"
    },
    {
        "pmid": "40583664",
        "title": "Frequency and Pattern of Premalignant and Malignant Lesions among Fecal Immunochemical Test Positive Patients.",
        "abstract": "Colorectal cancer challenging clinical entity worldwide Adenomatous polyp considered precursor cancer Detection confirmation mucosal healing ulcerative colitis require colonoscopy early detection polyp ulcers different screening investigation like colonoscopy Fecal Immunochemistry Test gFOBT CT colonography etc used Though gold standard colonoscopy diagnostic therapeutic roles Fecal Immunochemistry Test detect advanced adenoma established cancer mucosal status Ulcerative colitis Fecal Immunochemistry Test less expensive technique early detection colonic pathology suitable demographic aim study observe frequency pattern premalignant malignant lesion among Fecal Immunochemical Test FIT positive patients observational crosssectional study conducted July 2019 June 2020 among 105 Fecal Immunochemical Test FIT positive patients observational crosssectional study carried Department Colorectal Surgery Bangabandhu Sheikh Mujib Medical University private hospitals Bangladesh FIT test done ICDDRB Among 105 Fecal immunochemical test positive study patients colonoscopy evaluation done Among these 58 case 552 revealed different type polyps Pedunculated polyp 42400 predominant present 42400 patients polyps ulcer 14133 malignant looking growth 329 hemorrhoid 13124 normal finding 15143 cases age range 4070 years mean age 5173±797 years Adenomatous polyp malignancy 47447 548 Advanced adenoma 11104 cases Thirty six 621 polyp left colon Patients normal findings diverticulosis hemorrhoid undergone biopsy Fecal immunochemical test FIT predominantly detect adenomas especially advanced adenoma precursor lesions study finding showed nonneoplastic neoplastic polyp ulcer occult bleeding So became FIT positive Though colonoscopy gold standard detection polyps ulcers malignant lesions FIT good supportive tool screening",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Male",
            "Female",
            "Middle Aged",
            "Colorectal Neoplasms",
            "Adult",
            "Feces",
            "Colonoscopy",
            "Aged",
            "Precancerous Conditions",
            "Occult Blood",
            "Bangladesh",
            "Early Detection of Cancer",
            "Immunochemistry"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583664/"
    },
    {
        "pmid": "40583656",
        "title": "Association between Duration of Visual Symptoms and Early Postoperative Visual Outcome Following Pituitary Macroadenoma Surgery.",
        "abstract": "Pituitary tumor represent approximately 100170 intracranial tumors However may grow large extend surrounding structures resulting neurological hormonal complications including visual impairment duration visual involvement help predict visual outcome pituitary surgery helpful patient counseling prospective observational study conducted neurosurgery department Bangabandhu Sheikh Mujib Medical University BSMMU Bangladesh patient fulfilled selection criterion included specific criteria enrolled study divided two group according Duration visual symptoms total 24 patient selected 12 presented visual symptom less six month duration included first group 12 patient 6 month duration included second group Patient data recorded predetermined data sheet ophthalmologist examined visual status Data processed analyzed using SPSS version 220 appropriate statistical test data analysis Chisquare test student ttest performed Statistical significance pvalue 005 95 confidence interval level age distribution 24 patient ranged 1764 years mean ±SD age 3621±137 Males slightly preponderance female series maletofemale ratio 121 patient presented visual problem 1000 majority 933 patient presented headache 6 patient 250 presented acromegaly 1 patient 42 presented hypothyroid 3 patient 125 presented amenorrhea galactorrhea Regarding visual acuity symptom less 6 months 583 improved 417 improved Visual symptom 6 month duration 250 24 eye improved 18750 improve postoperatively found visual symptom less 6 month improved better postoperatively pvalue 0001 study reveals significant association duration preoperative visual symptom early postoperative visual outcome patient pituitary macroadenoma surgery Specifically patient presenting less 6 month visual symptom showed marked improvement compared six month duration finding provide valuable insight patient counseling early intervention strategies",
        "mesh_terms": [
            "Humans",
            "Female",
            "Male",
            "Adult",
            "Pituitary Neoplasms",
            "Middle Aged",
            "Prospective Studies",
            "Adenoma",
            "Adolescent",
            "Young Adult",
            "Vision Disorders",
            "Postoperative Complications",
            "Time Factors",
            "Treatment Outcome",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583656/"
    },
    {
        "pmid": "40583652",
        "title": "Incidence of Hypoparathyroidism Following Total Thyroidectomy in a Tertiary Care Hospital of Bangladesh.",
        "abstract": "Total thyroidectomy common surgical procedure MNG thyroid malignancy without lymph node metastasis Post total thyroidectomy hypoparathyroidism uncommon Understanding prevalence temporary permanent hypoparathyroidism posttotal thyroidectomy important improving patient outcomes prospective observational study conducted Mymensingh Medical College Hospital Mymensingh Bangladesh January 2023 December 2023 92 case selected purposively underwent total thyroidectomy MNG thyroid malignancy without extra thyroidal extension incidence transient permanent hypoparathyroidism total thyroidectomy demographic variables postoperative day onset hypocalcemia analyzed Data collection done patient record postoperative followups study revealed 230 patient experienced hypoparathyroidism postoperatively Hypoparathyroidism prevalent among patient underwent total thyroidectomy thyroid malignancy 4783 compared undergoing total thyroidectomy benign thyroid disease 1739 majority hypocalcemia case 6087 occurred second postoperative day Among 23 case postoperative hypoparathyroidism temporary hypoparathyroidism 6957 permanent hypoparathyroidism 3043 total thyroidectomy Hypoparathyroidism remains significant complication Early identification management atrisk patient necessary reduce severity complication",
        "mesh_terms": [
            "Humans",
            "Thyroidectomy",
            "Hypoparathyroidism",
            "Female",
            "Male",
            "Bangladesh",
            "Adult",
            "Incidence",
            "Middle Aged",
            "Tertiary Care Centers",
            "Prospective Studies",
            "Postoperative Complications",
            "Thyroid Neoplasms",
            "Hypocalcemia"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583652/"
    },
    {
        "pmid": "40583645",
        "title": "Relation of Hormonal Status with Clinical Features among Patients with Polycystic Ovarian Syndrome Attending in a Tertiary Care Hospital of Bangladesh.",
        "abstract": "Polycystic ovary syndrome PCOS common heterogeneous disorder characterized oligo anovulation menstrual disturbances androgen excess PCOS usually begin puberty manifested hirsutism obesity insulin resistance acanthosis nigricans acrochordons menstrual irregularities Aim study assess relation clinical feature PCOS different hormonal level pattern crosssectional descriptive type observational study conducted Department Obstetrics  Gynaecology Endocrinology Mymensingh Medical College Hospital MMCH Bangladesh period January 2018 December 2018 Total 108 patient included study Sample selected purposive non randomized sampling Data processed using Statistical Package Social Sciences version 230 Ethical clearance taken Institutional Review Board IRB MMC Majority 444 patient belonged age group 2130 year mean age 238±62 years Majority 574 patient married Majority 917 patient hirsutism followed 40370 acne 40370 acanthosis nigricans 16148 weight gain sub fertility study 0328 patient found underweight 40370 overweight 11102 obese mean Hirsutism Modified Ferriman Galway score found 105±29 range 4 20 three fourth 759 oligo menorrhea 20185 amenorrhea 656 patient menorrhagia Eighty 741 patient normal thyroid 28259 hypothyroid Sixty 556 patient found normal HDL 48 444 found high HDL level Mean serum testosterone found 128±022 ngml USG Pelvic Organs 27270 patient unilateral 73730 bilateral PCOS ovary 0874 patient PCOS USG Serum testosterone level 689315 higher bilateral group Based finding study concluded early detection specific clinical feature related PCOS effective screening hormone FSH LH TSH Prolactin Testosterone sonographic finding detect PCOS patient early stage thus reduce PCOS related symptom infertility",
        "mesh_terms": [
            "Humans",
            "Female",
            "Polycystic Ovary Syndrome",
            "Bangladesh",
            "Adult",
            "Cross-Sectional Studies",
            "Young Adult",
            "Tertiary Care Centers",
            "Hirsutism",
            "Testosterone",
            "Acanthosis Nigricans"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40583645/"
    },
    {
        "pmid": "40575949",
        "title": "Insomnia, Pain, and Pain-Related Dysfunctional Beliefs About Sleep among Patients with Cancer.",
        "abstract": "explored reliability validity Painrelated Beliefs Attitudes Sleep PBAS scale among patient cancer Further compared usability PBAS scale Cancerrelated Dysfunctional Beliefs Attitudes Sleep14 CDBAS14 among patient cancer medical record 252 patient cancer visited Sleep Clinic August 1 2023 June 30 2024 retrospectively analyzed response enrolled patient PBAS CDBAS14 Insomnia Severity Index ISI Numeric Rating Scale pain collected internal consistency reliability PBAS scale excellent Cronbachs alpha 096 Confirmatory factor analysis showed twofactor structure PBAS patient cancer good fit model CFI099 TLI099 RMSEA014 SRMR005 convergent validity Korean version PBAS patient cancer good indicated significant association pain severity r063 p0001 CDBAS14 r033 p0001 ISI r021 p001 PBAS adequately reflected increase pain severity effective appropriate capturing painrelated dysfunctional sleep belief CDBAS14 Korean version PBAS showed high reliability validity patient cancer applicability across cancer type cancerrelated beliefs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40575949/"
    },
    {
        "pmid": "40569503",
        "title": "Anticancer potential of daidzin: a comprehensive literature review.",
        "abstract": "Daidzin DZN naturally occurring isoflavone extracted leguminous plant soybeans gained significant attention anticancer properties study provides comprehensive overview pharmacokinetics PKs botanical sources therapeutic potential DZN focusing mechanistic insight cancer prevention treatment study data collected database PubMed Google Scholar Web Science reputable sources results DZN induces oxidative stress apoptosis cytotoxicity cell cycle arrest inhibiting proliferation migration invasion angiogenesis across various cancer cell lines including breast prostate cervical hepatocellular colon cancers anticancer efficacy mediated modulation key pathways Nuclear Factor kappalightchainenhancer activated B cell NFκB promotes inflammation survival Janus KinaseSignal Transducer Activator Transcription JAKSTAT essential proliferation immune evasion Rat Sarcoma virusRapidly Accelerated Fibrosarcoma RASRAF critical regulator cell growth chemoresistance inhibiting pathways DZN enhances apoptosis chemotherapy sensitivity Additionally DZNs pharmacokinetic profile reveals favorable absorption distribution metabolism excretion ADME properties minimal toxicity preclinical studies ability modulate pathway enhance chemotherapy sensitivity position DZN potential therapeutic candidate Despite promising preclinical findings lack clinical validation underscore need welldesigned human trial confirm efficacy safety paving way translational application oncology",
        "mesh_terms": [
            "Humans",
            "Animals",
            "Neoplasms",
            "Isoflavones",
            "Antineoplastic Agents",
            "Apoptosis",
            "Cell Proliferation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40569503/"
    },
    {
        "pmid": "40565458",
        "title": "Understanding Cancer Risk Among Bangladeshi Women: An Explainable Machine Learning Approach to Socio-Reproductive Factors Using Tertiary Hospital Data.",
        "abstract": "Breast cancer pose significant health challenge Bangladesh limited screening unique reproductive pattern contribute delayed diagnosis subtypespecific disparities reproductive risk factor age menarche parity contraceptive use well studied highincome countries association hormonereceptorpositive HR triplenegative breast cancer TNBC remain underexplored lowresource settings casecontrol study conducted National Institute Cancer Research Hospital NICRH including 486 histopathologically confirmed breast cancer case 246 HR 240 TNBC 443 cancerfree controls Sociodemographic reproductive data collected structured interviews Machine learning modelsincluding Logistic Regression Lasso Support Vector Machines Random Forest XGBoostwere trained using stratified fivefold crossvalidation Model performance evaluated using sensitivity F1score Area Receiver Operating Curve AUROC interpret model prediction quantify contribution individual features employed Shapley Additive exPlanation SHAP values XGBoost achieved highest overall performance F1score  0750 SHAPbased interpretability revealed key predictor subtype Rural residence low education ≤5 years undernutrition significant predictor across subtypes Cesarean delivery multiple abortion predictive TNBC urban residence employment higher education predictive HR Age menarche age first childbirth showed decreasing predictive importance increasing age HR larger gap marriage childbirth predictive TNBC finding underscore value machine learning coupled SHAPbased explainability identifying contextspecific risk factor breast cancer subtypes resourcelimited settings approach enhances transparency support development targeted public health intervention reduce breast cancer disparity Bangladesh",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40565458/"
    },
    {
        "pmid": "40564466",
        "title": "Hierarchical Swin Transformer Ensemble with Explainable AI for Robust and Decentralized Breast Cancer Diagnosis.",
        "abstract": "Early accurate detection breast cancer essential reducing mortality rate improving clinical outcomes However deep learning DL model used healthcare face significant challenges including concern data privacy domainspecific overfitting limited interpretability address issues propose BreastSwinFedNetX federated learning FLenabled ensemble system combine four hierarchical variant Swin Transformer Tiny Small Base Large Random Forest RF metalearner utilizing FL approach ensures collaborative model training across decentralized institutionspecific datasets preserving data locality preventing raw patient data exposure model exhibit strong generalization performs exceptionally well across five benchmark datasetsBreakHis BUSI INbreast CBISDDSM Combined datasetachieving F1 score 9934 BreakHis PR AUC 9889 INbreast Matthews Correlation Coefficient MCC 9961 Combined dataset enhance transparency clinical adoption incorporate explainable AI XAI GradCAM highlight classdiscriminative features Additionally deploy model realtime web application support uncertaintyaware prediction clinician interaction ensures compliance GDPR HIPAA secure federated deployment Extensive ablation study paired statistical analysis confirm significance robustness architectural component integrating transformerbased architectures secure collaborative training explainable outputs BreastSwinFedNetX provides scalable trustworthy AI solution realworld breast cancer diagnostics",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40564466/"
    },
    {
        "pmid": "40553330",
        "title": "Integrating Genetic Insights and Artificial Intelligence for Enhanced Oral and Maxillofacial Cancer Care.",
        "abstract": "integration artificial intelligence AI genetic insight present promising avenue revolutionizing landscape oral maxillofacial cancer OMC care proposed chapter titled aim explore synergistic potential AI genetic understanding advancing OMC diagnosis treatment prognosis chapter delve genetic changes including mutation polymorphisms contributing pathogenesis oral squamous cell carcinoma OSCCs malignancy oral maxillofacial region Additionally elucidate AIdriven applications computer vision machine learning offer novel opportunity early detection accurate diagnosis OMC thereby improving patient outcomes analyzing genetic data medical records AI algorithm identify subtle pattern indicative OMC development enabling clinician intervene earlier stages Moreover AI facilitates personalized treatment planning integrating genetic marker clinical data tailor therapy based individual patient profiles maximizing efficacy minimizing adverse effects Furthermore chapter discus role AI predicting treatment response longterm prognoses aiding clinician making informed decision improving patient outcomes Overall chapter aim highlight transformative potential integrating genetic insight AI technology OMC care leveraging AIdriven approach early detection accurate diagnosis personalized treatment significantly enhance patient outcome contribute broader understanding AIs role biomedical research clinical practice",
        "mesh_terms": [
            "Humans",
            "Mouth Neoplasms",
            "Artificial Intelligence",
            "Prognosis",
            "Precision Medicine",
            "Biomarkers, Tumor",
            "Machine Learning"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40553330/"
    },
    {
        "pmid": "40546399",
        "title": "In silico identification of PPARγ agonists from diffractaic acid analogs in prostate cancer: a comprehensive computational approach.",
        "abstract": "Prostate cancer PCa second frequent fifth greatest cause death men Although already therapy earlystage PCa effectiveness advanced PCa limited primarily medication resistance poor efficacy find new therapeutic indication repurpose current medications project intends use computational approach investigate possible antiPCa compound based simulated screening FDAapproved drug bank databases technique used study include virtual screening drug bank database utilising matrix user molecule Diffractaic acid DA integrated network pharmacology molecular docking detailed molecular dynamic simulation result showed 18 DA analogue total chosen drug bank database put integrated network pharmacology KEGG enrichment analysis indicated hsa05215 Prostate cancer one significant PCa enrichment signalling pathway exhibited 18 proteinprotein interaction including PDGFRB PDGFRA PPARG GSK3B MAP2K1 CREBBP HSP90AA1 HSP90AB1 CHUK PIK3CD BRAF PIK3CB MTOR AR PIK3CA PLAU CDK2 MAPK1 Subsequent molecular docking study best target protein PPARγ showed DB14929 molecule formed hydrogen bond Gln273 Arg280 Arg288 Ser342 residue exhibited high binding affinity   105 kcalmol PPARγ agonist PCa Furthermore molecular dynamic simulation showed DB14929 formed stable proteinligand complex RMSD RMSF Rg SASA values Furthermore dynamic behaviour PPARγ protein linked DB14929 conformational space analysed using PCA technique demonstrating excellent conformational space behaviour Additionally free binding energy value  5715 kcalmol DB14929 indicated could agonist PPARγ PCa online version contains supplementary material available 101007s13205025043765",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40546399/"
    },
    {
        "pmid": "40544728",
        "title": "Targeting MAP kinase for inhibiting Leishmania promastigotes and amastigotes stages by L-alanine derived molecules and their anticancer potential against PANC-1 cancer cell lines.",
        "abstract": "Home quarter global population World Health Organizations SouthEast Asia Region bear substantial burden Neglected Tropical Diseases NTDs Identifying mean eliminate NTDs region flagship priority since 2014 India Nepal Bangladesh committed eliminating Kalaazar Visceral Leishmaniasis VL sooner end 2026 WHO 2023a context vanillinderived molecule well established inhibiting several kinase present cancer cell high LDsub50sub value along broad therapeutic window view demand suitable oral candidate controlling Leishmania parasitic proliferation human body here reporting ortho vanillin lAlanine amino acid derived ligand molecule t2E2hydroxy3methoxyphenyl methylidene amino propanoate L CuII conjugate Lsub1sub  Lsub3sub watersoluble nontoxic drug candidate treatment Visceral Leishmaniasis silico binding study potential chemotherapeutic target MAP kinase MitogenActivated Protein Kinase PDB id 4QNY undertaken significant binding shown molecules compound demonstrated significant inhibition amastigote proliferation L donovani Lsub1sub exhibited ICsub50sub 1544 μgmlsup1sup Lsub3sub ICsub50sub 1691 μgmlsup1sup L mexicana ICsub50sub value 1750 μgmlsup1sup Lsub1sub 1748 μgmlsup1sup Lsub3sub result comparable standard reference drug Amphotericin B exhibited ICsub50sub 1450 μgmlsup1sup L donovani 1532 μgmlsup1sup L mexicana toxicity study undertaken macrophage THP1 cell line ICsub50sub value quite higher comparison AmphotericinB Additionally potential molecule checked PANC1 cancer cell line comparison normal HPNE cell lines complex caused doublestrand DNA nicks consistent higher cytotoxic activity observed Cancer cell lines Furthermore cell cycle result also confirmed Lsub1sub arrested PANC1 cell G1S phase cell cycle followed increase subG1 phase Lsub1sub shown population latesecondary cellular apoptotic cell increased 235  9356  whereas population earlyprimary apoptotic cell increased 013  control 1208  finding suggest Lsub1sub cause apoptosis cell death programmed",
        "mesh_terms": [
            "Humans",
            "Antineoplastic Agents",
            "Cell Line, Tumor",
            "Protein Kinase Inhibitors",
            "Alanine",
            "Structure-Activity Relationship",
            "Drug Screening Assays, Antitumor",
            "Cell Proliferation",
            "Antiprotozoal Agents",
            "Mitogen-Activated Protein Kinases",
            "Dose-Response Relationship, Drug",
            "Molecular Structure",
            "Leishmania",
            "Molecular Docking Simulation",
            "Parasitic Sensitivity Tests",
            "Benzaldehydes",
            "Leishmania donovani"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40544728/"
    },
    {
        "pmid": "40544495",
        "title": "First assessment of radiological impacts near the Rampal 1320 MW thermal power plant adjacent to the UNESCO world heritage site of Sundarbans, Bangladesh.",
        "abstract": "Environmental radioactivity significantly elevated coal combustion posing risk community living near coalfired thermal power plant CFTPPs study present first comprehensive assessment radiological impact around Rampal Thermal Power Plant 1320 MW facility located Rampal Upazila near UNESCO World Heritage site Sundarbans Bangladesh Thirty soil sample systematically collected distance 100 500 1000 2000 3000 power plant activity concentration sup226supRa sup232supTh sup40supK soil ranged 1731 2951 350670 Bq kgsup1sup respectively sample exceeding populationweighted global average sup226supRa 32 Bq kgsup1sup sup232supTh 45 Bq kgsup1sup almost sample exceeding average sup40supK 420 Bq kgsup1sup elevated level sup226supRa sup232supTh sup40supK soil sample attributed several interconnected factors including presence thoriumrich mineral monazite zircon granitic geological formations anthropogenic input like bottom ash discharge plant coal combustion byproducts radium equivalent activity hazard index generally fell within safety limits higher outdoor indoor absorbed dose rates effective doses increased lifetime cancer risk raised alarm potential health threat nearby resident time Moreover longterm radiological effect Sundarbans ecosystem could disturb fragile balance impacting biodiversity local community rely resources result highlight necessity evaluation remediation effort ensure safe use soil agricultural construction activities research also seek develop radiological distribution map provide crucial baseline data forthcoming Rooppur Nuclear Power Plant",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40544495/"
    },
    {
        "pmid": "40540462",
        "title": "Outcomes of complex decongestive therapy in managing upper limb lymphedema in female breast cancer patients at a palliative care unit of a tertiary care hospital in Bangladesh.",
        "abstract": "Lymphedema chronic condition significantly affect physical function quality life breast cancer patients Although definitive cure various treatment option exist alleviate symptoms Among these Complex Decongestive Therapy CDT widely regarded primary approach study seek evaluate effectiveness CDT breast cancer patient upper limb lymphedema aim assess benefit treatment despite challenge constraint resourcelimited settings observational study conducted among 42 female breast cancer patient unilateral upper limb lymphedema attending Lymphedema Clinic Department Palliative Medicine Bangladesh Medical University Dhaka Bangladesh Limb volume skin condition clinical sign symptom assessed baseline patient received intensive phase Complex Decongestive Therapy CDT 6 weeks followup assessment conducted 3rd week 6th week significant reduction volume affected limb observed baseline 6th week well 3rd week 6th week Although statistically significant improvement skin edema recorded period visible clinical improvement skin texture noted receiving CDT proper skin care 595 patient regained normal skin affected limb Additionally significant reduction selfreported symptom tightness heaviness pain affected limb baseline 6th week Lymphedema management using component Complex Decongestive Therapy CDT found effective reducing limb volume alleviating distressing symptom patients Timely referral lymphedema patient specialized clinic initiation CDT significantly reduce ongoing suffering Bangladesh",
        "mesh_terms": [
            "Humans",
            "Female",
            "Bangladesh",
            "Middle Aged",
            "Palliative Care",
            "Upper Extremity",
            "Tertiary Care Centers",
            "Lymphedema",
            "Breast Neoplasms",
            "Adult",
            "Treatment Outcome",
            "Aged",
            "Quality of Life"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40540462/"
    },
    {
        "pmid": "40824697",
        "title": "FDA Approval Summary: Nogapendekin Alfa Inbakicept-pmln with BCG for BCG-unresponsive carcinoma in situ.",
        "abstract": "April 22 2024 US Food Drug Administration FDA granted regular approval nogapendekin alfa inbakiceptpmln N803 Bacillus CalmetteGuerin BCG treatment adult patient BCGunresponsive nonmuscle invasive bladder cancer NMIBC carcinoma situ CIS without papillary tumors Substantial evidence effectiveness application obtained Cohort singlearm multicenter QUILT3032 trial Patients received N803 400 μg administered intravesically TICE BCG week 6 week induction therapy second induction course complete response CR achieved month 3 maintenance N803 BCG weekly 3 week month 4 7 10 13 19 for total 15 maintenance doses major efficacy outcome measure CR time as defined negative result cystoscopy with TURBTbiopsies applicable per local investigator assessment urine cytology duration response CR rate 77patient efficacy population per FDA review 62 95 confidence interval CI 51 73 48 patient CR 28 58 95 CI 26 55 19 40 95 CI 16 36 maintained response ≥12 month ≥24 months respectively common adverse reaction increased creatinine dysuria hematuria urinary frequency urinary urgency urinary tract infection article summarizes data FDA thought process supporting approval N803 BCG",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824697/"
    },
    {
        "pmid": "40824687",
        "title": "Uncovering the Understanding of the Concept of Patient Similarity in Cancer Research and Treatment: Scoping Review.",
        "abstract": "Patient similarity fundamental concept precision oncology offering pathway personalized medicine identifying pattern shared characteristic among patients concept enables stratification clinically meaningful subgroups prediction treatment responses tailoring therapeutic intervention individual needs Despite transformative potential definition measurement clinical application patient similarity remain inconsistently established creating challenge integration cancer research clinical practice study aimed synthesize evidence multidimensional concept patient similarity cancer research analyzing application across different point possible data types methodological frameworks biological contexts commonly studied cancer types scoping review followed PRISMAScR Preferred Reporting Items Systematic Reviews MetaAnalyses Extension Scoping Reviews framework Joanna Briggs Institute guidelines systematic search conducted across PubMed MEDLINE LIVIVO Web Science covering period 1998 February 2024 supplemented snowball sampling manual searches Duplicate record removed study selection carried 3 phases title abstract screening disagreement resolution fulltext screening step independently performed 2 reviewer Rayyan conflict resolved third reviewer Data extraction performed using predefined template capture methodological approaches data types cancer types research objective related similarity patient cancer scoping review synthesized evidence 137 studies emphasizing multidimensional concept patient similarity cancer research integrates diverse data types methodological frameworks research objectives cancer types Transcriptomic data 92137 671 clinical data 65137 474 frequently used often combined enhance comprehensiveness similarity analyses Machine learning 76137 555 networkbased approach 72137 525 prominent methods reflecting capacity handle complex highdimensional data uncover intricate relationships Cancer subtype identification 70137 511 biomarker discovery 41137 299 primary research objectives underscoring centrality patient similarity precision oncology Breast lung brain cancer frequently studied benefiting established research framework abundant datasets Conversely rare cancer underrepresented highlighting critical gap generalizability current methodologies comprehensive scoping review examines concept patient similarity cancer research highlight critical role multilayered perspective capturing complexity identification enhance understanding application precision oncology",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824687/"
    },
    {
        "pmid": "40824681",
        "title": "Divergent Clonal Evolution and Early Dissemination Promote Genetic Heterogeneity of Metastases in Castration Resistant Prostate Cancer.",
        "abstract": "Lethal prostate cancer PCa passed least two evolutionary bottlenecks acquisition metastatic potential development castration resistance better understanding impact genetic heterogeneity across metastatic site needed develop strategy block metastatic spread overcome resistance leveraging deep wholeexome sequencing 93 tumor 26 patients examined pattern metastatic dissemination clonal evolution PCa Phylogenetic reconstruction mathematical modeling enabled quantification number mutation clone cancer ecosystem characterization patients disease evolutionary process mutation earliest pathogenic genetic driver PCa truncal likely passenger mutations copynumber alterations clone arose cancer spread confined individual metastatic site due polyclonal polyphyletic seeding Singletissue sequencing tended overestimate mutation clonality and apart truncal drivers underestimate mutation rate individual patient cohorts study highlight independent evolution metastatic lesions implication diagnostic targeted therapy strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824681/"
    },
    {
        "pmid": "40824660",
        "title": "Intravenous Argatroban or Eptifibatide in Patients Undergoing Mechanical Thrombectomy: A Subgroup Analysis of the MOST Randomized Clinical Trial.",
        "abstract": "addition direct thrombin inhibitor glycoprotein platelet inhibitor intravenous thrombolysis patient undergoing endovascular thrombectomy acute ischemic stroke may improve reperfusion rate clinical outcomes investigate safety efficacy agents preplanned cohort analysis MultiArm Optimization Stroke Thrombolysis MOST randomized clinical trial lasted 2019 2023 90day followup Centrally read outcome assessed blinded treatment study multicenter multiarm adaptive singleblind phase 3 trial included patient acute ischemic stroke selected thrombectomy per standard care Patients randomized placebo argatroban eptifibatide within 75 minute intravenous thrombolysis 90day utilityweighted modified Rankin Scale UWmRS score range 010 higher score reflecting better outcomes used primary outcome measure Reperfusion rate safety hemorrhage rates also assessed good reperfusion defined Thrombolysis Cerebral Infarction score 2b2c3 completion angiogram total 5376 patient assessed eligibility individuals 4332 meet inclusion criteria 251 eligible patient consent obtained 279 excluded reasons 514 randomized trial total 254 planned thrombectomy 110 placebo group 31 argatroban group 113 eptifibatide group Mean SD age 68 143 years 134 53 female patients 219 received thrombectomy 94 placebo group 27 argatroban group 98 eptifibatide group effect treatment outcome mean UWmRS score eptifibatide 647 95 CI 579715 argatroban 535 95 CI 413658 placebo 668 95 CI 598739 Rates good reperfusion similar group 83 92 placebo group 83 17 27 argatroban group 63 82 98 eptifibatide group 84 proportion symptomatic intracranial hemorrhage similar groups Results secondary analysis randomized clinical trial reveal addition argatroban eptifibatide intravenous thrombolysis associated better reperfusion rate clinical outcome patient undergoing endovascular thrombectomy Future investigation agent intravenous adjunct thrombectomy focus population ineligible intravenous thrombolysis ClinicalTrialsgov Identifier NCT03735979",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824660/"
    },
    {
        "pmid": "40824627",
        "title": "Engaging Peer Mentors for Opportunity, Well-Being, and Equity Realization-A Leadership Intervention for Women in Academic Medicine.",
        "abstract": "biBackgroundib underrepresentation woman senior position persists academic medicine Datadriven strategy needed catalyze advancement biMethodsib designed novel National Institutes Healthfunded interventionEngaging Peer Mentors Opportunity WellBeing Equity Realization EMPOWER evaluated randomized study educational innovation modeled Leadership Learning Model Framework developed Executive Leadership Academic Medicine ELAM® program integrated existing research multidisciplinary content expertise EMPOWER strives support career advancement woman faculty cultivating fundamental leadership competency implemented within peer mentorship framework Early outcome surrounding perceptions feasibility well engagement described biResultsib share EMPOWER curriculum implemented among national cohort woman clinicianscientists within broader randomized trial design 94 consenting participant assigned intervention Many participant 68 ini  54 found EMPOWER valuable valuable personal career development easy easy 79 ini  63 participant access online educational materials 61 ini  49 attended almost peer circle meetings biConclusionsib describe EMPOWER novel potentially scalable virtual intervention address unmet need woman faculty academic medicine pivotal transition leadership EMPOWER intervention feasible report early lesson learned development Future evaluation include qualitative analysis comparison outcome program participant control subjects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824627/"
    },
    {
        "pmid": "40824613",
        "title": "Italian adaptation of the European guidelines for breast cancer diagnosis, staging, and preoperative planning: a GRADE-ADOLOPMENT approach.",
        "abstract": "Italian guideline panel issued national recommendation breast cancer diagnosis staging preoperative planning panel employed ADOLOPMENT process adopt adapt guideline developed European Commission Initiative Breast Cancer ECIBC process utilises Grading Recommendations Assessment Development Evaluation evidencetodecision framework Hereby present 15 prioritised recommendation second chapter Italian guidelines recommendation originally developed ECIBC adopted assessment woman positive screening result diagnostic recommendation suggest using digital breast tomosynthesis instead additional mammographic projections Recommendations include using needle core biopsy NCB instead fineneedle aspiration suspicious lesions stereotacticguided rather ultrasoundguided NCB suspicious calcifications preoperative planning recommend clip marking biopsy using additional magnetic resonance imaging MRI confirmed ductal carcinoma situ Contrastenhanced mammography preferred MRI presurgical planning needed imaging test recommended stage I IIa IIb BC without sign metastasis positron emission tomographycomputed tomography alone suggested stage III BC Adjuvant hormone therapy recommended 1 tumour cell show oestrogen progesterone receptor positivity replaces 10 threshold Adopting shared trustworthy guideline BC screening across Europe help standardise process across setting advance healthcare quality equity",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824613/"
    },
    {
        "pmid": "40824598",
        "title": "Comparison of short- and long-term outcomes among laparoscopic, robotic-assisted, and transanal total mesorectal excision procedures in patients with rectal cancer: a propensity score-matching analysis.",
        "abstract": "Total mesorectal excision TME remains oncologic standard rectal cancer surgery however technical challenge persist minimally invasive treatment low rectal cancer Transanal TME TaTME robotic TME developed overcome limitation laparoscopic TME confined pelvic spaces Despite promising results comparative evidence among approach remains limited heterogeneous address gap conducted propensity scorematched analysis evaluate compare clinical oncologic outcome TaTME robotic TME laparoscopic TME patient rectal cancer treated highvolume tertiary center retrospective study included patient rectal cancer underwent restorative proctectomy 2015 2021 Propensity score matching used balance demographic clinical treatment variable across three groups Outcomes analyzed using standard statistical methods matching 240 patient included 40 TaTME 40 robotic TME 160 laparoscopic TME TaTME robotic TME demonstrated significantly lower overall complication rate laparoscopic TME 275 versus 200 versus 394 p  0033 circumferential resection margin positivity rate highest laparoscopic group 106 versus 0 versus 25 p  0031 However 5year overall survival 825 versus 850 versus 881 p  0251 diseasefree survival 750 versus 725 versus 738 p  0772 local recurrence 175 versus 125 versus 247 p  0488 distal metastasis 175 versus 225 versus 252 p  0694 significantly differ among groups three minimally invasive TME technique achieved comparable longterm oncologic outcomes Surgical approach tailored basis surgeon expertise patientspecific factors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824598/"
    },
    {
        "pmid": "40824556",
        "title": "Developing a Comprehensive Framework for Cost-Effectiveness Evaluation in Metastatic Castration-Sensitive Prostate Cancer: Insights from a Systematic Review.",
        "abstract": "Metastatic castrationsensitive prostate cancer mCSPC imposes significant economic burden necessitates costeffective treatment strategies variability among component published economic evaluation model lead methodological inconsistencies underscoring need optimal framework minimise unwarranted structural variation paper review existing economic evaluations establishes comprehensive framework aim support future economic evaluation decisionmaking mCSPC systematic literature review SLR conducted identify relevant economic evaluation mCSPC Health technology assessment HTAs National Institute Health Care Excellence Canadas Drug Agency reviewed gather insight critique limitations basis findings comprehensive costeffectiveness modelling framework established Furthermore two additional SLRs conducted identify cost resource utilisation inputs well health state utility score derived published study HTA assessments Markov model partitioned survival model PSMs commonly reported literature published HTA evaluations Despite strong precedence PSMs propose optimal framework mCSPC utilising semiMarkov structure approach offer increased flexibility allowing transition rate progressed state depend time since progression occurred also present key source cost utility data identified SLR work aligns methodology recommended Innovative Medicine Initiative IMI PIONEER external group published studies optimal framework including healthcare resource utilisation utility data consolidates existing modelling precedent mCSPC assist costeffectiveness assessment treatment condition",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824556/"
    },
    {
        "pmid": "40824547",
        "title": "Boron neutron capture therapy: A new era in radiotherapy.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824547/"
    },
    {
        "pmid": "40824545",
        "title": "Hypoxia Modulates Membrane Mechanics in Pancreatic Cancer.",
        "abstract": "Aggressive cancer cell pancreatic cell exhibit enhanced metastatic phenotype involves cell migration invasion Cellular membrane deformation key process implicit cell movement implicates link altered lipid metabolism cancer progression modulated membrane property hence associated functions One key factor underlying aggressiveness pancreatic cancer presence highest percentage hypoxia add lipid metabolic reprogramming subsequent effect hypoxiainduced lipidome change membrane property governing cell movement investigated work using combination cell biology microscopy spectroscopy finding revealed hypoxia induces distinct lipidome signature celllinedependent fashion turn differentially modulates cell membrane stiffness correlation cell stiffness membrane property actin cytoskeleton show random correlation indicating hypoxic stress distinctly regulates specific membrane attribute governing cellular functioning consulted development effective treatment pancreatic cancer",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824545/"
    },
    {
        "pmid": "40824544",
        "title": "Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2- Breast Cancer.",
        "abstract": "standard approach using onesizefitsall endocrine therapy hormone receptorpositive HER2negative HRHER2 breast cancer faced significant challenge due variation treatment response among individuals overcome challenge conducted comprehensive study integrated data bench multiomics sequencing functional drug response testing bedside multicenter realworld clinical trial cohorts studies Classification HRHER2 breast cancer four subtypes enabled effective subtypingdirected precision treatment strategies endocrine therapy alone canonical luminal subtype addition CDK46 PARP inhibitor proliferative subtype immunotherapy immunogenic subtype tyrosine kinase inhibitor receptor tyrosine kinasedriven subtype Development clinically applicable deep learningbased digital pathology classification demonstrated matched treatment guided subtypingdirected precision treatment strategy outperformed unmatched approach realworld cohort ISPY2 trial Overall study emphasizes superiority subtypingdirected precision treatment strategy HRHER2 breast cancer",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824544/"
    },
    {
        "pmid": "40824541",
        "title": "[Options in nuclear medicine for advanced prostate cancer in practice].",
        "abstract": "last year diagnostic therapeutic advance contributed significant relevance prostatespecific membrane antigen PSMA positron emission tomographycomputed tomography PETCT PSMA radioligand therapy patient advanced prostate cancer PCa PSMAPETCT higher accuracy detection PCa metastasis combination CT bone scintigraphy Based theranostic approach PSMA radioligand therapy performed castrationresistant stage patient sufficient PSMA expression tumor lesion PSMA PETCT progression PCa chemotherapy therapy abiraterone androgen receptor signalling pathway inhibitor next years large number study effectiveness PSMA radioligand therapy earlier stage PCa part combination therapy drug conducted",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824541/"
    },
    {
        "pmid": "40824530",
        "title": "Treatment and survival of early non-metastatic breast cancer in men: real world data from a population-based registry.",
        "abstract": "study aimed characterize cohort male patient nonmetastatic breast cancer specifically focusing tumor characteristics treatment strategies determinant overall survival Data study obtained BadenWürttemberg Cancer Registry encompassing male patient diagnosed breast cancer 2015 2023 total 470 patient record included described patient tumor characteristic using descriptive statistics Overall survival analyzed using KaplanMeier survival curve Cox proportional hazard regression model identify significant determinants cohort male patient nonmetastatic breast cancer luminal subtype predominant tumor biology accounting 90 cases HER2positive tumor observed 9 patients triplenegative tumor rare four case identified Regarding tumor staging 817 patient diagnosed T1 T2 stages However substantial proportion 487 presented clinically involved lymph nodes 271 diagnosed UICC stage III fiveyear overall survival rate cohort 737 Treatment analysis revealed 86 patient underwent surgical intervention Mastectomy combined sentinel lymph node dissection frequent surgical procedure performed 506 cases Adjuvant radiotherapy administered 728 patients Cox regression analysis identified age nodal status surgical intervention significant determinant overall survival",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824530/"
    },
    {
        "pmid": "40824526",
        "title": "Future research direction of portal hypertension based on Baveno VII.",
        "abstract": "Baveno Cooperation consortium internationally renowned expert committed setting standard clinical management patient advanced chronic liver disease particular emphasis complication related portal hypertension Updated every five year endorsed major scientific societies Baveno recommendation significantly influenced clinical practice improved patient outcome worldwide latest Baveno consensus Baveno VII provided series recommendation shifted understanding chronic liver disease portal hypertension profoundly shaped clinical practice However many area research remain explored short intermediate term enable personalized medicine approach review highlight relevant advancement introduced Baveno VII discusses future challenges",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824526/"
    },
    {
        "pmid": "40824508",
        "title": "Chemotherapy response in primary peritoneal small cell carcinoma.",
        "abstract": "Small cell carcinoma SCC neuroendocrine tumor usually originates lung also arise extrapulmonary sites Extrapulmonary small cell carcinoma EPSCCs aggressive rare limited data guiding management case report contributes literature presenting diagnosis treatment primary peritoneal SCC case describes 69yearold man presented abdominal distension pain raising concern metastasis history prostate cancer treated radical prostatectomy pelvic lymph node dissection Biopsy imaging revealed metastatic SCC involving peritoneum omentum diagnosis primary peritoneal SCC SCC unknown primary origin made due absence detectable primary tumor typical sites patient underwent three separate course carboplatinetoposide chemotherapy 6 cycle each course resulting significant disease regression symptom relief Recurrence managed effectively repeated chemotherapy cycles longterm followup showed need continued treatment maintain disease control quality life case underscore importance multidisciplinary approach patientcentered care managing rare cancer like primary peritoneal SCC research essential clarify molecular characteristic improve therapeutic options",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824508/"
    },
    {
        "pmid": "40824502",
        "title": "Diagnosis and treatment of autoimmune retinopathy: review of current approaches.",
        "abstract": "provide comprehensive overview existing understanding regarding clinical characteristics diagnostic investigation treatment strategy autoimmune retinopathy AIR emphasize lack consensus field ongoing controversy regarding best practices Narrative review literature PubMed Google Scholar databases AIR comprises group rare autoimmune disorder causing retinal degeneration characterized rapid vision deterioration linked circulating antiretinal autoantibody ARAs spectrum includes primary autoimmune disease association retinitis pigmentosa various malignancies raising question causative role antibodies Nonparaneoplastic AIR patient may younger average paraneoplastic AIR patient may higher likelihood female history autoimmune disease Diagnosing AIR challenging due complex pathophysiology overlapping phenotypes absence standardized diagnostic criteria limited availability specialized serological testing ARAs Despite decade research progress exact mechanism underlying ocular immune privilege breakdown autoimmune attack retinal cell AIR remain unknown diagnosis management AIR present ongoing challenges international consensus diagnostic criterion treatment protocols several author consider identification circulating ARAs crucial diagnosis disagreement pathogenicity specific antibodies including antirecoverin lack randomized controlled trial universally accepted treatment protocol AIR contribute uncertainty management Despite recent advances AIR remains enigmatic condition necessitating research establish standardized diagnostic therapeutic guidelines",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824502/"
    },
    {
        "pmid": "40824501",
        "title": "CD99 is a potential diagnostic and immunological biomarker in pan-cancer.",
        "abstract": "cell adhesion factor cluster differentiation 99 CD99 mainly play role regulating cell differentiation cancer research CD99 primarily focus sarcoma Recent study revealed CD99 play critical role initiation progression several cancers However comprehensive pancancer analysis CD99 performed study utilized advanced bioinformatics technique conduct indepth investigation CD99 expression across diverse tumors prognostic diagnostic implications predominant mode genetic alteration correlation immune cell infiltration immune checkpoints enrichment analysis related gene expression mechanism drug resistance finding revealed CD99 significantly upregulated numerous common cancer associated diagnostic prognostic outcomes Notably genetic alteration CD99 predominantly manifest deletion sarcoma Furthermore CD99 exhibited strong correlation nearly infiltrating immune cell corresponding checkpoints Enrichment analysis emphasized potential role CD99 epithelialmesenchymal transition EMT pathway leukocyte migration Additionally investigation drug resistance indicated CD99 expression primarily linked resistance antitumor agent 5fluorouracil belinostat comprehensive pancancer analysis elucidated novel role CD99 various cancer types providing important insight clinical treatment strategy drug development",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824501/"
    },
    {
        "pmid": "40824494",
        "title": "Long-term urinary complications in patients with localized prostate cancer treated with radiotherapy and/or radical prostatectomy.",
        "abstract": "Although shortterm complication external beam radiotherapy EBRT radical prostatectomy RP combination RPEBRT prostate cancer extensively reported data longterm complication underreported primary objective compare rate severity longterm genitourinary GU toxicity EBRT RP RPEBRT secondary objective assess patient treatmentrelated risk factor GU toxicity retrospectively examined chart prostate cancer patient received EBRT RP RPEBRT 2010 2018 Sherbrooke University Hospital Center QC Canada Baseline patient characteristics treatmentrelated information late GU complication  1year posttreatment extracted study included 1246 patients 694 557 380 305 172 138 received EBRT RP RPEBRT respectively Mean followup 62 year range 15122 Based Common Terminology Criteria Adverse Events EBRT group 202 291 grade 2 38 55 grade 3 complications compared 66 174 grade 2 32 84 grade 3 RP patient p  0001 RPEBRT group 58 337 grade 2 29 169 grade 3 complication p  0001 patientrelated risk factor significantly increased rate GU toxicity except anticoagulation Patients underwent RPEBRT highest rate severity complications Although EBRT patient higher rate GU toxicity less severe RP patients reinforces importance fully disclosing risk type complication discussing treatment options",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824494/"
    },
    {
        "pmid": "40824493",
        "title": "Decipherment of disulfidptosis-related mutation profile, chemosensitivity, and prognosis in diffuse large B-cell lymphoma.",
        "abstract": "Diffuse large Bcell lymphoma DLBCL common subtype nonHodgkin lymphoma 3540 suffers recurrence standard chemotherapy treatment Disulfidptosis novel mode cell death found associated tumor environment prognosis several tumors Here applied transcriptome profile data 30 type tumors somatic mutation data scRNAseq data DLBCL patient analysis Disulfidptosisrelated gene DRGs expression found widely dysregulated across different tumors DRGs displayed obviously high expression DLBCL DRGs mutation correlated prognosis chemosensitivity DLBCL Molecular docking analysis found potential binding antitumor drug protein encoded mutated DRGs Besides scRNAseq analysis revealed discrepancy DRGs expression pattern biological pathway diverse cell clusters Differentially expressed gene DEGs disulfidptosisrelated cluster mainly enriched immune response metabolism related pathways Moreover novel DRGs risk score constructed demonstrated accurate prognosis prediction training validation cohorts Pancancer analysis showed DRGs score displayed wider application value different type tumors Chemosensitivity analysis found great discrepancy IC50 86 antitumor drug low highDRGs score groups temozolomide sorafenib Overall novel disulfidptosisrelated risk score biomarkers potential provide new insight risk stratification treatment recommendation DLBCL KEY MESSAGES expression disulfidptosisrelated gene DRGs significantly different 30 type tumors DRGs displayed high expression DLBCL DRGs mutation potential predict prognosis chemosensitivity DLBCL Function analysis based sequencing datasets indicated DRGs closely correlated tumor immune infiltration metabolism reprogramming DRGs score found accurate predicting prognosis chemosensitivity DLBCL Pancancer analysis revealed prognostic value DRGs score different tumors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824493/"
    },
    {
        "pmid": "40824476",
        "title": "Educational Targets for Patient-Reported Outcomes and Caregiver-Reported Outcomes in Psycho-oncology Research.",
        "abstract": "Patientreported outcome PROs caregiverreported outcome CROs tool evaluating behavioral medicine intervention bringing patient voice observational research study aimed identify barrier using PROsCROs behavioral cancer research equitably address barriers Fortynine member cancer special interest group research society completed survey early 2023 need related use PROs CROs Descriptive statistic used summarize results participant used PROs n  34 69 frequently used CROs n  12 24 80 sample familiar common PROCRO property reliability validity Participants reported considering wide variety population characteristic using PROs CROs including language n  31 70 education level n  31 70 common barrier using PROsCROs research time funding technology many reflecting potential reason inequitable representation certain group research Webinars preferred educational format n  38 78 resource related PROsCROs Many participant encountered barrier using PROs research Creation dissemination educational resource promote equitable use PROsCROs across underrepresented group overcome common barrier use measurement tool warranted",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824476/"
    },
    {
        "pmid": "40824466",
        "title": "Applications of nanomaterials in head and neck squamous cell carcinoma: current progress and perspectives.",
        "abstract": "Head neck squamous cell carcinoma HNSCC common malignant tumor affect head neck area HNSCC typically complex clinical symptom detected late stage Therefore quite difficult give patient best possible care treatment Faced challenges nanomaterials receiving increasing attention biomedical field due unique structural physicochemical properties application nanomaterial therapeutic produced innovative HNSCC treatment option go beyond constraint conventional surgery radiation therapy chemotherapy review first reviewed pathological mechanism HNSCC Subsequently detailed introduction nanomaterials given including classification definition Then use nanomaterials diagnosis therapy HNSCC discussed incorporating perspective organoids clinical trial increase feasibility nanomaterial applications addition also reviewed advantage disadvantage nanomaterials proposed idea nanomaterial design looking property may used improve understanding treatment HNSCC present approach detecting treating HNSCC improved integrating special quality nanomaterials available therapeutic modalities eventually enhance patient outcome battle highly invasive malignant tumor",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824466/"
    },
    {
        "pmid": "40824464",
        "title": "Impact of dynamic jaw width adjustment in tomotherapy on hippocampus sparing and treatment efficiency in whole-brain radiotherapy.",
        "abstract": "aim study evaluate impact dynamic jaw width adjustment tomotherapy hippocampal sparing target dose conformity treatment efficiency hippocampalavoidance wholebrain radiotherapy HAWBRT accordance RTOG 0933 guidelines retrospective study 60 patient treated HAWBRT conducted CTMRI fusion facilitated accurate hippocampal delineation Treatment plan created using Accuray Precision TPS delivered Radixact Tomotherapy system three jaw width 1 cm 25 cm 5 cm fixed pitch 0215 modulation factor 30 prescription dose 30 Gy 10 fractions Evaluation metric included PTV coverage D98 V95 D2 Dmax homogeneity index HI conformity index CI hippocampal lens doses beamon time BOT Plan verification performed ArcCHECK using 33 mm 32 mm gamma criteria 1 cm jaw achieved best PTV coverage D98  2922 Gy V95  9871 HI  009 CI  099 superior hippocampal sparing Dmax  1491 Gy Dmin  757 Gy longest BOT 1165 s Wider jaw 25 cm 5 cm reduced BOT 480 s 280 s slightly compromised conformity increased OAR doses within limits Jaw width selection Helical Tomotherapy influence dose distribution characteristic treatment delivery efficiency hippocampussparing WBRT 1 cm jaw width provides superior dosimetric conformity enhanced hippocampal sparing albeit cost increased BOT contrast wider jaw width 25 cm 5 cm improve delivery efficiency result modest reduction dose precision organatrisk sparing Therefore jaw width selection carefully individualized based clinical objectives balancing tradeoff organ preservation treatment efficiency",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824464/"
    },
    {
        "pmid": "40824457",
        "title": "Ferroptosis and ovarian cancer: a bibliometric study and visualization analysis.",
        "abstract": "Ovarian cancer rank first among malignant tumor female reproductive system Ferroptosis play crucial role occurrence development treatment ovarian cancer However research focusing bibliometric analysis ferroptosis ovarian cancer remains scarce study employ bibliometric method analyze research trend related ferroptosis field ovarian cancer providing direction scholar clinical practitioners Articles regarding ferroptosis ovarian cancer retrieved Web Science Core Database November 6 2024 rigorous screening bibliometric analysis utilized VOSviewer CiteSpace CoreMine facilitated text mining relation drug gene significantly associated ovarian cancer ferroptosis publication volume article ferroptosis ovarian cancer shown yearly increase significantly surging 2022 three country highest publication output China United States Japan top ten institution publication China ten frequently mentioned keywords ferroptosis ovarian cancer cell death apoptosis expression death iron resistance metabolism cells Text mining reveals cisplatin along genesproteins SLC7A11 GPX4 significantly correlate ovarian cancer ferroptosis article us bibliometric method reveal publication trends national distributions regional collaborations recent research hotspot related correlation ferroptosis ovarian cancer study provides objective data reference scientific research clinical work concerning ferroptosis ovarian cancer",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824457/"
    },
    {
        "pmid": "40824452",
        "title": "Can we obtain prognostic information from healthy tissue uptake and volume in baseline <sup>18</sup>F-FDG PET/CT imaging in diffuse large B-cell lymphoma?",
        "abstract": "Diffuse large Bcell lymphoma DLBCL patient often experience relapse progression treatment emphasizing need better prognostic markers study investigated baseline FDG uptake volume healthy tissue tumours assess association timetoprogression TTP DLBCL study included 259 newly diagnosed DLBCL patients Outcome twoyear TTP treatment initiation Automatic segmentation tissue performed low dose CT scans Tumour lesion outlined semiautomated segmentation method standardised uptake value ≥ 4 subtracted tissues Mean standardised uptake value SUVmean tissuetoblood SUVmean ratio volume total lesion glycolysis TLG determined spleen liver kidneys lungs brain SUVmean SUVmean ratio assessed fat bone skeletal muscle Intercorrelations among tissue correlation tumour TLG calculated Volume uptake measure compared patient without progression using Wilcoxon signedrank test measure significantly associated twoyear TTP added existing logistic regression model based baseline tumour characteristic assess added prognostic value Patients progression showed significantly higher spleentoblood SUVmean ratio lower SUVmean TLG brain lower SUVmean skeletal muscle larger liver volume Liver volume spleentoblood SUVmean ratio significantly improve prediction twoyear TTP compared original model based tumour characteristics Healthy tissue PETCT measure significantly associated twoyear TTP DLBCL patients However measure improve prediction twoyear TTP compared model using tumour characteristics HOVON84 EudraCT 2006005 174  42 retrospectively registered 01082008",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824452/"
    },
    {
        "pmid": "40824449",
        "title": "Generations in Flux: Tracking the Birth of Cellular Heterogeneity in Cancer.",
        "abstract": "Intratumor heterogeneity hallmark cancer enabling subpopulation cell evade therapy adapt immune attack thrive diverse microenvironments retrospective genomic epigenomic analysis mapped largescale history tumor evolution cannot capture rapid dynamic change cell state occur individual cell divide Panagopoulos colleague recently developed cellular platform monitor role transient replication stress real time tracking sister cell divide replicate author use technique show daughter granddaughter cell inherit different states often leading cellular instability work broadens understanding diverse cell state arise oncogenic stress cellular heterogeneity emerges",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824449/"
    },
    {
        "pmid": "40824448",
        "title": "A thymine-challenge test to prospectively evaluate dihydropyrimidine dehydrogenase activity for risk of severe 5-fluorouracil-induced gastrointestinal toxicity.",
        "abstract": "Inherited dihydropyrimidine dehydrogenase DPD deficiency risk factor severe 5fluorouracil toxicity report phenotyping approach thymine challenge test prospectively determine DPD activity association severe adverse events primary aim prospective study determine whether thymine challenge test could prospectively identify patient risk severe toxicity treatment 5fluorouracilcapecitabine combination chemotherapy schedule monotherapy focus prediction risk ≥ grade 3 gastrointestinal toxicity DPD activity determined thyminedihydrothymine THYDHT ratio measured urine sample thymine test dose 250 mg oral 166 patients 117 severe diarrhoeamucositis THYDHT ratio significantly different individual compared minimal toxicity However post hoc analysis found decreased DPD activity nongastrointestinal toxicity notably grade ≥ 2 HandFoot syndrome p  0001 data support primary hypothesis phenotyping approach would discriminate risk severelifethreatening gastrointestinal toxicity clinical factor influence gastrointestinal toxicity particularly patient receiving CAPOX require investigation ACTRN 12617001109392 registered 28072017",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824448/"
    },
    {
        "pmid": "40824437",
        "title": "GSTP1-mediated inhibition of ACSL4-dependent ferroptosis via JNK pathway in DOX-induced cardiomyopathy.",
        "abstract": "Doxorubicin hydrochloride DOX extensively used treatment various tumors However clinical application limited due dosedependent cardiotoxicity Currently effective strategy exist mitigate eliminate DOXinduced cardiomyopathy DIC Although ferroptosis implicated DIC inhibition partially alleviates condition direct target DOX progression cardiotoxicity remain unclear study aimed discover direct target DOX ferroptosismediated DIC DOX pulldown assay performed identify protein specifically binding DOX murine hearts followed liquid chromatographytandem mass spectrometry LCMSMS identify candidate proteins cardiac injury mouse model established DOX treatment Based this multiple ferroptosis biomarkers detected flow cytometry quantitative realtime polymerase chain reaction western blotting immunochemistry etc Besides specific activator inhibitor signaling pathway applied illuminate molecular mechanisms Glutathione Stransferase P1 GSTP1 identified DOX target GSTP1 activity inhibited DOXtreated cardiomyocytes overexpression significantly alleviated DIC Moreover GSTP1 overexpression inhibited acylCoA synthetase longchain family member 4 ACSL4dependent ferroptosis Mechanistically GSTP1 overexpression suppressed cJun Nterminal kinase JNK phosphorylation thereby reducing reactive oxygen specie ROS production inhibiting ferroptosis DIC study identifies DOXGSTP1JNK axis critical pathway mediating ACSL4dependent ferroptosis DIC GSTP1 highlighted potential key mediator ferroptosis promising therapeutic target DIC",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824437/"
    },
    {
        "pmid": "40824431",
        "title": "Malignancy in Idiopathic Inflammatory Myopathies: Recent Insights.",
        "abstract": "Idiopathic inflammatory myopathy IIMs group rare autoimmune disease several subtypes primarily dermatomyositis DM associated high risk malignancy Although relationship pathogenesis IIMs cooccurring malignancy poorly understood growing evidence base specific risk factor associated cancerassociated myositis CAM including myositisspecific myositisassociated autoantibody MSAsMAAs addition given patient different subtypes IIMs classified according clinical manifestation serum autoantibody measurement exhibit heterogeneity tumorigenesis research urgently needed explore pathogenesis CAM order develop novel biomarkers therapeutic alternative patients review discusses risk protective factor CAM using available evidence thereby offering fresh insight pathogenesis screening management strategy highlighting possible future breakthrough obstacle field",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824431/"
    },
    {
        "pmid": "40824419",
        "title": "Mapping Current Research Status and Emerging Frontiers of T-Cell Exhaustion: A Comprehensive Data-Mining-Based Study.",
        "abstract": "Tcell exhaustion Tex represents distinct immunological state characterized progressive functional deterioration cell persistent antigenic stimulation recent years field Tex research attracted considerable attention accompanied dramatic surge related scientific literature study employed bibliometric method conduct comprehensive analysis Texrelated publications scientific literature focusing Tex published 2005 2024 retrieved Web Science Core Collection comprehensive bibliometric evaluation tool including CiteSpace VOSviewer online website used construct visual networks including coauthorship cocitation cooccurrence analysis Quantitative assessment research output impact performed multiple metrics analysis included total 2831 publications data fitting analysis indicated exponential growth number publication per year Regarding research contributions United States China consistently demonstrated leading positions Among academic institution individual researchers Harvard University emerged productive organization Reference analysis showed chimeric antigen receptor CAR Tcell therapy one field attract greatest attention current Tex research Keyword analysis revealed cancer studied disease area followed hepatocellular carcinoma HIV Analysis highfrequency keywords also found current research focus field centered around immunotherapy immune checkpoint inhibitors functional status cell mechanism underlying Tex tumor microenvironment prognosis biomarkers role Tex specific diseases addition coming years several key area remain forefront scientific exploration include machine learning pancancer programmed death1 blockade scRNAseq immune tolerance VISTA immunotherapy resistance exosome chronic inflammation gene editing triplenegative breast cancer tumor microenvironment solid tumors multiple myeloma extracellular vesicles research represents inaugural effort perform extensive bibliometric evaluation literature focusing Tex 2005 2024 finding derived analysis offer credible resource scholar aiming swiftly grasp essential insight emerging trends well future hotspot within domain",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824419/"
    },
    {
        "pmid": "40824417",
        "title": "Response-Adapted Oncologic Surgery in Cutaneous Squamous Cell Carcinoma: A Paradigm Shift Following Neoadjuvant Immunotherapy.",
        "abstract": "Recent study suggested neoadjuvant cemiplimab achieve significant pathologic response patient cutaneous squamous cell carcinoma CSCC retrospective cohort study 20182021 determine whether responseadapted oncologic surgery RAOS reduce surgical morbidity maintaining oncological safety thus offering viable alternative standard resection total 41 patient head neck CSCC treated neoadjuvant cemiplimab followed surgery either RAOS standard resection extent intended surgery ie standard resection defined using 10mm margin clinically measured lesion RAOS defined resection smaller intended surgery Main outcome surgical margins local recurrencefree survival rates organ preservation need freeflap reconstruction pathologic response compared surgical groups total 17 patient underwent RAOS 24 patient underwent standard resection Neoadjuvant treatment allowed organ preservation four 24 patient RAOS group four 24 patient RAOS group meant freeflap reconstruction need free flap resection Clear margin achieved 16 94 patient RAOS group 22 92 patient standard resection group p  03 2year locoregional recurrencefree survival rate 95 RAOS group 90 standard resection group p  04 RAOS following neoadjuvant cemiplimab CSCC appears oncologically safe similar survival outcome less surgical morbidity standard resection prospective study needed confirm findings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824417/"
    },
    {
        "pmid": "40824415",
        "title": "ASO Visual Abstract: Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors-a Feasibility Study.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824415/"
    },
    {
        "pmid": "40824413",
        "title": "Glucocorticoid receptor-targeted liposomal delivery of wnt/β-catenin pathway inhibitor selectively induces efficient colorectal tumor regression.",
        "abstract": "Wntβcatenin signaling pathway highly conserved developmental pathway pathway also involved colorectal cancer thus selective targeting cancer cells albeit risk involved serve promising therapeutic approach Glucocorticoid receptor GR nuclear hormone receptor present cancer noncancer cells Previously showed cancer cellassociated GR without eliciting effect normal cells could targeted selective drugsensitization cancer cells Based unique feature intended sensitize wntβcatenin pathway coformulating GRtargeted cationic liposomal formulation carrying dexamethasone synthetic GRligand wntβcatenin pathway inhibitor FH535 form D1XFH formulation nanometric positively charged D1XFH formulation selectively kill colorectal cancer cell much lower FH535 concentration free drug drugassociated GRnontargeted liposome exhibiting unique nuclear uptake increased ROS generation apoptosis G2M phase cell cycle arrest cancer cells Further vivo data show enhanced tumorspecific localization formulation significant tumor growth inhibition increased mouse survivability signifying efficacy biocompatibility mouse colon subcutaneous orthotopic tumor models Protein expression analysis reveals enhanced reversal epithelialtomesenchymal transition EMT inhibition various downstream protein wntβcatenin pathway Additionally analysis tumor lysate D1XFHtreated group show increased Th1Th2 ratio indicating favorable antitumor immune response formulation exhibit subchronic toxicity healthy mice overall data strongly suggest GRtargeted FH535 liposomal delivery safely target highly sensitive wntβcatenin pathway effective treatment colorectal tumor",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824413/"
    },
    {
        "pmid": "40824376",
        "title": "Personalized survival predictions in chromophobe renal cell carcinoma: development of a machine learning-based web tool.",
        "abstract": "Chromophobe renal cell carcinoma ChRCC rare subtype renal cancer characterized distinct clinical genetic features Existing study ChRCC limited critical need explore prognostic factor treatment outcome patient population used machine learning ML build prognostic model developed first predictive webbased tool survival SEER database 20002020 used studys analysis identify prognostic variables conducted Cox regression analysis constructed prognostic model using five ML algorithm predict 5year survival validation method incorporating area curve AUC receiver operating characteristic ROC curve used validate accuracy reliability ML models also performed KaplanMeier survival analysis study analyzed 10700 patient ChRCC identified metastasis tumor size significant predictor survival Subtotal nephrectomy associated highest survival rates Chemotherapy radiotherapy infrequently used associated worse survival outcomes particularly patient metastasis developed ML model demonstrated high accuracy predicting survival webbased tool offered realtime survival prediction based patientspecific data study identified key prognostic factor developed machine learningbased web tool personalized survival predictions Metastasis tumor size critical determining patient outcomes subtotal nephrectomy showing highest survival rate",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824376/"
    },
    {
        "pmid": "40824344",
        "title": "Enhancing radiosensitivity of boron neutron capture therapy for liver cancer with homologous recombination repair inhibitor.",
        "abstract": "Hepatocellular carcinoma HCC particularly recurrent treatmentrefractory cases often exhibit poor responsiveness radiation therapy increasing risk radiationinduced liver disease necessitating innovative treatment approaches Boric acidmediated boron neutron capture therapy BABNCT emerged promising approach liver cancer study aim improve BABNCT efficacy radioresistant HCC exploring sensitization agents enhancing treatment minimizing irradiation dos side effects targeted DNA homologous recombination repair HRR protein RAD51 neutron irradiation RAD51 inhibitor B02 administered evaluate sensitization effect HepG2 radioresistant HepG2R cells examined cell death mechanism focusing expression profile LC3B BABNCT investigate impact DNA repair responses especially autophagy apoptosis observed inhibition RAD51 led increased γH2AX DNA doublestrand break marker Additionally combining RAD51 inhibitor B02 BABNCT resulted tumor cell arrest Gsub0subGsub1sub phase indicating altered cell cycle regulation exploring cell death mechanisms observed increased autophagy following BNCT potentially response cellular stress induced DNA damage tumor cells combination B02 BABNCT significantly disrupted autophagic flux promoted apoptosis tumor cells Combining RAD51 inhibitor BABNCT significantly enhances antitumor efficacy radioresistant HCC parental HCC cells proofofconcept study suggests combination treatment achieve comparable superior therapeutic effect using lower radiation doses thereby reinforcing potential BNCT treating recurrent HCC",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824344/"
    },
    {
        "pmid": "40824334",
        "title": "PET-based radiomic analysis in multicentre lung cancer study and impact of feature domain harmonization.",
        "abstract": "Radiomic biomarkers demonstrated significant potential noninvasively assessing tumor biology providing essential insight precision medicine However clinical translation often hindered challenge multicenter studies primarily due lack standardization variation scanner models acquisition protocols reconstruction techniques etc study aim assess impact various harmonization method multicenter 18 FFDG PETbased radiomics classification lung cancer histological subtypes using machine learning model Retrospective data included 178 lung cancer cohorts comprising 117 adenocarcinoma 61 squamous cell carcinoma three different centers PET DICOM image data preprocessed 3D ROI segmentation lung tumor healthy liver followed extraction 111 radiomic features Subsequently ZScore Quantile ComBat applied generate three different harmonized datasets Feature distribution analyzed top ten feature selected using recursive feature elimination eXtreme gradient boosting model built dataset performance assessed using accuracy precision sensitivity specificity AUC 95 confidence interval Variations radiomic feature distribution feature selection observed applying different harmonization methods validation trained model AUC improved 0556 95 CI 05510563 unharmonized data 0719 95 CI 07100720 0952 95 CI 09510954 0996 95 CI 09950996 ZScore Quantile ComBat harmonized data respectively classifying adenocarcinoma squamous cell carcinoma subtypes study indicates feature selection affected different harmonization methods ComBat method shown significantly enhance performance AIassisted PET radiomics",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824334/"
    },
    {
        "pmid": "40824310",
        "title": "Objective measurement of physical activity levels and patient-reported outcomes in cancer patients receiving immune-checkpoint inhibitors: a cross-sectional study.",
        "abstract": "study aimed objectively assess physical activity level cancer patient treated immunecheckpoint inhibitor ICIs explore association patientreported fatigue quality life QoL crosssectional study conducted among adult patient solid cancer receiving ICI treatment day hospital institution March 26 April 24 2024 Physical activity level assessed using accelerometer monitor IPAQ questionnaire patientreported fatigue QoL assessed FACITFatigue EQ5D questionnaires respectively Descriptive statistic betweengroup comparison performed specifically active nonactive patients based recommendation healthy PA ≥ 150 minweek moderatetovigorous PA MVPA well patient without problem QoL domains total 23 patient enrolled mean age 61 ± 12 years 655 male Eleven patient 478 active mean MVPA 225 ± 165 minday based objective measurements Active nonactive subgroup balanced characteristic BMI Based 18 objective measurements mean MVPA time 225 ± 165 minday Reported fatigue higher population norms 857 reported issue QoL domains Patients without problem selfcare usual activity reached higher PA levels patient without problem mobility selfcare paindiscomfort reported less fatigue higher index global health Less half ICItreated patient follow recommendation healthy PA Patients engaging MVPA may less problem selfcare usual activities reinforces need promote PA immunotherapy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824310/"
    },
    {
        "pmid": "40824271",
        "title": "First-in-India Experience with 90Y-BhabhaSphere: An Indigenous 90Y-TheraSphere Biosimilar for Transarterial radioembolization of Hepatic Malignancies.",
        "abstract": "Primary secondary hepatic malignancy significant cause cancerrelated mortality worldwide Radioembolization yttrium90 90Y microspheres emerged promising treatment option unresectable hepatic tumors However high cost commercially available Y90 microspheres 90YTheraSphere 90YSirSphere limit accessibility developing countries present first Indian clinical experience indigenously developed 90Y Yttria Alumino Silicate glass microspheres known 90YBhabhaSphere radioembolization hepatic malignancies 90YBhabhaSphere formulation developed XXXXXX XXXXXX XXXXXXXX XXXXXX XXXX XXXXX used treat small cohort five patient unresectable hepatic malignancies 90YBhabhaSphere delivery system developed rigorous process vitro tested using microcatheter connection simulate TARE procedure Feasibility safety delivery efficiency preliminary efficacy treatment using 90YBhabhaSphere assessed initial clinical experience 90YBhabhaSphere demonstrates safety feasibility treating hepatic malignancies 90YBhabhaSphere demonstrated excellent delivery efficiency reaching 99 vitro dummy run 97 vivo clinical delivery 90YBhabhaSphere successfully administered four patients whereas one patient delivery terminated due leakage delivery system treatment welltolerated minimal adverse effects Preliminary efficacy analysis show promising results significant reduction tumor size improvement liver function 90YBhabhaSphere offer costeffective alternative commercially available 90Ymicrospheres initial clinical experience demonstrates safety feasibility preliminary efficacy treating hepatic malignancies Large clinical trial need conducted establish longterm efficacy safety 90YBhabhaSphere study highlight key advantage 90YBhabhaSphere significantly higher specific activity approximately 6000 Bqsphere compared commercially available 90YTheraSphere 2700 Bqsphere suggests potential delivering higher tumor dos whileminimizing radiation exposure healthy liver tissue thereby reducing risk radiationinduced liver damage",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824271/"
    },
    {
        "pmid": "40824267",
        "title": "Effects of Oxygen Manipulation on Myofibroblast Phenotypic Transformation in Patients With Radiation-Induced Fibrosis.",
        "abstract": "tested hyperoxic condition reduce proportion active myofibroblasts assumed major driver head neck radiationinduced fibrosis measured expression level profibrotic genes Radiated noncancerous soft tissue head neck skinsoft tissue nonradiated flap donor site collected patient Myofibroblast density quantified using immunofluorescence staining αSMA DAPI visualisation confocal microscopy compared baseline nonradiated radiated tissue patient tissue specimen fibroblast cell line cultured exposed either normoxic hypoxic hyperoxic condition 10 days Total RNA extracted reversetranscribed gene expression level quantified using RTPCR Relative gene expression level profibrotic gene COL1A1 COL3A1 FNEDA αSMA HIF1α VEGFα VEGFR compared normoxic hypoxic hyperoxic treatment groups Three patient six total tissue sample acquired Radiated tissue contained higher density myofibroblasts calculated cellsmmsup2sup demonstrated higher expression profibrotic gene nonradiated donor site tissue Hyperoxia decrease expression level profibrotic gene radiated nonradiated tissue hypoxia increase profibrotic gene expression level radiated nonradiated tissue Study finding indicate hypoxia driver myofibroblast activation subject radiationinduced fibrosis head neck increased expression myofibroblastic phenotype Hyperoxygenation reduce proportion active myofibroblasts revealing potential therapeutic method halt chronic fibrotic pathways",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824267/"
    },
    {
        "pmid": "40824258",
        "title": "Impact of Empowerment Education Concept Plus Humanistic Care on Moods and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy.",
        "abstract": "Background evaluate clinical efficacy integrating empowerment education humanistic care enhancing cognitive function selfcare ability mood regulation quality life among lung cancer LC patient undergoing chemotherapy Methods total 149 LC patient receiving chemotherapy May 2022 January 2024 included study divided 2 groups control group n63 receiving routine care joint group n 86 receiving empowerment education humanistic care Outcomes measured included cognitive function selfcare ability using Exercise SelfCare Agency scale mood using Hospital Anxiety Depression Scale cancerrelated fatigue using Revised Piper Fatigue Scale adverse reactions QoL using Functional Assessment Cancer TherapyLung scale Results joint group exhibited significant improvement cognitive function selfcare ability QoL compared control group P  05 also lower score anxiety depression cancerrelated fatigue P  05 incidence adverse reaction markedly lower joint group 1047 compared control group 3968 Conclusion Combining empowerment education humanistic care effectively improves cognitive function reduces negative emotion adverse reactions enhances selfcare ability improves overall QoL LC patient undergoing chemotherapy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824258/"
    },
    {
        "pmid": "40824253",
        "title": "PolyIC as an adjuvant outperforms anti-VEGF in combination with anti-PD-L1 therapy in mouse liver tumor models.",
        "abstract": "Immune checkpoint inhibitor combined antiangiogenic therapy become standard care advanced HCC albeit limited therapeutic benefit previous study demonstrated immunomodulatory antitumor effect polyIC synthetic dsRNA Here compared efficacy antiprogrammed death ligand 1 αPDL1 plus polyIC versus αPDL1 plus antivascular endothelial growth factor αVEGF mouse tumor models established primary liver tumor model using hydrodynamic tail vein injection RasMyc oncogene metastasized tumor model via intrasplenic injection colon cancer cells Flow cytometry gene expression analysis performed assess immune profile across treatment groups Key factor contributing antitumor efficacy explored models αPDL1 plus polyIC demonstrated superior antitumor effect relative αPDL1 plus αVEGF Unlike αVEGF polyIC enhanced immune response αPDL1 increasing cell infiltration effector memory CD8 cells CD8 CD4 cell ratio CD8 cell function combination also promoted apoptosis tumor accumulation conventional dendritic cell invariant natural killer cells addition αPDL1 plus polyIC treatment led upregulation cytokine chemokines CCL5 blockade partially reducing CD8 CD4 cell ratio attenuating polyICdriven antitumor effects preclinical study identifies polyIC efficacious adjuvant αPDL1 treatment liver cancer providing better strategy improve immunotherapy outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824253/"
    },
    {
        "pmid": "40824225",
        "title": "Insula Deep Brain Stimulation for Neuropathic Pain: A Cross-Over, Randomized, Sham-Controlled Trial.",
        "abstract": "Despite neuropathic pain affecting significant portion population many people still experience refractory conditions Here evaluated efficacy safety posteriorsuperior insula deep brain stimulation pharmacoresistant neuropathic pain phase 2 randomized doubleblind shamcontrolled crossover trial Subjects chronic pharmacoresistant neuropathic pain whose pain previously responded deep repetitive transcranial magnetic stimulation posteriorsuperior insula underwent stereotactically guided implantation electrode targeting region study comprised three phases doubleblind 2 × three months singleblind three months openlabel six months primary outcome proportion participant achieving ≥30 reduction average pain intensity compared baseline Secondary outcome included pain interference quality life neuropsychiatric assessments Ten participant 80 men age range 3167 years enrolled 823 posterior probability active posteriorsuperior insuladeep brain stimulation yield higher responder rate sham stimulation three months 95 credible interval difference ranging 10 130 Probabilities pain interference score reduction exceeded 95 followup particularly concerning sleep mood Qualityoflife score also showed significant improvement active compared sham stimulation treatments major adverse event reported stimulation well tolerated study showed posteriorsuperior insula deep brain stimulation feasible potentially useful treatment people refractory neuropathic pain reasonable safety profiles Phase 3 trial warranted confirm finding explore applicability intervention Clinicaltrialsgov registration number study NCT04279548",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824225/"
    },
    {
        "pmid": "40824206",
        "title": "Early Detection of Cardiovascular Disease in Chest Population Screening: Challenges for a Rapidly Emerging Cardiac CT Application.",
        "abstract": "lung cancer screening LCS reduces lung cancerrelated mortality highrisk individuals cardiovascular disease CVD remains leading cause death due shared risk factor smoking age Coronary artery calcium CAC assessment offer opportunity concurrent cardiovascular screening higher CAC score indicating increased CVD risk mortality Despite guideline recommending CACscoring noncontrast chest CT scans lack standardization lead underreporting missed opportunity preventive care Routine CACscoring LCS enable personalized CVD management reduce unnecessary treatments However challenge persist achieving adequate diagnostic quality one combined image acquisition lung cardiovascular assessment Advancements CT technology improved CAC quantification lowdose CT scans Electronbeam tomography valued superior temporal resolution replaced multidetector CT better spatial resolution general usability Dualsource CT improved temporal resolution reduced motion artifacts making nongated CT protocol CACassessment possible Additionally artificial intelligencebased CAC quantification reduce added workload cardiovascular screening within LCS programs review explores recent advancement cardiac CT technology address prior challenge opportunistic CVD screening considers key factor integrating CVD screening LCS programs aiming highquality standardization CAC reporting",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824206/"
    },
    {
        "pmid": "40824199",
        "title": "A Dual Role for NKG7 in T-cell Cytotoxicity and Longevity.",
        "abstract": "effectiveness cellbased immunotherapy depends durable Tcell response efficiently eliminate tumor cells NKG7 discovered three decade ago protein associated lytic granules However study published past 5 year contributed substantially understanding NKG7 Tcell biology NKG7 recognized important Tcell functional marker response immune checkpoint inhibitor therapy prognosis certain cancers Besides role generation trafficking release lytic granules critical efficient Tcell cytotoxicity tumor cells NKG7 identified key negative regulator mTORC1 activity restraining mTORC1 activity NKG7 promotes Tcell longevity memory generation infection Importantly NKG7 upregulation demonstrated therapeutic potential preclinical Tcell therapy cancer Collectively NKG7 emerging promising biomarker therapeutic addition cellbased immunotherapies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824199/"
    },
    {
        "pmid": "40824171",
        "title": "USP44 Regulates Chemoresistance Induced by ROS and the MAPK/NF-κB Pathway Through the Stabilization of ITGB4 in Gastric Cancer.",
        "abstract": "Cisplatin DDP typical chemotherapy agent employed gastric cancer GC Resistance development significantly impairs success GC therapy essential mechanism yet fully understood Deubiquitinase enzyme pivotal mediating drug resistance across various cancer via ubiquitinmediated protein degradation USP44 deubiquitinase known ubiquitinspecific peptidase 44 implicated development tumors spread resistance treatment although specific role gastric cancer yet clarified found significant upregulation USP44 expression GC tissue compared normal tissues serf potential indicator chemotherapy response survival GC proteomic analysis ITGB4 recognized new substrate USP44 Mechanistically USP44 stabilizes ITGB4 via deubiquitination thereby mitigating cisplatin resistance GC cell modulating ROS MAPKNFκB pathway addition ITGB4 affect expression Pgp activity antioxidant enzyme MAPKNFκB pathway thereby promoting cisplatin efflux chemoresistance research uncovers novel mechanism behind cisplatin resistance indicates USP44 could promising therapeutic target overcoming cisplatin resistance gastric cancer patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824171/"
    },
    {
        "pmid": "40824151",
        "title": "Cross-Sectional Analysis of Metabolic Tumor Burden Detected by F-18 FDG PET/CT and Circulating Tumor DNA in Advanced Breast Cancer.",
        "abstract": "study investigated relationship circulating tumor DNA ctDNA parameter metabolic parameter FDG PETCT advanced breast cancer ABC patients retrospective singlecenter study 47 ABC patient underwent liquid biopsy FDG PETCT analyzed Results showed 27 patient 574 detectable ctDNA Patients detectable ctDNA demonstrated significantly higher wholebody metabolic tumor volume WBMTV p  0002 wholebody total lesion glycolysis WBTLG p  0006 compared without ctDNA significant difference found SUVmax SUVmean moderate correlation observed variant allele frequency VAF value metabolic parameters maximum VAF correlated SUVmax WBMTV WBTLG r  0407 p  0005 r  0457 p  0001 r  0415 p  0004 respectively Mean VAF correlated SUVmax WBMTV WBTLG r  0406 p  0005 r  0446 p  0002 r  0404 p  0005 respectively total VAF correlated SUVmax WBMTV WBTLG r  0394 p  0006 r  0465 p  0001 r  0430 p  0003 respectively excluding patient without detectable ctDNA correlation VAF value WBMTV WBTLG disappeared correlation SUVmax persisted Total alteration number ctDNA showed moderate correlation WBMTV WBTLG r  0563 p  0001 r  0459 p  0001 respectively Correlation WBMTV remained significant excluding patient without detectable ctDNA r  0500 p  0008 finding suggest metabolic tumor burden correlate ctDNA detection characteristics potentially offering complementary information disease monitoring treatment selection response assessment ABC combined use parameter may improve prognostic evaluation guide personalized treatment strategies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824151/"
    },
    {
        "pmid": "40824136",
        "title": "Comparison of changes in dynamic contrast-enhanced magnetic resonance imaging and flourine-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters from baseline to post-neoadjuvant therapy in predicting pathological response in breast cancer.",
        "abstract": "study aimed compare value difference Δ parameter obtained via dynamic contrastenhanced DCE magnetic resonance imaging MRI flourine18 fluorodeoxyglucose positron emission tomographycomputed tomography sup18supFFDG PETCT baseline postneoadjuvant therapy predicting pathological response neoadjuvant therapy breast cancer total 109 patient underwent baseline postneoadjuvant therapy DCEMRI sup18supFFDG PETCT examination retrospectively analyzed DCEMRI parameter sup18supFFDG PETCT parameter metabolic tumor volume MTV standardized uptake value SUVsubmaxsub SUVsubmeansub total lesion glycolysis recorded time points Additionally Δs parameter calculated Postsurgical pathology report documented patient subsequently categorized two groups exhibiting pathologic complete response pCR exhibiting partial response Parameters DCEMRI sup18supFFDG PETCT compared determine predicted pathological response neoadjuvant therapy effectively Patients partial response demonstrated higher rate histologic grade 3 pCR iPi  0030 DCEMRI parameter indicate significant difference two group iPi  0024 Δwashout rate Among baseline parameters MTV successfully predicted pathological response iPi  0033 postneoadjuvant therapy parameter predictive pathological response iPi  0003 SUVsubmeansub receiver operating characteristic analysis ΔSUVsubmeansub emerged significant parameter predicting pathological response followed postneoadjuvant SUVsubmeansub area curve 0724 95 confidence interval 06300805 0673 05770760 respectively Δsup18supFFDG PETCT parameter better ΔDCEMRI predicting pathologic response neoadjuvant therapy Among parameters ΔSUVsubmeansub successful Neoadjuvant chemotherapy NAC response one important criterion breast cancer prognosis two important imaging modality breast cancer diagnosis followup protocol MRI sup18supFFDG PETCT However clear two modality successful predicting difference treatment response baseline postNAC",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824136/"
    },
    {
        "pmid": "40824132",
        "title": "Histopathological assessment of thymoma based on the World Health Organization 2021 classification with emphasis on transcapsular invasion: experience from a tertiary care center.",
        "abstract": "Histological classification staging crucial management prognostication thymoma different staging system used significance transcapsular invasion debatable especially light pathological tumornodemetastasis pTNM staging American Joint Committee Cancer 8th edition objective study analyze histological subtypes transcapsular invasion clinical outcome thymoma regard World Health Organization WHO 2021 classification retrospective study included thymectomy specimen diagnosed thymoma period 10 years 2013 2023 Clinical detail histopathology slide reviewed histologically subtyped per 2021 classification Transcapsular invasion assessed pTNM modified Masoka staging done Descriptive statistic used summarize data total 45 thymoma case identified two extensive infarction excluded mean age 465 year range 2568 years study 28 male 15 female maletofemale ratio 181 Myasthenia gravis presenting feature 31 729 cases B2 B3 subtypes constituted half case 2243 mixed pattern 4 93 total 9 case showed macroscopic invasion 80 B3 subtype 23 case showed transcapsular invasion three common subtypes listed here B3 common followed AB B2 Masaoka staging showed 11 255 stage I 22 stage IIa 511 6 stage IIb 139 1 stage III 23 2 stage IVa 46 1 stage IVb 23 Followup available 38 43 case range 4127 months showed recurrence one case B3 subtype stage IVb None stage stage II as per Masoka staging patient recurrence Masaoka stage widely used staging system transcapsular invasion important parameter upgrading stage stage II However present study Masaoka stage II patient recurrence questioning significance capsular invasion staging Accurate histological subtyping thymoma challenging achieved adherence morphological criterion 2021 classification",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824132/"
    },
    {
        "pmid": "40824119",
        "title": "Controlling nanocage assembly, towards developing a one-health \"plug & play\" platform for targeted therapy.",
        "abstract": "growing interest developing onehealth plug play platform making different therapeuticsprophylactics target various biological entity viruses cancer cells bacteria platform could benefit advance artificial intelligence AI sustainable manufacturing respect naturally occurring protein nanocages ironstorage protein ferritin emerging ideal candidate various application nanomedicine However spontaneous selfassembly naturally occurring nanocages bottleneck application onehealth plug play platform review take fresh look application natural protein nanocages nanomedicine discussing current understanding selfassembly process highlight recent progress engineering ferritin subunit create onehealth plug play platform technology develop various therapeutic prophylactic nanomedicines discus advantage technology implication understanding nanocage assembly potential future application areas",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824119/"
    },
    {
        "pmid": "40824081",
        "title": "Urinary soluble CD163 is useful to predict lupus nephritis activity and to monitor standard-of-care therapy response.",
        "abstract": "study aim assess urinary soluble CD163 normalized creatinuria usCD163Cre alongside conventional biomarkers indicator renal activity therapeutic response lupus nephritis LN monocentric retrospective cohort analysis involving 214 patient systemic lupus erythematosus SLE conducted among 129 referred LN assessed longitudinally these 39 underwent kidney biopsy sample collection Data extracted medical records including metric renal activity SLEDAIR histological characteristics therapeutic response according KDIGO 2024 outcome criteria characteristic usCD163Cre ELLAG2 compared routinely used biomarkers confounding factor including renal function concomitant medication use crosssectional analysis indicated usCD163Cre AUC  0999 spot urine proteincreatinine ratio PCR AUC  0994 serum albumin level AUC  0940 distinguished active LN inactive states correlated SLEDAIR scores time kidney biopsy usCD163Cre reliable predictor histological activity AUC 0962 threshold 1200 ngmmol followup assessments usCD163Cre outperformed PCR discriminate disease flare 520 ngmmol categorization low 520 ngmmol medium 5201200 ngmmol high 1200 ngmmol usCD163Cre level 3 6months following therapy introduction allows predict complete partial nonresponders independent factor finding support involvement CD163 positive macrophage M2c pathophysiology LN advocate inclusion usCD163Cre measurement standard LN management assess LN flare episode early predictor therapy response",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824081/"
    },
    {
        "pmid": "40824063",
        "title": "Anti-cancer activity of Ajwa Dates extract (<i>Phoenix Dactylifera</i> L.) through analysis of MCL-1 levels, EGFR, and p53 expressions on apoptosis in human prostate cancer cell lines PC3: an <i>in vitro</i> study.",
        "abstract": "Prostate cancer recognized global burden disease related malignancy men Several fruit plantbased supplementation studied evaluate utility management prostate cancer Ajwa date Phoenix Dactylifera L known contain various beneficial compounds make potential anticancer therapy aim study assess effect Ajwa date prostate cancer cell line PC3 analysis MCL1 levels EGFR p53 expression apoptosis study experimental vitro study posttestonly control design Groups divided four control group abiraterone group Ajwa date group combination group abiraterone Ajwa dates Viability test conducted using CCK8 method determine inhibitory concentration IC50 Ajwa date 72hour incubation period PC3 cells MCL1 level rated using ELISA EGFR p53 expression analyzed using immunofluorescence microscopic staining Apoptosis measured using fluorescenceactivated cell sorting FACS SPSS version 25 Rstudio used statistical analysis study found IC50 Ajwa date 9133 μgml data indicated Ajwa date decrease MCL1 levels EGFR p53 expression also induced apoptosis compared control Furthermore effect became evident combined abiraterone study demonstrates potential Ajwa date complementary therapy prostate cancer research still needed clinical testing carried out",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824063/"
    },
    {
        "pmid": "40824023",
        "title": "Evaluation of the risk-benefit of thoracic paravertebral nerve block combined with propofol anesthesia and inhalation combined anesthesia for radical treatment in elderly lung cancer based on diaphragm functional parameters.",
        "abstract": "evaluate benefitrisk thoracic complex propofol anesthesia elderly lung cancer based diaphragm function parameters 137 elderly patient lung cancer undergoing radical resection thoracic surgery Hangzhou First Peoples Hospital selected patient divided into paravertebral complex propofol anesthesia PPA N  68 group static aspiration compound anesthesia SGA N  69 group PPA group amount remifentanil postoperative sufentanl 24h anesthesia onset time eye opening time directional force recovery time instruction time IL10 6h 12h 48 h VAS score active cough 6h 12h 24 h postoperative respiratory depression upper airway obstruction pulmonary complication significantly lower SGA group P 005 diaphragm function parameter DTF DD diaphragm contraction velocity significantly higher SGA group P 005 benefit value PPA SGA group 83 47 Risk value 17 respectively 39 Benefittotal risk 55 36 benefitrisk value highest PPA group PPA anesthesia effectively improve effect radical resection elderly lung cancer diaphragm function also characteristic high anesthesia quality adverse reactions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824023/"
    },
    {
        "pmid": "40824021",
        "title": "Formulation development and pharmacokinetic evaluation of celecoxib loaded hydroxyl propyl methyl cellulose (HPMC) microparticles in in-vivo model.",
        "abstract": "investigation aimed formulate Celecoxibloaded microparticles targeted delivery colon employing Hydroxypropylmethylcellulose HPMC Celecoxibs effectiveness managing colorectal cancer CRCrelated pain inflammation compromised low solubility gastrointestinal side effects total seventeen formulation synthesized emulsion solvent evaporation ESE oilinoil technique physicochemical property formulation analyzed Fourier Transform Infrared Spectroscopy Xray Diffraction Scanning Electron Microscopy Differential Scanning Calorimetry however rabbit served biological specimen vivo pharmacokinetic evaluation Rabbits plasma Celecoxib pure drug F1 F2 given rabbit one time dose assess pharmacokinetics evaluation average particle size F 1 49793μm 49793 μm F 2 vitro showed cumulative release rate 8877 F1 8885 F2 24 hours FTIR analysis confirmed compatibility formulation ingredients XRD revealed transition Celecoxib crystalline amorphous form DSC indicated formulations thermal stability SEM image showed dense spherical microparticles Given factors using HPMC micro particle carry Celecoxib could enhance drug delivery released body may result effective treatment fewer side effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824021/"
    },
    {
        "pmid": "40823991",
        "title": "In situ and localized primary invasive pregnancy-associated melanoma: Maternal and perinatal outcomes.",
        "abstract": "Pregnancyassociated melanoma PAM melanoma diagnosed pregnancy 12 month postpartum longstanding debate regarding impact pregnancy melanoma prognosis Previous study analysed pooled data PAM diagnosis stages finding may reflect outcome associated diagnosis situ localized PAM commonly diagnosed later stage PAM describe incidence perinatal survival outcome situ localized primary invasive PAM melanoma stage 0II populationbased retrospective cohort study New South Wales NSW Australia performed comprising woman birthed 1 January 1994 31 December 2013 babies mortality data available September 2018 Women grouped gestational PAM diagnosed earlystage melanoma pregnancy postpartum PAM diagnosed earlystage melanoma within 1 year postpartum control women gave birth without diagnosis cancer Perinatal outcome compared using generalized estimating equation model mortality compared using Cox regression KaplanMeier curve logrank test total 1785876 pregnancy identified including 223 woman 228 babies gestational PAM 467 woman 478 babies postpartum PAM incidence situ PAM increased 87 95 CI 40135 per year 2002 2013 incidence localized primary invasive PAM increase 1994 2013 significant maternal neonatal morbidity identified Sixteen death observed woman diagnosed localized primary invasive PAM mortality rate woman gestational PAM differ significantly woman postpartum PAM 241000 personyears vs 161000 personyears p value  0394 Diagnosis early PAM pregnancy postpartum associated significant adverse outcome woman babies Early diagnosis remains important ensure appropriate treatment positive outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823991/"
    },
    {
        "pmid": "40823983",
        "title": "Advances in CAR-T therapy for small cell lung cancer.",
        "abstract": "Small cell lung cancer SCLC highly aggressive subtype lung cancer limited treatment option poor prognosis patients Traditional treatments including platinumbased drug etoposide chemotherapy provide good initial response highly susceptible drug resistance resulting markedly reduced longterm survival rate recent years success chimeric antigen receptor cell CART therapy hematologic malignancy potential treatment solid tumor brought new hope treatment SCLC article present review application CART cell therapy SCLC including examination structural optimization CART cells analysis therapeutic target SCLC discussion latest progress preclinical clinical research objective study present novel insight pioneering strategy immunotherapy SCLC aim advancing field tumor immunotherapy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823983/"
    },
    {
        "pmid": "40823980",
        "title": "Consensus on the Diagnosis and Management of Patients with Breakthrough Cancer Pain (BTcP), Including Procedural BTcP: DIOPRO Study.",
        "abstract": "develop consensus recommendation improving diagnosis treatment breakthrough cancer pain BTcP including procedural BTcP opinion 107 medical expert managing patient cancer Spain collected using tworound Delphi method Consensus assessed 76 item using Likert scale 19 Agreement reached median MED score ≥ 7 interquartile range IQR ≤ 3 disagreement considered MED ≤ 3 IQR ≤ 3 Consensus reached 90 statements Experts agreed main characteristic BTcP may variable number episode per day occur patient opioidcontrolled background pain resounding agreement need evaluate pain severity background breakthrough cancer pain patient cancer involving adequately trained physician nursing staff Procedural BTcP subtype BTcP common cancer diagnosis andor treatment procedures this premedication appropriate fastacting shortduration drug necessary finding highlight need standardized protocol specific training improve quality life patient suffering BTcP including procedural BTcP efficiency healthcare resource management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823980/"
    },
    {
        "pmid": "40823962",
        "title": "MULTIFOCALITY AND BILATERALITY IN MEDULLARY THYROID CANCER: BASIS FOR A PROOF-OF-CONCEPT SAFETY OF LOBECTOMY.",
        "abstract": "present total thyroidectomy central neck dissection surgical approach recommended initial treatment medullary thyroid cancer MTC independently size number tumor foci age patient demographic clinicalpathological parameters aim present study assess prevalence multifocality hereditary hMTC sporadic sMTC patient correlate presence multifocality clinical pathological parameter provide proof concept lobectomy safely performed selected cases analyzed epidemiological pathological clinical data 389 MTC 311 sMTC 78 hMTC diagnosed center 2005 2018 Multifocality found 89389 case 229 45311 145 sMTC 4478 564 hMTC bilaterality detected 27311 87 sMTC particularly 2745 60 multifocal ones 4478 hMTC 564 Multifocality resulted correlated aggressive phenotype sMTC hMTC multivariate analysis showed statistically independently associated tumoral extrathyroidal extension N1 status sMTC N1 status persistent disease hMTC However none presurgical factor could predict presence multifocality bilaterality study demonstrated rarity multifocality particular bilaterality sMTC represents proof concept starting think conservative surgical approach selected sMTC cases approach cannot considered hMTC high prevalence multifocal bilateral cases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823962/"
    },
    {
        "pmid": "40823889",
        "title": "EXPRESS: CB2 receptor agonist AM1241 regulating the polarization of microglia reduces morphine tolerance through IL-4/STAT6 pathway.",
        "abstract": "Pain seriously effect patients life quality use morphine pain common tolerance limit application clinic However exact mechanism tolerance study explored effect microglial polarization role ILinterleukin4 administrating microglial polarization reducing morphine tolerance CB2 receptor agonist cell cultivated morphine combined CB2R agonist AM1241 CB2R antagonist AM630 CB1R antagonist AM281 IL4 inhibitor IL4I mouse injected drug 7 consecutive days hot plate behavioral test performed 30 minute administration respectively Mice received single morphine injection day 8 sample taken behavioral tests expression iNOS SOCS3 IL4 STAT6 mRNA detected qPCR expression iNOS SOCS3 pSTAT6 STAT6 protein detected Western blot Inflammatory cytokine detected Elisa kit M1 marker iNOS increased M2 marker SOCS3 decreased pSTAT6 protein change cytokine increased morphine treatment PWL value IL4 mRNA pSTAT6 protein increased AM1241 treatment iNOS decreased SOCS3 increased AM1241 treatment AM1241 decreased proinflammatory cytokines increased IL4 IL10 secretion AM630 IL4I reversed effect AM1241 PWL M1 M2 markers polarization microglia direction M1 caused morphine tolerance AM1241 increased IL4 mRNA induced phosphorylation protein STAT6 reduce tolerance AM1241 induced microglia polarization direction M2 AM1241 regulated microglia polarization IL4STAT6 pathway thereby reducing tolerance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823889/"
    },
    {
        "pmid": "40823885",
        "title": "Endocrine therapy may be warranted in patients with ER-low, early-stage breast cancer.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823885/"
    },
    {
        "pmid": "40823849",
        "title": "Mechanical properties of Palacos<sup>®</sup> MV bone cements containing magnetic glass-ceramic particles.",
        "abstract": "Polymethylmethacrylate PMMA used bone cement orthopaedic surgery fixation prosthetic component filling bone defects PMMA bone cement containing magnetic particle explored treatment bone cancer using magnetic induction hyperthermia study different formulation magnetic bone cement developed mixing 40 wt magnetic glassceramics Palacossup®sup MV commercial PMMA bone cement medium viscosity Mechanical property magnetic bone cement investigated compared nonmagnetic commercial Palacossup®sup MV cement used control Setting time setting temperature compressive strength bending strength bending modulus magnetic bone cement evaluated using ISO 58332002 standard guidelines Vickers hardness test carried using ASTM E38422 standard Setting time increased amount magnetic glassceramic bone cement Setting temperature magnetic cement nonmagnetic control similar magnetic bone cement average compressive strength 70 MPa average bending modulus 18 GPa meet requirement ISO 58332002 standard magnetic cement containing 30 wt magnetic glassceramic average bending strength 50 MPa comply ISO 58332002 standard requirement magnetic bone cement Vickers hardness higher control cements Thus magnetic cement containing 30 wt magnetic glassceramic potential used treatment bone cancers",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823849/"
    },
    {
        "pmid": "40823818",
        "title": "Homologous Repair-Deficient Pancreatic Cancer: Refined Targeting of DNA Damage Response is an Effective Therapeutic Strategy.",
        "abstract": "Pancreatic ductal adenocarcinoma PDAC devastating malignancy high mortality rate 20 PDAC patient harbor mutation gene involved homologous recombination HR repair 5 germline BRCA12 mutation carrier approved treatment option PARP inhibitor PARPi olaparib Characterizing HRdeficient HRD genotype beyond gBRCA12 susceptible PARPi potential substantially broaden eligible patient population defining optimal inhibitor may optimize treatment strategy advance personalized medicine PDAC previous preclinical work showed synthetic lethality multipronged DNA damage repair interference strategy using PARPi olaparib ATR inhibitor VE822 DNAPK inhibitor CC115 termed PAD ATM deficiency present study challenged role olaparib PAD combination assessed regimens efficacy across various HRD genotypes assessed spectrum DNA damage repairinterfering drug identify potent inhibitor HRD Using ATM BRCA1 BRCA2 PALB2defective versus HRproficient murine PDAC cells systematically investigated feasibility expanding optimized PAD regimen within defined HRD genotype vitro vivo regimens efficacy validated PDAC patientderived organoids without deleterious class IVV alteration HRD genes Here demonstrate remarkable potency PARPi talazoparib HRD PDAC Substituting olaparib currently approved inhibitor PDAC talazoparib PAD regimen enhanced efficacy maintaining comparable tolerability vivo Importantly show PAD effective therapeutic regimen extended prevalent HRdefective genotype PDAC including ATM BRCA1 BRCA2 PALB2 preclinical setting Collectively data provide strong rationale implement refined regimen talazoparibbased PAD therapeutic concept tailored HRD PDAC patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823818/"
    },
    {
        "pmid": "40823817",
        "title": "Colorectal cancer treatments show promise: Studies find longer progression-free survival and a potential relative reduction in the risk of death with treatment advances.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823817/"
    },
    {
        "pmid": "40823803",
        "title": "Combined single- and dual-energy CT workflow for dose calculation in radiotherapy.",
        "abstract": "Dualenergy computed tomography DECT increasingly used radiotherapy delineation due enhanced soft tissue contrast DECT also support direct dose calculation However current DECT scanner allow use certain body regions conventional singleenergy computed tomography SECT still needed patients safe clinical introduction DECT thus requires combined workflow study therefore investigates whether unified Hounsfield lookup table HLUT applied across SECT DECT reconstructions Patientmaterial methods Gammex Advanced Electron Density phantom containing tissueequivalent insert scanned using SECT 70140 kVp Sn100Sn140 kVp Sn meaning tinfiltered dualspiral DECT identify matching HLUTs three SECT methods including standard reconstruction only 120 kVp Method 1 kVpindependent reconstruction providing mass density MD Method 2 relative electron density RED Method 3 Dose agreement subsequently tested two anthropomorphic phantoms SECT method DECT reconstruction compared voxelwise analysis computed tomography CT numbers performing dose calculation three anatomical regions head thorax abdomenpelvis Across three SECT methods DECT reconstruction acceptable clinical CT number agreement identified Corresponding dose calculation SECT DECTbased plan showed minimal differences phantom study demonstrates unified HLUT applied across SECT DECT using standard 120 kVp MD RED reconstructions approach may streamline clinical workflow support safe practical transition DECTbased treatment planning",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823803/"
    },
    {
        "pmid": "40823765",
        "title": "Mitochondria-Targeted Ferroptosis Nanodrug for Triple-Negative Breast Cancer Therapy via Fatty Acid Metabolism Remodeling and Tumor Bacterial Symbiosis Inhibition.",
        "abstract": "Triplenegative breast cancer TNBC considered one aggressive subtypes breast cancer due pronounced propensity metastasis challenge amplified critical role mitochondrion metastasis regulating process like fatty acid metabolism drive tumor cell migration Moreover emerging evidence suggests bacterial infiltration particularly Staphylococcus xylosus S xylosus could exacerbate TNBC metastasis address metabolic dysregulation bacterial involvement mitochondriatargeted ferroptosisactivated nanosystem developed named ICM integrated mitochondrial membrane MM mitochondrial targeting FeClsub3sub ferroptosis therapy photosensitizer indocyanine green cytochrome c CytC selfassembly technology assembly CytC interacted cardiolipin MM endowing ICM peroxidaselike catalaselike activities Dual enzymatic activities combined phototherapy enhance FeClsub3subinduced ferroptosis tumor cell mitochondria thereby reprogramming fatty acid metabolism inhibiting metastasis Additionally amplified ferroptosis effect also effectively inhibit S xylosus disrupting tumorbacteria symbiosis preventing metastatic spread Finally ICM nanoparticles significantly suppress TNBC metastasis modulating lipid metabolism inhibiting bacterialmediated metastasis finding suggest ICM offer multifaceted therapeutic approach combating TNBC metastasis providing potential strategy cancer treatments",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823765/"
    },
    {
        "pmid": "40823741",
        "title": "Advanced Strategies for Constructing Self-Assembled Peptide Hydrogels/Nanoparticles for Cancer Treatment.",
        "abstract": "Peptide hydrogel wellsuited porous structure high biocompatibility ease penetration facile functionalization review several triggering method summarized producing anticancer peptidebased nanofibers nanohydrogels nanoparticles NPs employing various factor heatingcooling solventswitch method ionic strength concentration sonication hydrogen ion concentration pH photocrosslinking liquidliquid phase separation LLPS methods linear cyclic peptide incorporated selfassembled nanofibers nanoparticles nanohydrogels andor structure may used alternatively specific circumstances Furthermore mild residuefree approach disrupt hydrogel structure supercritical carbon dioxide scCOsub2sub also incorporated solve challenging problem hydrogel sterilization",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823741/"
    },
    {
        "pmid": "40823738",
        "title": "A high-accuracy hybrid method for detecting retinal blood vessel changes across different phases of fluorescein angiography in diabetic retinopathy patients.",
        "abstract": "iObjectivei Fundus fluorescein angiography FFA remains gold standard retinal vascular imaging especially detecting leakage neovascularization ischemia despite advancement noninvasive technique like optical coherence tomography angiography OCTA color fundus photography CFP FFAs unique role particularly latephase imaging crucial diagnosing managing diabetic retinopathy DR study introduces novel dualphase segmentation framework FFA enhancing analysis early latephase images study aim overcome challenge noise blurring latephase FFA developing method enhances vascular map detection monitor change across two phases enabling precise identification lesion responsible leakage Validated expert evaluation quantitative metrics model enhances diagnostic accuracy diabetic retinopathy complement existing imaging technologiesiApproachi prospective randomized study 280 image 87 DR patient various stage included study approach involved using four different image enhancement technique including 1 histogram equalization HE 2 contrast limited adaptive CLAHE 3 recursive meansquare RMSHE 4 proposed method paper CLAHE combined RMSHE addition robust noise reduction edge sharpening enhancement method combined median match Hessian filter used Finally four different thresholding methods including i Cmeans fuzzy thresholding ii IsoData thresholding iii modified active contour MACOtsu thresholding iv proposed method paper MAC IsoData used vessel segmentation FFA across different datasetsiMain resultsi effective segmentation method MACIsoData assessed using three metric DSC early 084 ± 005 late 084 ± 003 Jaccard index early073 ± 006 late074 ± 005 Boundary F1 score early 098 ± 002 late 097 ± 002 result validated three expert ophthalmologistsiSignificancei work demonstrates MACOtsu following CLAHE enhancement effectively delineates detail necessary precise identification lesion responsible leakage across two different phases Additionally MACIsoData proposed method enhancement early phase RMSHE enhancement late phases successfully reveals vascular map",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823738/"
    },
    {
        "pmid": "40823695",
        "title": "The functional and therapeutic potential of epitranscriptomics in breast cancer.",
        "abstract": "Breast cancer BCa one commonly diagnosed malignancy worldwide clinically heterogenous BCa classified distinct histopathological molecular subtypes inform diagnosis treatment prognosis Although therapeutic advances particularly targeted therapies improved outcomes metastatic BCa remains unmet clinical need addition treatment option remain limited especially triple negative BCa TNBC urgent need develop novel approach prevent delay reverse disease progression patients role genetic epigenetic alteration BCa well established Emerging evidence highlight dysregulation epitranscriptomic mechanism involving covalent RNA modification contributing factor BCa pathogenesis Notably recent evidence support functional crosstalk epigenetic epitranscriptomic process potential clinical therapeutic relevance review explores key epitranscriptomic RNA modifications msup6supA msup6supAsubmsub msup5supC msup7supG msup1supA context BCa functional consequence epitranscriptomic regulator writers erasers readers discussed alongside accumulating evidence contribution cancer development progression review considers RNA modification regulator might serve biomarkers therapeutic target offer new direction translational research clinical intervention BCa",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823695/"
    },
    {
        "pmid": "40823689",
        "title": "Transcytosis-mediated drug delivery for cancer therapy: integrating chemotherapy and immune modulation.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823689/"
    },
    {
        "pmid": "40823672",
        "title": "Precision medicine and music therapy for Parkinson's Disease.",
        "abstract": "bBackgroundb Parkinsons disease PD complex neurodegenerative disorder requiring multidimensional treatment approaches Recent breakthrough precision medicine growing evidence music therapy efficacy present new opportunity comprehensive PD management address biological mechanism quality life outcome bObjectivesb mini review evaluates current state precision medicine music therapy intervention PD three primary aims 1 synthesize evidence geneticbased treatment musicbased interventions 2 identify potential synergy approaches 3 highlight critical implementation challenge clinical practice bFindingb analysis revealed precision medicine approaches including GBA1targeted venglustat LRRK2 kinase inhibitors show significant promise clinical trial guided genetic profiling Concurrently music therapy demonstrates robust clinical benefits RAS producing 1520 improvement gait parameter group singing program enhancing speech function psychosocial wellbeing Emerging technologies particularly wearable sensor adaptive AI platforms enhancing precision personalization treatment modalities However identified persistent challenge including need standardized biomarkers precision medicine rigorous clinical validation music therapy protocols bConclusionsb strategic integration precision medicine music therapy offer novel patientcentered framework PD management simultaneously target pathological mechanism functional outcomes Future implementation focus overcoming accessibility barriers conducting largescale longitudinal studies developing integrated treatment protocol combine genetic insight personalized neuromodulation approaches",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823672/"
    },
    {
        "pmid": "40823670",
        "title": "Assessing the Relative Contribution of DSB Repair Proteins as a Function of LET.",
        "abstract": "Particle therapy gaining popularity due dosimetric benefits Particle radiation also higher linear energy transfer LET Xrays leading complex DNA damage higher relative biological effectiveness RBE potentially beneficial remains significant uncertainty RBE depends genetic feature irradiated cells Understanding cell respond repair damage crucial optimising radiotherapy study evaluates loss different DNA double strand break DSB repair gene impact radiosensitivity CRISPRmodified RPE1 cell exposed 6 different LETs using Xrays protons carbon ions alpha particles following clonogenic survival DNA DSB repair kinetics measured Experimental data compared prediction mechanistic model radiation response Medras Clonogenic assay showed cell lacking ATM NHEJ repair gene particularly radiosensitive even high LET exposures RBE increased LET analysed knockout lines RBE increased slower rate cell sensitive Xrays regardless affected pathway Moreover data showed significant difference DNA repair pathway dependence function LET Medraspredicted response good agreement genetic background LET dependency radiosensitivity without assumption change repair pathway dependence LET research highlight importance DSB repair pathways particularly NHEJ determining cellular sensitivity different radiation qualities suggests system little difference pathway dependence Xrays highLET radiation Mechanistic approach like Medras offer promising approach predict radiation responses support personalised effective cancer treatment based genetic profiles",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823670/"
    },
    {
        "pmid": "40823592",
        "title": "A Propensity-Score Matched Analysis to Evaluate Local Treatment Modalities for Esophageal Squamous Cell Carcinoma in Over 80 years on A SEER Database.",
        "abstract": "aim study investigate impact Local treatment modality survival of≥80 year older patient squamous cell esophageal cancer including cancerdirected surgery CDS radiotherapy RT Patients Surveillance Epidemiology End Results SEER database divided CDS Group RT Group according different Local treatment modalities Propensity score matching PSM performed adjust baseline difference two groups Overall survival OS cancerspecific survival CSS calculated using KaplanMeier method compared using Log rank test total 1588 esophageal squamous cell cancer patient ≥80 year older 1975 2021 included final study cohort including 165 104 patient underwent CDS 1423 896 patient received radiotherapy RT therapy Univariate multivariate analysis showed local treatment modality prognostic factor causespecific survival CSS overall survival OS Patients received CDS better CSS HR  0674 95 CI  05440836 P  0000 OS HR  0717 95 CI  05950863 P  0000 propensityscore matched PSM dataset CDS associated better CSS P  0008 OS P  0011 patient ≥80 year older Subgroup analysis showed prognostic effect local treatment modality significantly influenced Age Nevertheless difference observed CSS P  0584 OS P  0434 patient ≥85 year old conclusion CDS preferred treatment esophageal squamous cell cancer patient 8084 year older difference CDS RT patient with≥85 year older study highlight value different local treatment esophageal squamous cell carcinoma 80 year patients especially ≥85 year older study needed understand driver bias enhance equality old patient treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823592/"
    },
    {
        "pmid": "40823573",
        "title": "Identification and synthesis of end-of-life decision-making measures: a scoping review.",
        "abstract": "Cognitive impairment CI related condition known affect decisionmaking DM particularly older adult populations intersection CI DM ability crucial endoflife EoL care confluence heterogenous preference value often across different constituent eg healthcare providers family members proxies Standardized questionnaire necessary characterize patients EoL decisions preferences readiness extent available measure widely unknown scoping review aim summarize current state literature regarding EoL decisionmaking measures effort support development Advancing Reliable Measurement Cognitive Aging Decisionmaking Ability ARMCADA research initiative seek develop decisionmaking battery use older adults Following Arksey OMalley framework conducted scoping review multiple domain DM study published January 2018 November 2023 paper assessed characterized DM participant 45 year older extracted DM domain population characteristics DM measures initial search identified 16286 articles 705 classified assessing DM those 34 article included measure EoL domain 28 unique measure identified MacArthur Competence Assessment Tool Treatment MacCATT Decisional Conflict Scale DCS Decision Regret Scale DRS assessment used scoping review Many study assessed clinical populations including CIdementia 12 cancer 24 chronic condition 16 Findings show measure used end life emphasize decisional preferences efficacy conflict Overall review highlight lack DM ability measure assess older adults capacity make decision regarding EoLspecific issue eg lifesustaining treatment pain management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823573/"
    },
    {
        "pmid": "40823511",
        "title": "Synchronous Presentation of Type 2 Marine-Lenhart Syndrome and Differentiated Thyroid Carcinoma Manifesting as Thyroid Storm.",
        "abstract": "MarineLenhart syndrome MLS rare condition characterized coexistence hyperfunctioning thyroid nodule Graves disease GD prevalence thyroid nodule thyroid cancer higher patient GD report case 42yearold female presented thyroid storm found underlying GD initial thyroid ultrasound US revealed two nodule classified TIRADS 3 whereas repeat US achieving euthyroidism showed change size consistency nodule identified new nodule classification TIRADS 6 nodule 24h radioactive iodine thyroid uptake scan demonstrated diffuse increase uptake 751 one hyperfunctioning two warm nodules including newly identified TIRADS 6 nodule Fineneedle aspiration FNA biopsy confirmed papillary thyroid cancer Bethesda VI right R warm nodule the TIRADS 6 nodule two nodule benign Bethesda II patient underwent R hemithyroidectomy complicated recurrent laryngeal nerve RLN injury Pathology examination revealed unifocal papillary thyroid microcarcinoma positive anterior surgical margin patient furtherly treated radioactive iodine therapy thyroid nodule GD managed cautiously Emerging evidence challenge previous notion hyperthyroidism provides protection thyroid cancer association GD thyroid malignancy remains area ongoing investigation variable management strategy prognostic implication reported literature",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823511/"
    },
    {
        "pmid": "40823500",
        "title": "Regional lymph node invasion in pediatric non-rhabdomyosarcoma soft tissue sarcoma: an international cohort study from the International Soft Tissue Sarcoma Consortium.",
        "abstract": "pediatric nonrhabdomyosarcoma soft tissue sarcoma NRSTS frequency prognostic impact regional lymph node involvement N1 clearly defined may vary according histological type therefore analyze rate N1 diagnosis pattern nodal relapse prognostic impact N1 pediatric patient NRSTS Data collected analyzed International Soft Tissue SaRcoma ConsorTium INSTRuCT Patients aged 021 year NRSTS prospectively enrolled European North American cooperative group trial October 1 1990 October 1 2018 included Descriptive statistics logistic regressions Cox proportional hazard model used analyze data assess prognostic factors 1937 patient eligible inclusion main histotypes synovial sarcoma 628 cases 32 undifferentiatedunclassified sarcoma 396 cases 20 malignant peripheral nerve sheath tumor 275 cases 14 Distant metastasis present 197 102 patients N1 present 152 78 patients median followup 72 year 95 CI 7074 615 patient 317 local relapse progression 30 15 nodal relapse including four initial N1 287 148 developed metastases multivariate analysis node positive N1 status associated high pathologic grade p  0010 distant metastasis p  00001 tumor size invasiveness histological subgroup p  036 nonmetastatic tumor 1740 cases metastaticfreesurvival differed node negative N0 N1 patients overall survival eventfreesurvival nodal relapsefreeinterval not N1 rare NRSTS childhood 8 mainly present subset histotypes Regional nodal control 5 year adequate However N1 NRSTS marker aggressive disease Cancer Research Foundation Childrens Research Foundation Comer Development Board KickCancer King Baudouin Foundation Rally Foundation Childhood Cancer Research Seattle Childrens Foundation Kats Crew Guild Scleroderma Research Foundation St Baldricks Foundation Andrew McDonough B Foundation Maddies Promise Summers Way Foundation Friends TJ Foundation Sebastian Strong Childrens Oncology Group Foundation Sarah Jane Adicoff Endowment Research Rhabdomyosarcoma Seattle Childrens Foundation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823500/"
    },
    {
        "pmid": "40823499",
        "title": "Management of <i>Clostridioides difficile</i> infection in patients with haematological malignancies and after cellular therapy: guidelines from 10th European Conference on Infections in Leukaemia (ECIL-10).",
        "abstract": "iClostridioides difficilei infection CDI pose significant challenge patient haematological malignancy HM undergoing cellular therapy haematopoietic cell transplantation HCT CAR Tcell therapy patient high rate colonization iClostridioides difficilei diarrhoea due noninfectious causes leading challenge establishing diagnosis optimal management CDI especially setting molecular detection toxin gene alone Current severity criterion limited usefulness since underlying haematological disease treatment impact white blood count inflammatory manifestation severe CDI Extensive exposure antibiotics profound microbiota damage bidirectional relationship gastrointestinal graftversushost disease transplant complicate clinical management Therefore 10th European Conference Infections Leukemia ECIL10 group comprehensively reviewed literature published 0101201015092024 epidemiology treatment prevention CDI formulated consensus recommendation management CDI specific population New definition proven probable possible CDI population developed proposed use clinical research standardise reporting",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823499/"
    },
    {
        "pmid": "40823490",
        "title": "Discovery of an orally bioavailable, CNS active pan-mutant RET kinase heterobifunctional degrader.",
        "abstract": "Point mutation chromosomal fusion Rearranged Transfection RET transmembrane receptor tyrosine kinase cause constitutive substratefree activation driving numerous human cancers RETselective kinase inhibitor selpercatinib pralsetinib current clinical use RETdriven tumors However emergence resistance mutations solventfront G810 residue result reduced efficacy sought exploit eventdriven pharmacology targeted protein degradation achieve panmutant activity RETdriven cancer single selective RET degrader utilizing nonphthalimide cereblon CRBN ligand discover orally bioavailable heterobifunctional degraders describe medicinal chemistry effort led compound 20 orally bioavailable brainpenetrant panmutant panfusion RET heterobifunctional degrader",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823490/"
    },
    {
        "pmid": "40823487",
        "title": "Asymptomatic Splenic Infarction Following Total Gastrectomy: A Case Report.",
        "abstract": "Splenic infarction disease develops result thrombotic predisposition area malperfusion usually small unnoticeable However massive infarction occurs often diagnosed onset clinical symptoms abdominal pain fever contrast asymptomatic postoperative extensive splenic infarction occasionally observed Although conservative management generally firstline treatment splenic infarction surgical intervention indicated case complicated splenic abscess rupture report suggest extensive splenic infarction may result atrophy complete loss spleen time 65yearold woman presented chronic epigastric pain diagnosed gastric cancer upper gastrointestinal endoscopy endoscopy revealed ulcerated mass lesser curvature middle gastric body biopsy confirmed moderately differentiated adenocarcinoma laparoscopic distal gastrectomy initially planned However surgical approach converted open total gastrectomy spread tumor greater curvature gastric body enlargement distal lymph node splenic artery included planned lymphadenectomy Postoperatively patient experienced abdominal pain fever However POD 7 blood test revealed elevated hepatobiliary enzymes contrastenhanced CT CECT scan showed loss flow splenic artery vein leading diagnosis extensive splenic infarction followup CECT scan 3 month later revealed notable reduction splenic parenchyma time rare case asymptomatic extensive splenic infarction incidentally diagnosed following total gastrectomy successfully treated conservative management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823487/"
    },
    {
        "pmid": "40823470",
        "title": "Immune Checkpoint Inhibitor-Induced Myositis Myocarditis and Myasthenia Gravis (MMM) Overlap Syndrome in a Rural District General Hospital: An Institutional Case Series Involving Four Patients.",
        "abstract": "Immune checkpoint inhibitor ICIs commonly used treatment advanced cancers Although effective cause side effects case series describes four patient treated ICIinduced myositis myocarditis myasthenia gravis MMM overlap syndrome rural general hospital United Kingdom 2023 2025 best knowledge first openaccess case series describing management specifically rural lowresource setting Patients exclusively male mean age 689 year received either dual nivolumabipilimumab pembrolizumab monotherapy metastatic melanomas renal cell carcinoma synchronous oesophageal lung cancer Symptoms included fatigue proximal muscle weakness dysphagia diplopia dyspnea Highdose intravenous methylprednisolone mainstay treatment additional immunomodulators like mycophenolate mofetil tocilizumab tacrolimus intravenous immunoglobulin added based clinical progression specialist input Two patient recovered treatment remained progression free following ICI discontinuation two patient died due respiratory failure likely related delayed initiation myasthenia gravisdirected therapy Prominent bulbar symptom presentation high myasthenia gravis composite score appear correlate poor outcomes Early access diagnostics autoantibody MG tissue biopsy electrodiagnostics often limited logistical barriers However biomarkers like creatine kinase troponins imaging modality consistently available series highlight challenge managing MMM syndrome nonspecialist resourcelimited setting potential danger delayed immunosuppression high index suspicion early multidisciplinary involvement rapid initiation therapy critical improving outcomes Furthermore case series support need simplified contextappropriate guideline prioritise clinically impactful investigation also highlight emerging potential neutrophiltolymphocyte ratio practical prognostic tool ICI indication expand awareness MMM overlap syndrome among frontline clinician essential reduce treatment delay prevent avoidable mortality",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823470/"
    },
    {
        "pmid": "40823461",
        "title": "Suspected Urine-Induced Chemical Peritonitis Secondary to Invasive Bladder Cancer: A Case Report.",
        "abstract": "Chemical urineinduced peritonitis rare potentially lifethreatening complication patient advanced bladder cancer may result sterile urinary leakage peritoneal cavity typically microscopic wall disruption tumor necrosis condition mimic perforation bacterial peritonitis posing significant diagnostic challenge describe case 78yearold male de novo highgrade urothelial carcinoma presenting persistent gross hematuria bilateral hydronephrosis severe anemia Despite initial tumor resection nephrostomy placement patients condition deteriorated sign peritoneal irritation systemic inflammation Emergency cystoprostatectomy revealed extensive tumor necrosis inflammatory peritoneal fluid macroscopic bladder perforation Histopathology confirmed muscleinvasive highgrade urothelial carcinoma pT2b necrosis angioinvasion report illustrates diagnostic therapeutic challenge management advanced bladder cancer complicated suspected sterile chemical peritonitis emphasizing importance early source control critically ill patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823461/"
    },
    {
        "pmid": "40823455",
        "title": "Pneumopericardium, Pneumomediastinum, and Bilateral Pneumothoraxes Following Intubation and Repositioning in a 64-Year-Old Male Patient Undergoing Thoracic Decompression and Fusion.",
        "abstract": "Pneumomediastinum pneumopericardium pneumothorax recognized rare complication associated endotracheal intubation mechanical ventilation perioperative setting simultaneous occurrence three pathology following intubation intraoperative repositioning previously described literature case report detail presentation management 64yearold male patient metastatic prostate cancer undergoing thoracic decompression fusion developed pneumomediastinum pneumopericardium bilateral pneumothoraces following endotracheal intubation repositioning patients medical history included prior smoking history known bullous emphysematous changes Induction general anesthesia uneventful Following repositioning supine prone patient experienced acute ventilatory compromise characterized elevated peak airway pressures reduced tidal volumes hypotension endotracheal tube ETT suctioned albuterol delivered patient returned baseline Shortly after another ventilatory compromise occurred Interventions included suctioning ETT administration albuterol conversion manual ventilation fiberoptic examination ETT Chest radiography computed tomography angiogram identified pneumomediastinum pneumopericardium bilateral pneumothoraces patient transferred surgical intensive care unit conservative management including serial chest radiographs ultimately recovered without cardiopulmonary complications simultaneous occurrence pneumomediastinum pneumopericardium pneumothorax following prone repositioning general anesthesia present previously undocumented complication pathway requiring rapid diagnosis management Future work explore standardized protocol early recognition intervention can intubate cannot ventilate scenarios well preventive ventilatory strategy patient underlying pulmonary pathology",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823455/"
    },
    {
        "pmid": "40823452",
        "title": "Pancreatic Schwannoma: A Rare Culprit But Accurate Diagnosis Can Avoid Resection.",
        "abstract": "Pancreatic schwannomas extremely rare benign tumor originating Schwann cell peripheral nerves often mimicking common pancreatic tumors neuroendocrine neoplasm solid pseudopapillary neoplasms making preoperative diagnosis challenging describe 65yearold asymptomatic man referred evaluation incidental pancreatic body mass detected ultrasound Laboratory findings including liver enzyme tumor marker CA199 CEA normal Contrastenhanced CT revealed welldefined 20 mm mass delayed enhancement MRI showed low intensity T1weighted images mildly high T2 slight diffusion restriction Based imaging pancreatic neuroendocrine neoplasm initially suspected Endoscopic ultrasoundguided tissue acquisition 22gauge needle performed Histology revealed bundle spindleshaped cell mild atypia eosinophilic cytoplasm Immunohistochemistry diffusely positive S100 protein negative AE1AE3 CD34 cKit desmin confirming pancreatic schwannoma Given benign nature patient managed conservatively without surgery tumor growth observed two year followup case highlight importance including schwannoma differential diagnosis solid pancreatic lesion illustrates endoscopic ultrasound EUSguided biopsy immunohistochemistry enable accurate preoperative diagnosis avoid unnecessary surgical resection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823452/"
    },
    {
        "pmid": "40823361",
        "title": "Mechanistic Perspectives on Radiation-Induced Skin Injury and the Protective Effects of Berberine.",
        "abstract": "Radiationinduced skin injury RISI common complication radiotherapy affecting 95 cancer patients manifest acute erythema ulceration chronic fibrosis telangiectasia severely compromising patients quality life pathogenesis RISI involves oxidative stress inflammation DNA damage cellular senescence However current treatment largely supportive fail address underlying mechanisms Berberine BBR natural isoquinoline alkaloid exhibit antiinflammatory antioxidant woundhealing properties making promising candidate managing RISI Singlecell RNA sequencing proteomic analysis employed characterize molecular cellular change patient rat cell exposed ionizing radiation Differentially expressed gene DEGs protein identified functional enrichment analysis performed Key senescence marker validated using molecular docking vitro assays therapeutic effect BBR validated skin cell mouse model radiationinduced skin injury focusing wound healing systemic health Transcriptomic analysis identified 217 DEGs RISI highlighting pathway TNF p53 NFkappa B signaling Key senescence markers including CDKN1A IGFBP7 CTSL overexpressed correlating impaired wound healing Proteomic analysis revealed BBR modulated 684 proteins enhancing keratinocyte migration reducing oxidative damage BBR treatment promoted proliferation migration skin cells alleviated radiationinduced cellular senescence downregulated inflammatory pathway including p53 ROS JAKSTAT BBRtreated mouse exhibited significantly reduced skin injury scores improved body weight retention enhanced wound healing Radiation injury lead persistent senescence inflammation impaired wound healing skin tissues CDKN1A IGFBP7 CTSL core senescence marker RISI downregulating expression senescence marker suppressing inflammatory pathway including p53 ROS JAKSTAT BBR accelerates radiationinduced wound healing offering novel therapeutic strategy managing RISI",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823361/"
    },
    {
        "pmid": "40823339",
        "title": "Refining Prognosis and Treatment Strategies Beyond the Barcelona Clinic Liver Cancer Stage in Hepatocellular Carcinoma with Lung Metastases: A Multicenter Cohort Study.",
        "abstract": "Lung metastasis common site extrahepatic spread hepatocellular carcinoma HCC associated significantly poorer outcomes Current guideline classify patient Barcelona Clinic Liver Cancer BCLC stage C recommending systemic therapy alone However onesizefitsall approach may overlook potential benefit selected patients multicenter cohort study 1203 HCC patientsincluding 119 lung metastaseswe evaluated prognostic factor treatment outcomes Lung metastasis significantly reduced overall survival propensity score matching However among patient earlystage intrahepatic tumors curative locoregional treatment hepatectomy radiofrequency ablation improved survival led outcome comparable without metastasis Systemic therapy including tyrosine kinase inhibitor TKIs immune checkpoint inhibitor ICIs prolonged survival combination regimen yielding greatest benefit Interestingly lung metastasis impaired intrahepatic response systemic monotherapy effect mitigated combining TKIs ICIs finding suggest subset HCC patient lung metastasis may benefit individualized multimodal treatment strategies challenging current staging framework supporting refined personalized therapeutic approach population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823339/"
    },
    {
        "pmid": "40823316",
        "title": "Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working Party.",
        "abstract": "Natural killer NKTcell lymphoma NKTCLs rare aggressive lymphoma prevalent East Asia South America Despite improvements largely due asparaginasebased therapies outcome advanced disease remain poor role autologous stem cell transplantation autoHCT remains controversial study evaluated realworld outcome autoHCT NKTCL patient across Asia Europe included 130 adult NKTCL patient undergoing autoHCT 2011 2022 using data European Society Blood Marrow Transplantation EBMT registry South Korean registry data Median age 513 years 669 male patient 951 Eastern Cooperative Oncology Group ECOG score 01 653 Stage IIIIV disease One prior therapy line reported 531 ≥2 line 469 Asparaginasebased regimen used 795 pretransplant Responses autoHCT included complete 597 partial 279 remission stableprogressive disease 124 EpsteinBarr virus EBVDNA peripheral blood reported 373 median followup 46 years 3year overall survival OS progressionfree survival PFS 638 476 Relapse NRM rate 3 year 467 57 Patients complete remission improved 3year OS 752 compared PR 528 stableprogressive disease 320 P  0007 Detectable EBVDNA blood autoHCT associated poor outcome 3year OS 267 vs 781 patient undetectable EBVDNA P  00001 Patients achieving complete remission undetectable EBVDNA blood autoHCT favorable survival suggesting autoHCT may treatment option selected highrisk patients largest multinational cohort evaluating prognostic factor autoHCT NKTCL",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823316/"
    },
    {
        "pmid": "40823305",
        "title": "Eukaryotic initiation factors: central factor associating mRNA translational plasticity during neuropathic pain progression.",
        "abstract": "Neuropathic pain cause plasticity nervous system often associated altered protein synthesis Proteins key executor cellular functions alteration closely related occurrence neuropathic pain Protein synthesis finely regulated process involving interaction multiple biomolecules Among them eukaryotic translation initiation factor eIFs group key regulatory protein control initiation phase protein translation thus influence rate type protein synthesis Recent study shown eIFs involved regulation neuropathic pain regulating translation phosphorylation affecting transmission processing neuropathic pain signals Among them eIF4E eIF2α core initiation factors change expression activity closely associated various neuropathic pain review aim summarize evidence involvement eIFs especially eIF4E eIF2α painassociated mRNA translational plasticity propose relevant therapeutic approaches hope review provide important idea future research mechanism neuropathic pain new target treatment neuropathic pain",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823305/"
    },
    {
        "pmid": "40823261",
        "title": "The integration of machine learning into traditional Chinese medicine.",
        "abstract": "Traditional Chinese medicine TCM ancient medical system distinctive effective treating cancer depression coronavirus disease 2019 COVID19 diseases However relatively abstract diagnostic method TCM lack objective measurement complex mechanism action difficult comprehend hinders application internationalization TCM Recently breakthrough made utilizing method network pharmacology virtual screening TCM research rise machine learning ML significantly enhanced integration TCM article introduces representative methodological case quality control mechanism research diagnosis treatment process TCM revealing potential application ML technology TCM Furthermore challenge faced ML TCM application summarized future direction discussed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823261/"
    },
    {
        "pmid": "40823257",
        "title": "COVID-19 pandemic-related emotional, social, and medical concerns of Latino patients with cancer: perspectives of mental health providers.",
        "abstract": "Latino people cancer might face additional health emotional socioeconomic burden COVID19 pandemic study included data two wave independent assessment provider mental health service LatinoHispanic people cancer United States Spain Latin America first wave MayJuly 2020 second wave MarchJuly 2021 completed crosssectional online survey open closedended questions including concern people cancer withwithout COVID19 response rate 15 Wave 1 N88 14 Wave 2 N115 Wave 1 74 survey completed clinician included analyses Wave 2 115 survey included Providers first 77 second 84 waves reported patient concern stresssymptoms anxiety followed concern COVID19 exposure first 74 second 82 waves family members exposure second wave 75 hospital visit appointment 82 79 respectively treatmenttesting delay 69 72 respectively general health 58 71 respectively incomesalary loss reduction 60 50 respectively According providers concern patient diagnosed COVID19 included fear death dying spreading disease getting worse lack appropriate medical care finding reveal need address health emotional socioeconomic burden COVID19 pandemic throughout Latin America Spain United States Latino people cancer Interventions targeting healthcare access emotional socioeconomic need Latino people cancer warranted",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823257/"
    },
    {
        "pmid": "40823252",
        "title": "Cost-effectiveness analysis of sugemalimab combined with chemotherapy as first-line treatment for advanced gastric cancer.",
        "abstract": "Based finding GEMSTONE303 trial sugemalimab plus capecitabine oxaliplatin regimen showed superior clinical efficacy compared chemotherapy alone advanced gastric cancer patients economic evaluation study assesses costeffectiveness sugemalimab combination therapy within Chinas healthcare system framework partitioned survival model constructed based data GEMSTONE303 study cycle length 3 weeks model simulated patients direct medical cost qualityadjusted life year QALYs 10year period incremental costeffectiveness ratio ICER used evaluation metric comparing ICER willingnesstopay WTP threshold 3 time Chinas per caput GDP 2024 287391 CNYQALY Oneway sensitivity analysis probabilistic sensitivity analysis conducted assess robustness results basecase analysis showed sugemalimab regimen provided greater health benefit compared placebo group 136 QALYs vs 124 QALYs incurred significantly higher cost 27104124 CNY vs 4417469 CNY yielding ICER 189055458 CNYQALY Oneway sensitivity analysis indicated utility value progressive disease PD state progressionfree survival PFS state cost sugemalimab substantial impact ICER Probabilistic sensitivity analysis demonstrated stable results 0 probability sugemalimab combination regimen costeffective current economic condition China sugemalimab combined chemotherapy firstline treatment advanced gastric cancer costeffective",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823252/"
    },
    {
        "pmid": "40823189",
        "title": "High-dose use of pregabalin and gabapentin in France: a retrospective, population-based cohort study.",
        "abstract": "Following recent development regarding gabapentinoid ie pregabalin gabapentin abuse misuse France study aim describe new user gabapentinoids 2017 2021 estimate incidence highdose use identify associated factors used French National Health Data System retrospective populationbased cohort study included new user pregabalin gabapentin aged 18 year older two separate cohorts defined new user patient least three dispensings either pregabalin gabapentin within 12month period first dispensing occurring January 1 2017 December 31 2021 dispensing previous 12 months used highdose use proxy potential abuse misuse defined highdose use exposure average daily dose exceeding maximum recommended dose followed patient 24 months Then calculated cumulative incidence highdose use cohort Finally identified factor associated highdose use cohort using Cox models included 898887 new user pregabalin 271832 new user gabapentin Since 2020 monthly number new user pregabalin decreased monthly number new user gabapentin increased cohorts median age 64 years 60 patient women Incidence rate 260 95 CI 258 263 per 1000 personyears highdose use pregabalin 100 97 103 per 1000 personyears highdose use gabapentin treatment episode highdose use identified patient pregabalin cohort used higher daily dos gabapentin cohort main factor associated highdose use pregabalin gabapentin included prior exposure gabapentinoid prior exposure opioid agonist treatments prior exposure strong opioid analgesics younger age man paraplegia active cancers higher number prescribers Prescribers exercise extra caution initiating gabapentinoids patient risk highdose use study part METEOR study funded EPIPHARE httpswwwepipharefr",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823189/"
    },
    {
        "pmid": "40823182",
        "title": "Meta-analysis of clinical efficacy and safety of immunotherapy combined with chemotherapy in non-small cell lung cancer.",
        "abstract": "study aimed assess clinical effectiveness safety combining immunotherapy chemotherapy nonsmall cell lung cancer comprehensive search study published January 2024 conducted Quality assessment performed using NOS scale metaanalysis carried RevMan 541 software Heterogeneity assessed using iQitest combined effect calculated fixed random effect models Results visualized using forest plots sensitivity analysis performed 1061 sources 11 met inclusion criteria metaanalysis indicated combination treatment significantly improved 1year overall survival objective response rate disease control rate compared chemotherapy alone iPi  005 significant difference adverse reaction iPi  005 Immune function marker CD4 CD4CD8 higher CD8 lower combined treatment group Sensitivity analysis confirmed stability reliability result OR 95 CI 372 234590 iPi  000001 although publication bias indicated funnel plots combination chemotherapy immunotherapy exhibit potential enhance survival rate clinical effectiveness without concomitant rise severe adverse reactions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823182/"
    },
    {
        "pmid": "40823177",
        "title": "Plasma proteomic signature for preoperative prediction of microvascular invasion in HCC.",
        "abstract": "Microvascular invasion MVI major determinant poor prognosis hepatocellular carcinoma HCC However reliable noninvasive biomarkers preoperative evaluation diagnosis MVI urgently needed clinical practice Plasma sample collected 160 patient HCC 80 MVIpositive 80 MVInegative four medical centers Plasma proteomic profiling obtained using dataindependent acquisition mass spectrometry Principal component analysis differential protein abundance analysis used assess proteomic change two group patients Protein biomarker candidate quantitatively validated ELISA Proteomic analysis 50 patient HCC 25 MVIpositive 25 MVInegative identified three plasma protein biomarkers TALDO1 PDIA3 PGK1 significantly upregulated MVIpositive patient FDRadjusted ipi 005 subsequently crossvalidated ELISA machine learningbased bPblasma pbRbotein MVbIb risk bMbodel PRIM developed preoperative prediction MVI PRIM demonstrated excellent discriminatory ability area receiver operating characteristic curve value ranging 078 099 across three independent cohorts Singlecell RNA sequencing five HCC tumor provided cell typeresolved atlas biomarker expression showing predominant presence malignant cell macrophage within MVIpositive tumor microenvironment compared MVInegative tumors study provides comprehensive analysis plasma proteomic landscape HCC present promising bloodbased tool preoperative MVI risk stratification study highlight transformative potential plasma proteomic profiling improving preoperative prediction microvascular invasion hepatocellular carcinoma HCC integrating dataindependent acquisition mass spectrometry machine learning identified three plasma protein biomarkers TALDO1 PDIA3 PGK1 developed Plasma pRotein MVI risk Model PRIM demonstrated robust diagnostic accuracy across multicenter validation cohorts finding pave way preoperative risk stratification personalized therapeutic strategy HCC management",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823177/"
    },
    {
        "pmid": "40823170",
        "title": "Genome-wide meta-analysis identifies nine loci associated with higher risk of hepatocellular carcinoma development.",
        "abstract": "genetic underpinnings hepatocellular carcinoma HCC remain largely unknown Thus aimed identify new genetic risk locus HCC performed genomewide association study GWAS metaanalysis 11 cohort validation two independent cohorts identified variant tested effect hepatobiliary endpoints incident HCC stratified underlying risk factors Mendelian randomization used assess causal effect range trait risk HCC metaanalyses totaling 6540 case 2096759 controls identified 10 association HCC five in iKLF15i iHSD17B13i iAPOEi iHFEi iMTARC1i previously implicated HCC genomewide statistical significance Known association iPNPLA3i iTM6SF2i iTERTi iIFNL4i iHLADP1i confirmed association except iKLF15i validated independent cohort totaling 7630 case 733689 controls largest perallele effect seen iTM6SF2i beta  061 followed iPNPLA3i 055 iHFEi 045 iIFNL4i 031 iAPOEi 027 iHSD17B13i iHLADP1i iTERTi all 021 iMTARC1i 017 identified variant comparable effect incident HCC individual prevalent obesity high alcohol intake diabetes cirrhosis Mendelian randomization analysis confirmed causal role obesity HCC found strong correlation genetic effect HCC hepatic steatosis rsup2sup  075 HCC cirrhosis rsup2sup  069 whereas three locus iAPOEi iHFEi iTERTi concordant effect HCC biliary tract cancer identified validated nine genetic variant associated increased risk HCC development genetic underpinnings HCC remain largely unknown genomewide association metaanalysis totaling 6540 case HCC 21 million controls identified validated nine genetic locus associate risk HCC deeper insight genetic factor affect risk HCC could improve ability predict ultimately prevent treat deadly cancer",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823170/"
    },
    {
        "pmid": "40823168",
        "title": "Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma.",
        "abstract": "aimed assess safety diagnosticprognostic value tumor nontumor biopsy systematically collected radiofrequency ablation RFA hepatocellular carcinoma HCC prospectively included patient first diagnosis HCC underwent tumor nontumor biopsy percutaneous RFA 2015 2021 analyzed complications percentage diagnostic tumor biopsies ability perform molecular biology nontumor liver biopsy results correlated histology prior noninvasive diagnosis oncological outcomes total 248 patient 86 male median age 68 302 tumor treated RFA available tumor biopsy included HCC single 78 bifocal 21 patients median size 24 mm Bleeding occurred six case 19 without related deaths Biopsies enabled HCC diagnosis 66 cases positivity linked nodule size ipi 00001 location ipi  004 ultrasound visibility ipi  0004 discrepancy prior tumor board subsequent histological diagnosis observed 5 cases Among 302 biopsies 34 nondiagnostic 61 HCC 3 cholangiocarcinoma CCAhepatocholangiocarcinoma cHCCCCA 2 dysplastic nodules Survival shorter patient CCAcHCCCCA ipi 0001 Macrotrabecularmassive HCC associated higher rate global tumor recurrence ipi  0037 25 tumor cell paraffinembedded sample associated expression cancer gene transcriptomic analysis corresponding frozen samples assuring usefulness molecular analysis nontumor biopsies cirrhosis histologically confirmed 82 cases 15 discrepancy diagnosis cirrhosis tumor board biopsy Systematic tumor nontumor biopsy RFA first diagnosis HCC feasible safe brings valuable diagnostic therapeutic prognostic data Tumor nontumor biopsy radiofrequency ablation hepatocellular carcinoma safe feasible low complication rate procedurerelated deaths demonstrated diagnostic utility biopsies revealing discrepancy 5 case tumor board histological results could refine patient management strategies identified significant association hepatocellular carcinoma subtypes recurrence rates found molecular analysis based frozen tumor sample feasible case could guided percentage tumor cell paraffinembedded samples",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823168/"
    },
    {
        "pmid": "40823119",
        "title": "Bacterial Synergism in Breast Necrotizing Fasciitis: A Case Report on Diagnostic Dilemmas, Therapeutic Challenges, and Reconstructive Management.",
        "abstract": "bIntroductionb Necrotizing fasciitis NF rapidly progressive lifethreatening soft tissue infection primarily involves fascia subcutaneous tissues typically affect extremities perineum trunk NF breast remains exceptionally rare underdiagnosed entity often leading delayed intervention high morbidity bCase Presentationb report case 57yearold woman poorly controlled Type 2 diabetes presented emergency department diabetic ketoacidosis erythema left breast Initial arterial blood gas analysis revealed profound metabolic acidosis pH 689 PaCOsub2sub 128 mmHg bicarbonate 25 mmolL base excess 315 mmolL Despite initial antibiotic therapy breast symptom worsened raising concern inflammatory breast cancer Imaging revealed subcutaneous emphysema extensive soft tissue inflammation diagnosis NF confirmed prompting emergency surgical intervention left mastectomy performed resection necrotic fascia pectoralis major Microbiological culture identified polymicrobial infection iEscherichia colii iCitrobacteri iActinotignum schaaliii patient received targeted antibiotic therapy supportive care including pain management fluidelectrolyte balance Reconstruction initiated 8 month later contralateral breast reduction fat grafting bDiscussionb Breast NF pose significant diagnostic challenge due organs unique vascular anatomy rarity condition Delays diagnosis fatal case underscore importance clinical vigilance prompt imaging early surgical debridement synergistic effect polymicrobial infection evident rapid progression Reconstruction remains essential component care satisfactory outcome achievable fat grafting symmetry procedures bConclusionb Breast NF requires rapid diagnosis aggressive multidisciplinary management case illustrates need increased awareness reduce diagnostic delay improve survival reconstructive outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823119/"
    },
    {
        "pmid": "40823100",
        "title": "Strengthening Collaborations in Latin America for Advancing Oral cancer research and public health policies.",
        "abstract": "Oral cancer OC represents significant public health challenge Latin America similar challenge presented country region Regional partnership needed enhance development educational campaigns prevention strategy addressing shared risk factors institutional strengthening Additionally expanding collaboration attract international funding integrate LAC researcher global initiatives review examines state OC research region highlighting collaborative efforts gaps opportunity advancement identified 17 study studied different aspect oral cancer Latin American country LAC Studies varied design ecological study case series common study focused purely OC research oral potentially malignant disorder OPMD remains limited Collaborative study increased past decade growing focus regional risk factor tobacco alcohol use Despite advances challenge persist including limited epidemiological data underreporting cases inadequate public health infrastructure Collaborative network potential reduce gap pooling resources expertise data Improved public health policy supported robust local data crucial reducing OC burden LAC Strengthening regional international collaboration fundamental advancement OC research improving early detection implementing effective prevention treatment strategy tailored regions unique challenges bKey wordsbOral cancer mouth neoplasms Latin America oral potentially malignant disorders",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823100/"
    },
    {
        "pmid": "40823094",
        "title": "Pembrolizumab for treatment-related neuroendocrine prostate carcinoma with a high tumor mutational burden: a case report.",
        "abstract": "Pembrolizumab emerged significant therapeutic option treatment solid tumor high tumor mutational burden TMBhigh However report use treatmentrelated neuroendocrine prostate carcinoma tNEPC TMBhigh present case 66yearold man metastatic prostate cancer adenocarcinoma Gleason score 4  5 initial prostatespecific antigen PSA level 267 ngmL clinical stage T3bN0M1b initially treated doublet therapy including apalutamide leuprorelin leading reduction circulating level PSA  0001 ngmL However 35 month diagnosis retroperitoneal mass developed neuronspecific enolase NSE level elevated 626 ngmL Computed tomographyguided biopsy tumor confirmed metastasis tNEPC genetic profiling revealed TMBhigh status Pembrolizumab treatment initiated 39month diagnosis 41month diagnosis 75 reduction retroperitoneal mass decrease NSE level 31 ngmL observed case suggests pembrolizumab potential treatment option tNEPCs TMBhigh",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823094/"
    },
    {
        "pmid": "40823091",
        "title": "Arginine methylation regulates Ewing sarcoma cell viability in a <i>EWSR1::FLI1</i> dependent manner and provides a therapeutic opportunity.",
        "abstract": "Ewing sarcoma rare type cancer arising bone soft tissue mainly affecting child young adults Treatments include intensive chemotherapy surgery radiotherapy however 30 patient die disease Direct drug targeting EWSFLI1 remains significant challenge therefore new approach urgently required Analysis iPRMT1i iPRMT5i transcript expression using R2 platform focusing Filion dataset sarcoma includes Ewing sarcoma patient alongside fusionpositive sarcoma breast lung cancer datasets Immunoblotting across panel Ewing sarcoma cell line detected PRMT1 PRMT5 expression associated activity Cell viability assay PRMT inhibition without olaparib conducted trypan blue exclusion MTT assay DNA damage detected immunofluorescence staining marker DNA damage γH2AX doublestrand break 53BP1 show expression activity arginine methyltransferases PRMT1 PRMT5 elevated Ewing sarcoma inhibition PRMT1 PRMT5 preclinical inhibitor lead growth arrest apoptosis dependent expression driver oncogene iEWSR1FLI1i Mechanically show PRMT1 PRMT5 inhibitor promote DNA damage PRMT5 inhibitor synergise PARP inhibitor olaparib induce elevated DNA damage reduced cell viability study implies PRMT1PRMT5 important mediator iEWSR1FLI1i oncogenicity drug targeting PRMT1PRMT5 combination DNA damaging chemotherapy could effective therapeutic strategy treatment ES patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823091/"
    },
    {
        "pmid": "40823089",
        "title": "Risk modeling for esophageal cancer based on adaptive Lasso and Cox regression.",
        "abstract": "Esophageal cancer EC one aggressive tumor type worldwide malnutrition extremely common among EC patients identifying EC biomarkers conducting risk assessment patients accurate diagnosis treatment plan developed prolong patients survival study developed risk assessment model postsurgical EC patient using clinical data patient underwent esophagectomy Prognostic factor influencing survival evaluated using Adaptive Lasso variable selection followed Cox proportional hazard regression Receiver Operating Characteristic ROC curve Among multiple clinical variables International Normalized Ratio INR emerged significant predictor survival Elevated INR level significantly associated improved 3year 5year survival outcome compared Prognostic Nutritional Index PNI Patients higher INR exhibited notably better postoperative survival rates analysis demonstrated INR significantly correlated final differentiation degree final infiltration degree final positivenegative status EC INR serf valuable independent prognostic biomarker postoperative survival assessment EC patients Incorporating INR clinical risk model enhance accuracy prognosis assist clinician optimizing individualized therapeutic strategy surgical EC patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823089/"
    },
    {
        "pmid": "40823087",
        "title": "Small-molecule and peptide inhibitors of m6A regulators.",
        "abstract": "N6methyladenosine m6A reversible mRNA modification play important role malignant tumor processes m6A modification emerged significant research focus Studies function mechanism m6A regulatory factor across various tumor grown increasingly comprehensive indepth Accumulating evidence demonstrated m6A modification associated regulatory protein serve biomarkers cancer treatment prognosis Consequently surge research development application m6A regulatory factor inhibitors particularly regarding efficacy mechanism tumor therapy advancement enhance understanding therapeutic potential diverse cancer also facilitate integration existing treatments accelerating design effective specific selective inhibitors effort hold promise advancing m6Atargeted pharmaceutical development promoting clinical applications review summarizes smallmolecule peptide inhibitor m6A regulator malignant tumors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823087/"
    },
    {
        "pmid": "40823086",
        "title": "Applications of 3D models in cholangiocarcinoma.",
        "abstract": "prognosis patient diagnosed cholangiocarcinoma CCA dismal overall 5yearmortality rate 80 Therapeutic approach cancer limited curative treatment total surgical resection despite recent advancement CCA research However minority patient eligible surgery due latestage diagnosis Therefore urgent need gain deeper understanding CCA discover new treatments achieved utilization optimization 3D tumor models Traditional 2D cell culture still undeniably important cancer research especially discovery biomarkers drug screening However classical 2D tumor model represent tumor biology full complexity lack vital interaction cancer cells angiogenesis tumor microenvironment recent years 3D models including spheroids 3D coculture systems organoids tumorsonachip iin vivoi chorioallantoic membrane CAM model used CCA research model enable study tumor microenvironment investigation metastases drug development testing cholangiocarcinogenesis personalized therapy review summarizes application different 3D tumor model used investigation CCA Moreover advantage disadvantage different 3D tumor model discussed suggestion future research possibility described optimizing 3D models gap basic research finding clinical application bridged enabling discovery effective therapy CCA cancers",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823086/"
    },
    {
        "pmid": "40823084",
        "title": "Multiple surgical interventions improve survival in locally recurrent retroperitoneal sarcoma: a retrospective cohort analysis.",
        "abstract": "Locally recurrent retroperitoneal sarcoma RPS pose substantial clinical challenges especially patient experiencing multiple recurrences study aim evaluate survival benefit conferred repeated surgical resection management recurrent RPS retrospective cohort study conducted involving 56 patient underwent repeated surgical resection locally recurrent RPS institution June 2016 September 2023 Demographic clinical histopathological variables including age sex tumor differentiation FNCLCC grade prior radiotherapy chemotherapy surgical margin status postoperative complication were collected analyzed Survival outcome assessed using KaplanMeier estimate Cox proportional hazard models median age cohort 53 year range 2872 maletofemale ratio 3026 Compared single resection median overall survival OS improved successive surgeries 793 month two surgeries 1580 month three 1817 month four However OS declined 1219 month following five resections Tumor differentiation FNCLCC grade significantly associated survival outcomes Multivariate analysis identified age pathological subtype tumor grade number surgery independent prognostic factors Although severe adverse event SAEs recorded 30day postoperative mortality occurred Repeated surgical resection appears confer substantial survival benefit patient locally recurrent RPS underscoring clinical value surgical management selected cases finding highlight importance individualized surgical strategies emphasizing need investigation optimize treatment paradigms",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823084/"
    }
]